Section 53

EurekaMag PDF full texts Chapter 52,092


Jung, H.J.; Suh, Y. 2014: Circulating mi RNAs in ageing and ageing-related diseases. Journal of Genetics and Genomics 41(9): 465-472
Punga, T.; Le Panse, R.; Andersson, M.; Truffault, F.éd.ér.; Berrih-Aknin, S.; Punga, A.R. 2014: Circulating mi RNAs in myasthenia gravis: miR-150-5p as a new potential biomarker. Annals of Clinical and Translational Neurology 1(1): 49-58
Leuenberger, N.; Robinson, N.; Saugy, M. 2013: Circulating miRNAs: a new generation of anti-doping biomarkers. Analytical and Bioanalytical Chemistry 405(30): 9617-9623
Turchinovich, A.; Samatov, T.R.; Tonevitsky, A.G.; Burwinkel, B. 2013: Circulating miRNAs: cell-cell communication function?. Frontiers in Genetics 4: 119
Egea, V.; Schober, A.; Weber, C. 2012: Circulating miRNAs: messengers on the move in cardiovascular disease. Thrombosis and Haemostasis 108(4): 590-591
Pleister, A.; Selemon, H.; Elton, S.M.; Elton, T.S. 2013: Circulating miRNAs: novel biomarkers of acute coronary syndrome?. Biomarkers in Medicine 7(2): 287-305
Qu, H.; Xu, W.; Huang, Y.; Yang, S. 2011: Circulating miRNAs: promising biomarkers of human cancer. Asian Pacific Journal of Cancer Prevention: Apjcp 12(5): 1117-1125
Cheng, G. 2015: Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. Advanced Drug Delivery Reviews 81: 75-93
Heegaard, N.H.H.; Schetter, A.J.; Welsh, J.A.; Yoneda, M.; Bowman, E.D.; Harris, C.C. 2012: Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. International Journal of Cancer 130(6): 1378-1386
Schrauder, M.G.; Strick, R.; Schulz-Wendtland, R.üd.; Strissel, P.L.; Kahmann, L.; Loehberg, C.R.; Lux, M.P.; Jud, S.M.; Hartmann, A.; Hein, A.; Bayer, C.M.; Bani, M.R.; Richter, S.; Adamietz, B.R.; Wenkel, E.; Rauh, C.; Beckmann, M.W.; Fasching, P.A. 2012: Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. Plos one 7(1): E29770
Molitoris, J.K.; Molitoris, B.A. 2011: Circulating micro-RNAs in acute kidney injury: early observations. Clinical Journal of the American Society of Nephrology: Cjasn 6(7): 1517-1519
Clarke, J.D.; Sharapova, T.; Lake, A.D.; Blomme, E.; Maher, J.; Cherrington, N.J. 2014: Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis. Journal of Applied Toxicology: Jat 34(6): 726-732
Qu, X.; Zhao, M.; Wu, S.; Yu, W.; Xu, J.; Xu, J.; Li, J.; Chen, L. 2014: Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma. Medical Oncology 31(10): 219
Rekker, K.; Saare, M.; Roost, A.M.; Salumets, A.; Peters, M. 2013: Circulating microRNA Profile throughout the menstrual cycle. Plos one 8(11): E81166
Oyama, R.; Jinnin, M.; Kakimoto, A.; Kanemaru, H.; Ichihara, A.; Fujisawa, A.; Honda, N.; Masuguchi, S.; Fukushima, S.; Maruo, K.; Ihn, H. 2011: Circulating microRNA associated with TNF-α signaling pathway in patients with plaque psoriasis. Journal of Dermatological Science 61(3): 209-211
Witwer, K.W. 2015: Circulating microRNA biomarker studies: pitfalls and potential solutions. Clinical Chemistry 61(1): 56-63
Hafizi, R.; Tersoff, J.; Perebeinos, V. 2017: Band Structure and Contact Resistance of Carbon Nanotubes Deformed by a Metal Contact. Physical Review Letters 119(20): 207701
Zhao, S.; Zhong, Y.; Jiang, Y.-H.; Yi, Z.-W. 2013: Circulating microRNA expression in children with idiopathic short stature. Zhongguo Dang Dai Er Ke Za Zhi 15(12): 1104-1108
Lai, C.T.M.; Ng, E.K.O.; Chow, P-cheong.; Kwong, A.; Cheung, Y-fai. 2013: Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries. BMC cardiovascular disorders 13: 73
Xu, Y.; Zhang, X.; Pu, S.; Wu, J.; Lv, Y.; Du, D. 2014: Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions. Acta Biochimica et Biophysica Sinica 46(11): 942-949
Ayaz, L.; Çayan, F.; Balci, Ş; Görür, A.; Akbayir, S.; Yıldırım Yaroğlu, H.; Doğruer Unal, N.; Tamer, L. 2014: Circulating microRNA expression profiles in ovarian cancer. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 34(7): 620-624
Zhang, J.; Zhang, K.; Bi, M.; Jiao, X.; Zhang, D.; Dong, Q. 2014: Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy. Anti-Cancer Drugs 25(3): 346-352
Hanson, E.K.; Ballantyne, J. 2013: Circulating microRNA for the identification of forensically relevant body fluids. Methods in Molecular Biology 1024: 221-234
Kosaka, N.; Iguchi, H.; Ochiya, T. 2010: Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Science 101(10): 2087-2092
Ichikawa, D.; Komatsu, S.; Konishi, H.; Otsuji, E. 2012: Circulating microRNA in digestive tract cancers. Gastroenterology 142(5): 1074-1078.E1
Zahm, A.M.; Hand, N.J.; Boateng, L.A.; Friedman, J.R. 2012: Circulating microRNA is a biomarker of biliary atresia. Journal of Pediatric Gastroenterology and Nutrition 55(4): 366-369
Zahm, A.M.; Thayu, M.; Hand, N.J.; Horner, A.; Leonard, M.B.; Friedman, J.R. 2011: Circulating microRNA is a biomarker of pediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition 53(1): 26-33
Yan, S.; Wang, J.; Zhang, W.; Dai, J. 2014: Circulating microRNA profiles altered in mice after 28 d exposure to perfluorooctanoic acid. Toxicology Letters 224(1): 24-31
Sluijter, J.P.G.; Doevendans, P.A. 2013: Circulating microRNA profiles for detection of peripheral arterial disease: small new biomarkers for cardiovascular disease. CIRCULATION. Cardiovascular Genetics 6(5): 441-443
Ward, J.; Kanchagar, C.; Veksler-Lublinsky, I.; Lee, R.C.; McGill, M.R.; Jaeschke, H.; Curry, S.C.; Ambros, V.R. 2014: Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis. Proceedings of the National Academy of Sciences of the United States of America 111(33): 12169-12174
Cheng, H.H.; Mitchell, P.S.; Kroh, E.M.; Dowell, A.E.; Chéry, L.; Siddiqui, J.; Nelson, P.S.; Vessella, R.L.; Knudsen, B.S.; Chinnaiyan, A.M.; Pienta, K.J.; Morrissey, C.; Tewari, M. 2013: Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia. Plos one 8(7): E69239
Joerger, M.; Baty, F.; Früh, M.; Droege, C.; Stahel, R.A.; Betticher, D.C.; von Moos, R.; Ochsenbein, A.; Pless, M.; Gautschi, O.; Rothschild, S.; Brauchli, P.; Klingbiel, D.; Zappa, F.; Brutsche, M. 2014: Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer 85(2): 306-313
Pirola, C.J.; Fernández Gianotti, T.; Castaño, G.O.; Mallardi, P.; San Martino, J.; Mora Gonzalez Lopez Ledesma, M.ía.; Flichman, D.; Mirshahi, F.; Sanyal, A.J.; Sookoian, S. 2015: Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut 64(5): 800-812
Fesler, A.; Jiang, J.; Zhai, H.; Ju, J. 2014: Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients. Molecular Diagnosis and Therapy 18(3): 303-308
Ai, J.; Zhang, R.; Li, Y.; Pu, J.; Lu, Y.; Jiao, J.; Li, K.; Yu, B.; Li, Z.; Wang, R.; Wang, L.; Li, Q.; Wang, N.; Shan, H.; Li, Z.; Yang, B. 2010: Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and Biophysical Research Communications 391(1): 73-77
Fu, Y.; Wei, X.; Tang, C.; Li, J.; Liu, R.; Shen, A.; Wu, Z. 2013: Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Oncology Letters 6(6): 1811-1815
Ding, X.; Ding, J.; Ning, J.; Yi, F.; Chen, J.; Zhao, D.; Zheng, J.; Liang, Z.; Hu, Z.; Du, Q. 2012: Circulating microRNA-122 as a potential biomarker for liver injury. Molecular Medicine Reports 5(6): 1428-1432
Luo, J.; Chen, M.; Huang, H.; Yuan, T.; Zhang, M.; Zhang, K.; Deng, S. 2013: Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma. Oncotargets and Therapy 6: 577-583
Roderburg, C.; Luedde, M.; Vargas Cardenas, D.; Vucur, M.; Scholten, D.; Frey, N.; Koch, A.; Trautwein, C.; Tacke, F.; Luedde, T. 2013: Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. Plos one 8(1): E54612
Chen, Q.; Yang, L.; Xiao, Y.; Zhu, J.; Li, Z. 2014: Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer. Medical Oncology 31(11): 225
Zhong, J.; He, Y.; Chen, W.; Shui, X.; Chen, C.; Lei, W. 2014: Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarction. International Journal of Molecular Sciences 15(11): 20355-20364
Ren, W.; Qiang, C.; Gao, L.; Li, S.-M.; Zhang, L.-M.; Wang, X.-L.; Dong, J.-W.; Chen, C.; Liu, C.-Y.; Zhi, K.-Q. 2014: Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 19(7): 590-596
Tomimaru, Y.; Eguchi, H.; Nagano, H.; Wada, H.; Kobayashi, S.; Marubashi, S.; Tanemura, M.; Tomokuni, A.; Takemasa, I.; Umeshita, K.; Kanto, T.; Doki, Y.; Mori, M. 2012: Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. Journal of Hepatology 56(1): 167-175
Wang, Z.; Han, J.; Cui, Y.; Fan, K.; Zhou, X. 2013: Circulating microRNA-21 as noninvasive predictive biomarker for response in cancer immunotherapy. Medical Hypotheses 81(1): 41-43
Wang, H.; Lin, Y.-z.; Lu, H.-m.; Zhou, Y.; Luo, C.; Lu, S.-h.; Zhao, L.; Liu, F. 2011: Circulating microRNA-92a in patients with ST-segment elevation myocardial infarction. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23(12): 718-722
Wang, G.-K.; Zhu, J.-Q.; Zhang, J.-T.; Li, Q.; Li, Y.; He, J.; Qin, Y.-W.; Jing, Q. 2010: Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal 31(6): 659-666
Jin, H.; Li, C.; Ge, H.; Jiang, Y.; Li, Y. 2013: Circulating microRNA: a novel potential biomarker for early diagnosis of intracranial aneurysm rupture a case control study. Journal of Translational Medicine 11: 296
Qi, J.; Wang, J.; Katayama, H.; Sen, S.; Liu, S.M. 2013: Circulating micro RNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma 60(2): 135-142
Nabiałek, E.; Wańha, W.; Kula, D.; Jadczyk, T.; Krajewska, M.; Kowalówka, A.; Dworowy, S.; Hrycek, E.; Włudarczyk, W.; Parma, Z.; Michalewska-Włudarczyk, A.; Pawłowski, T.; Ochała, B.; Jarząb, B.; Tendera, M.; Wojakowski, W. 2013: Circulating micro RNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease. Minerva Cardioangiologica 61(6): 627-637
Mahn, R.; Heukamp, L.C.; Rogenhofer, S.; von Ruecker, A.; Müller, S.C.; Ellinger, J.ör. 2011: Circulating micro RNAs (miRNA) in serum of patients with prostate cancer. Urology 77(5): 1265.E9-16
Olivieri, F.; Antonicelli, R.; Capogrossi, M.C.; Procopio, A.D. 2013: Circulating micro RNAs (miRs) for diagnosing acute myocardial infarction: an exciting challenge. International Journal of Cardiology 167(6): 3028-3029
Lippi, G.; Mattiuzzi, C.; Cervellin, G. 2013: Circulating micro RNAs (miRs) for diagnosing acute myocardial infarction: meta-analysis of available studies. International Journal of Cardiology 167(1): 277-278
Stammet, P.; Goretti, E.; Vausort, M.él.; Zhang, L.; Wagner, D.R.; Devaux, Y. 2012: Circulating micro RNAs after cardiac arrest. Critical Care Medicine 40(12): 3209-3214
Bye, A.; Røsjø, H.; Aspenes, S.T.; Condorelli, G.; Omland, T.ør.; Wisløff, U. 2013: Circulating micro RNAs and aerobic fitness--the HUNT-Study. Plos one 8(2): E57496
Egidi, M.G.; Cochetti, G.; Serva, M.R.; Guelfi, G.; Zampini, D.; Mechelli, L.; Mearini, E. 2013: Circulating micro RNAs and kallikreins before and after radical prostatectomy: are they really prostate cancer markers?. Biomed Research International 2013: 241780
D'Alessandra, Y.; Devanna, P.; Limana, F.; Straino, S.; Di Carlo, A.; Brambilla, P.G.; Rubino, M.; Carena, M.C.; Spazzafumo, L.; De Simone, M.; Micheli, B.; Biglioli, P.; Achilli, F.; Martelli, F.; Maggiolini, S.; Marenzi, G.; Pompilio, G.; Capogrossi, M.C. 2010: Circulating micro RNAs are new and sensitive biomarkers of myocardial infarction. European Heart Journal 31(22): 2765-2773
Martino, F.; Lorenzen, J.; Schmidt, J.; Schmidt, M.; Broll, M.; Görzig, Y.; Kielstein, J.T.; Thum, T. 2012: Circulating micro RNAs are not eliminated by hemodialysis. Plos one 7(6): E38269
Wang, R.; Li, N.; Zhang, Y.; Ran, Y.; Pu, J. 2011: Circulating micro RNAs are promising novel biomarkers of acute myocardial infarction. Internal Medicine 50(17): 1789-1795
Chen, Y.-J.; Zhu, J.-M.; Wu, H.; Fan, J.; Zhou, J.; Hu, J.; Yu, Q.; Liu, T.-T.; Yang, L.; Wu, C.-L.; Guo, X.-L.; Huang, X.-W.; Shen, X.-Z. 2013: Circulating micro RNAs as a Fingerprint for Liver Cirrhosis. Plos one 8(6): E66577
Wang, L.; Chen, Y.-J.; Xu, K.; Xu, H.; Shen, X.-Z.; Tu, R.-Q. 2014: Circulating micro RNAs as a fingerprint for endometrial endometrioid adenocarcinoma. Plos one 9(10): E110767
Anadol, E.; Schierwagen, R.; Elfimova, N.; Tack, K.; Schwarze-Zander, C.; Eischeid, H.; Noetel, A.; Boesecke, C.; Jansen, C.; Dold, L.; Wasmuth, J.-C.; Strassburg, C.P.; Spengler, U.; Rockstroh, J.ür.K.; Odenthal, M.; Trebicka, J. 2015: Circulating micro RNAs as a marker for liver injury in human immunodeficiency virus patients. Hepatology 61(1): 46-55
Wang, R.; Wen, H.; Xu, Y.; Chen, Q.; Luo, Y.; Lin, Y.; Luo, Y.; Xu, A. 2014: Circulating micro RNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles. Plos one 9(11): E113401
Gupta, S.K.; Bang, C.; Thum, T. 2010: Circulating micro RNAs as biomarkers and potential paracrine mediators of cardiovascular disease. CIRCULATION. Cardiovascular Genetics 3(5): 484-488
Leuenberger, N.; Schumacher, Y.O.; Pradervand, S.; Sander, T.; Saugy, M.; Pottgiesser, T. 2013: Circulating micro RNAs as biomarkers for detection of autologous blood transfusion. Plos one 8(6): E66309
Qu, K.Z.; Zhang, K.; Li, H.; Afdhal, N.H.; Albitar, M. 2011: Circulating micro RNAs as biomarkers for hepatocellular carcinoma. Journal of Clinical Gastroenterology 45(4): 355-360
Sepramaniam, S.; Tan, J.-R.; Tan, K.-S.; DeSilva, D.A.; Tavintharan, S.; Woon, F.-P.; Wang, C.-W.; Yong, F.-L.; Karolina, D.-S.; Kaur, P.; Liu, F.-J.; Lim, K.-Y.; Armugam, A.; Jeyaseelan, K. 2014: Circulating micro RNAs as biomarkers of acute stroke. International Journal of Molecular Sciences 15(1): 1418-1432
Peng, Q.; Huang, W.; John-Baptiste, A. 2014: Circulating micro RNAs as biomarkers of retinal toxicity. Journal of Applied Toxicology: Jat 34(6): 695-702
Ajit, S.K. 2012: Circulating micro RNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors 12(3): 3359-3369
Steer, C.J.; Subramanian, S. 2012: Circulating micro RNAs as biomarkers: a new frontier in diagnostics. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 18(3): 265-269
Roth, C.; Rack, B.; Müller, V.; Janni, W.; Pantel, K.; Schwarzenbach, H. 2010: Circulating micro RNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Research: Bcr 12(6): R90
Wang, H.; Peng, W.; Ouyang, X.; Li, W.; Dai, Y. 2012: Circulating micro RNAs as candidate biomarkers in patients with systemic lupus erythematosus. Translational Research: the Journal of Laboratory and Clinical Medicine 160(3): 198-206
Roderburg, C.; Luedde, T. 2014: Circulating micro RNAs as markers of liver inflammation, fibrosis and cancer. Journal of Hepatology 61(6): 1434-1437
Li, J.; Xu, J.; Cheng, Y.; Wang, F.; Song, Y.; Xiao, J. 2013: Circulating micro RNAs as mirrors of acute coronary syndromes: MiRacle or quagMire?. Journal of Cellular and Molecular Medicine 17(11): 1363-1370
Cortez, M.A.; Welsh, J.W.; Calin, G.A. 2012: Circulating micro RNAs as noninvasive biomarkers in breast cancer. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 195: 151-161
Li, C.; Pei, F.; Zhu, X.; Duan, D.D.; Zeng, C. 2012: Circulating micro RNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clinical Biochemistry 45(10-11): 727-732
Willeit, P.; Zampetaki, A.; Dudek, K.; Kaudewitz, D.; King, A.; Kirkby, N.S.; Crosby-Nwaobi, R.; Prokopi, M.; Drozdov, I.; Langley, S.R.; Sivaprasad, S.; Markus, H.S.; Mitchell, J.A.; Warner, T.D.; Kiechl, S.; Mayr, M. 2013: Circulating micro RNAs as novel biomarkers for platelet activation. Circulation Research 112(4): 595-600
Deddens, J.C.; Colijn, J.M.; Oerlemans, M.I.F.J.; Pasterkamp, G.; Chamuleau, S.A.; Doevendans, P.A.; Sluijter, J.P.G. 2013: Circulating micro RNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. Journal of Cardiovascular Translational Research 6(6): 884-898
Heneghan, H.M.; Miller, N.; Lowery, A.J.; Sweeney, K.J.; Newell, J.; Kerin, M.J. 2010: Circulating micro RNAs as novel minimally invasive biomarkers for breast cancer. Annals of Surgery 251(3): 499-505
Wang, W.; Sun, G.; Zhang, L.; Shi, L.; Zeng, Y. 2014: Circulating micro RNAs as novel potential biomarkers for early diagnosis of acute stroke in humans. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 23(10): 2607-2613
Sui, W.; Lin, H.; Li, H.; Yan, Q.; Chen, J.; Dai, Y. 2014: Circulating micro RNAs as potential biomarkers for nephrotic syndrome. Iranian Journal of Kidney Diseases 8(5): 371-376
Huang, Y.; Dai, Y.; Zhang, J.; Wang, C.; Li, D.; Cheng, J.; Lu, Y.; Ma, K.; Tan, L.; Xue, F.; Qin, B. 2012: Circulating micro RNAs as potential biomarkers for smoking-related interstitial fibrosis. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 17(5): 435-440
Huang, F.; Huang, J-Ping.; Yin, R-Xing.; Wu, J-Zhen. 2013: Circulating micro RNAs as potential biomarkers for the early diagnosis of acute myocardial infarction: promises and challenges. International Journal of Cardiology 168(4): 4510-4511
Mooren, F.C.; Viereck, J.; Krüger, K.; Thum, T. 2014: Circulating micro RNAs as potential biomarkers of aerobic exercise capacity. American Journal of Physiology. Heart and Circulatory Physiology 306(4): H557-H563
Contu, R.; Latronico, M.V.G.; Condorelli, G. 2010: Circulating micro RNAs as potential biomarkers of coronary artery disease: a promise to be fulfilled?. Circulation Research 107(5): 573-574
Starkey Lewis, P.J.; Dear, J.; Platt, V.; Simpson, K.J.; Craig, D.G.N.; Antoine, D.J.; French, N.S.; Dhaun, N.; Webb, D.J.; Costello, E.M.; Neoptolemos, J.P.; Moggs, J.; Goldring, C.E.; Park, B.K. 2011: Circulating micro RNAs as potential markers of human drug-induced liver injury. Hepatology 54(5): 1767-1776
Ng, E.K.O.; Li, R.; Shin, V.Y.; Jin, H.C.; Leung, C.P.H.; Ma, E.S.K.; Pang, R.; Chua, D.; Chu, K.-M.; Law, W.L.; Law, S.Y.K.; Poon, R.T.P.; Kwong, A. 2013: Circulating micro RNAs as specific biomarkers for breast cancer detection. Plos one 8(1): E53141
Morley-Smith, A.C.; Mills, A.; Jacobs, S.; Meyns, B.; Rega, F.; Simon, A.é R.; Pepper, J.R.; Lyon, A.R.; Thum, T. 2014: Circulating micro RNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device. European Journal of Heart Failure 16(8): 871-879
Wang, Y-Ting.; Tsai, P-Chien.; Liao, Y-Chu.; Hsu, C-Y.; Juo, S-Hang.Hank. 2013: Circulating micro RNAs have a sex-specific association with metabolic syndrome. Journal of Biomedical Science 20: 72
Dorval, V.ér.; Nelson, P.T.; Hébert, S.éb.S. 2013: Circulating micro RNAs in Alzheimer's disease: the search for novel biomarkers. Frontiers in Molecular Neuroscience 6: 24
Wang, J.; Raimondo, M.; Guha, S.; Chen, J.; Diao, L.; Dong, X.; Wallace, M.B.; Killary, A.M.; Frazier, M.L.; Woodward, T.A.; Wang, J.; Sen, S. 2014: Circulating micro RNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. Journal of Cancer 5(8): 696-705
Yamada, H.; Itoh, M.; Hiratsuka, I.; Hashimoto, S. 2014: Circulating micro RNAs in autoimmune thyroid diseases. Clinical Endocrinology 81(2): 276-281
Zhu, W.; Qin, W.; Atasoy, U.; Sauter, E.R. 2009: Circulating micro RNAs in breast cancer and healthy subjects. Bmc Research Notes 2: 89
Zhou, L.; Zhao, Y.-P.; Liu, W.-J.; Dong, J.; Chen, W.-Y.; Zhang, T.-P.; Chen, G.; Shu, H. 2012: Circulating micro RNAs in cancer: diagnostic and prognostic significance. Expert Review of Anticancer Therapy 12(2): 283-288
Osaki, M.; Kosaka, N.; Okada, F.; Ochiya, T. 2014: Circulating micro RNAs in drug safety assessment for hepatic and cardiovascular toxicity: the latest biomarker frontier?. Molecular Diagnosis and Therapy 18(2): 121-126
Ji, F.; Yang, B.; Peng, X.; Ding, H.; You, H.; Tien, P. 2011: Circulating micro RNAs in hepatitis B virus-infected patients. Journal of Viral Hepatitis 18(7): E242-E251
Lorenzen, J.M.; Menne, J.; Schmidt, B.M.W.; Schmidt, M.; Martino, F.; Dietrich, R.; Samiri, S.; Worthmann, H.; Heeren, M.; Weissenborn, K.; Haller, H.; Schiffer, M.; Kielstein, J.T.; Thum, T. 2012: Circulating micro RNAs in patients with Shiga-Toxin-producing E. coli O104: H4 induced hemolytic uremic syndrome. Plos one 7(10): E47215
Cermelli, S.; Ruggieri, A.; Marrero, J.A.; Ioannou, G.N.; Beretta, L. 2011: Circulating micro RNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. Plos one 6(8): E23937
Fichtlscherer, S.; De Rosa, S.; Fox, H.; Schwietz, T.; Fischer, A.; Liebetrau, C.; Weber, M.; Hamm, C.W.; Röxe, T.; Müller-Ardogan, M.; Bonauer, A.; Zeiher, A.M.; Dimmeler, S. 2010: Circulating micro RNAs in patients with coronary artery disease. Circulation Research 107(5): 677-684
Celikbilek, M.; Baskol, M.; Taheri, S.; Deniz, K.; Dogan, S.; Zararsiz, G.; Gursoy, S.; Guven, K.; Ozbakır, O.; Dundar, M.; Yucesoy, M. 2014: Circulating micro RNAs in patients with non-alcoholic fatty liver disease. World Journal of Hepatology 6(8): 613-620
Ding, C.-F.; Chen, W.-Q.; Zhu, Y.-T.; Bo, Y.-L.; Hu, H.-M.; Zheng, R.-H. 2015: Circulating micro RNAs in patients with polycystic ovary syndrome. Human Fertility 18(1): 22-29
Zhang, H.; Su, Y.; Xu, F.; Kong, J.; Yu, H.; Qian, B. 2013: Circulating micro RNAs in relation to EGFR status and survival of lung adenocarcinoma in female non-smokers. Plos one 8(11): E81408
Yabushita, S.; Fukamachi, K.; Tanaka, H.; Sumida, K.; Deguchi, Y.; Sukata, T.; Kawamura, S.; Uwagawa, S.; Suzui, M.; Tsuda, H. 2012: Circulating micro RNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas. Pancreas 41(7): 1013-1018
Machida, A.; Ohkubo, T.; Yokota, T. 2013: Circulating micro RNAs in the cerebrospinal fluid of patients with brain diseases. Methods in Molecular Biology 1024: 203-209
Liu, M.; Guo, Y.-C.; Liu, X.-H. 2014: Circulating micro RNAs in vascular biology and endothelial dysfunction-related diseases. Sheng Li Ke Xue Jin Zhan 45(3): 167-171
Fan, K.-L.; Zhang, H.-F.; Shen, J.; Zhang, Q.; Li, X.-L. 2013: Circulating micro RNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian Heart Journal 65(1): 12-16
Li, P.; Zhang, Q.; Wu, X.; Yang, X.; Zhang, Y.; Li, Y.; Jiang, F. 2014: Circulating micro RNAs serve as novel biological markers for intracranial aneurysms. Journal of the American Heart Association 3(5): E000972
Seto, A.G.; van Rooij, E. 2012: Circulating micro RNAs to identify human heart failure. European Journal of Heart Failure 14(2): 118-119
Xu, J.; Wu, C.; Che, X.; Wang, L.; Yu, D.; Zhang, T.; Huang, L.; Li, H.; Tan, W.; Wang, C.; Lin, D. 2011: Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Molecular Carcinogenesis 50(2): 136-142
Chen, Y.; Yang, W.; Wang, G.-N.; Li, J.; Li, X.-R.; Zhang, J.; Yuan, W.; Wang, D.-W.; Zhang, J.-S.; Cao, K.-J. 2012: Circulating microRNAs, novel biomarkers of acute myocardial infarction: a systemic review. World Journal of Emergency Medicine 3(4): 257-260
Sukata, T.; Sumida, K.; Kushida, M.; Ogata, K.; Miyata, K.; Yabushita, S.; Uwagawa, S. 2011: Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicology Letters 200(1-2): 46-52
Wang, K.; Zhang, S.; Marzolf, B.; Troisch, P.; Brightman, A.; Hu, Z.; Hood, L.E.; Galas, D.J. 2009: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proceedings of the National Academy of Sciences of the United States of America 106(11): 4402-4407
Zhang, J.-S.; Qi, Y.-F.; Tang, C.-S. 2012: Circulating microRNAs--novel bioactive molecules regulating body homeostasis. Sheng Li Ke Xue Jin Zhan 43(5): 341-344
Reid, G.; Kirschner, M.B.; van Zandwijk, N. 2011: Circulating microRNAs: Association with disease and potential use as biomarkers. Critical Reviews in Oncology/Hematology 80(2): 193-208
Zen, K.; Zhang, C.-Y. 2012: Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Medicinal Research Reviews 32(2): 326-348
Sayed, A.S.M.; Xia, K.; Yang, T.-L.; Peng, J. 2013: Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction. Disease Markers 35(5): 561-566
Lindner, K.; Haier, J.; Wang, Z.; Watson, D.I.; Hussey, D.J.; Hummel, R. 2015: Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers. Clinical Science 128(1): 1-15
Blanco-Calvo, M.és.; Calvo, L.; Figueroa, A.él.; Haz-Conde, M.; Antón-Aparicio, L.; Valladares-Ayerbes, M. 2012: Circulating microRNAs: molecular microsensors in gastrointestinal cancer. Sensors 12(7): 9349-9362
Allegra, A.; Alonci, A.; Campo, S.; Penna, G.; Petrungaro, A.; Gerace, D.; Musolino, C. 2012: Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). International Journal of Oncology 41(6): 1897-1912
Bianchi, F.; Nicassio, F.; Veronesi, G.; di Fiore, P.P. 2012: Circulating microRNAs: next-generation biomarkers for early lung cancer detection. Ecancermedicalscience 6: 246
Creemers, E.E.; Tijsen, A.J.; Pinto, Y.M. 2012: Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circulation Research 110(3): 483-495
Xu, J.; Zhao, J.; Evan, G.; Xiao, C.; Cheng, Y.; Xiao, J. 2012: Circulating microRNAs: novel biomarkers for cardiovascular diseases. Journal of Molecular Medicine 90(8): 865-875
Zhou, S.-L.; Wang, L.-D. 2010: Circulating microRNAs: novel biomarkers for esophageal cancer. World Journal of Gastroenterology 16(19): 2348-2354
Gao, W.; Liu, L.; Lu, X.; Shu, Y. 2011: Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma. Clinical Lung Cancer 12(1): 14-17
Yu, D.-C.; Li, Q.-G.; Ding, X.-W.; Ding, Y.-T. 2011: Circulating microRNAs: potential biomarkers for cancer. International Journal of Molecular Sciences 12(3): 2055-2063
Heneghan, H.M.; Miller, N.; Kerin, M.J. 2011: Circulating microRNAs: promising breast cancer Biomarkers. Breast cancer research: BCR 13(1): 402; author reply 403
Elfimova, N.; Schlattjan, M.; Sowa, J.-P.; Dienes, H.P.; Canbay, A.; Odenthal, M. 2012: Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis. Frontiers in Physiology 3: 476
Hardikar, A.A.; Farr, R.J.; Joglekar, M.V. 2014: Circulating microRNAs: understanding the limits for quantitative measurement by real-time PCR. Journal of the American Heart Association 3(1): E000792
Hilton, C.; Karpe, F. 2013: Circulating microRNAs: what is their relevance?. Clinical Chemistry 59(5): 729-731
Anuradha, R.; George, P.J.; Pavan Kumar, N.; Fay, M.P.; Kumaraswami, V.; Nutman, T.B.; Babu, S. 2012: Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease. Plos Pathogens 8(6): E1002749
Hashimoto, T.; Kajiyama, Y.; Tsutsumi-Ishii, Y.; Nagaoka, I.; Tsurumaru, M. 2008: Circulating micrometastases of esophageal cancer detected by carcinoembryonic antigen mRNA reverse transcriptase-polymerase chain reaction: clinical implications. Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus 21(8): 690-696
Amabile, N.; Boulanger, C.M. 2011: Circulating microparticle levels in patients with coronary artery disease: a new indicator of vulnerability?. European Heart Journal 32(16): 1958-1960
Rautou, P-Emmanuel.; Vion, A-Clémence.; Luyendyk, J.P.; Mackman, N. 2014: Circulating microparticle tissue factor activity is increased in patients with cirrhosis. Hepatology 60(5): 1793-1795
Bharthuar, A.; Khorana, A.A.; Hutson, A.; Wang, J-Guo.; Key, N.S.; Mackman, N.; Iyer, R.V. 2013: Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers. Thrombosis Research 132(2): 180-184
Jayachandran, M.; Litwiller, R.D.; Owen, W.G.; Miller, V.M. 2009: Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric: the Journal of the International Menopause Society 12(2): 177-184
Iversen, L.V.; Østergaard, O.; Ullman, S.; Nielsen, C.T.; Halberg, P.; Karlsmark, T.; Heegaard, N.H.H.; Jacobsen, S. 2013: Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis. Scandinavian Journal of Rheumatology 42(6): 473-482
Forest, A.; Pautas, E.; Ray, P.; Bonnet, D.; Verny, M.; Amabile, N.; Boulanger, C.; Riou, B.; Tedgui, A.; Mallat, Z.; Boddaert, J. 2010: Circulating microparticles and procoagulant activity in elderly patients. Journals of Gerontology. Series A Biological Sciences and Medical Sciences 65(4): 414-420
Enjeti, A.K.; Lincz, L.F.; Scorgie, F.E.; Seldon, M. 2010: Circulating microparticles are elevated in carriers of factor V Leiden. Thrombosis Research 126(3): 250-253
Azevedo, L.C.P.; Pedro, M.A.; Laurindo, F.R.M. 2007: Circulating microparticles as therapeutic targets in cardiovascular diseases. Recent Patents on Cardiovascular Drug Discovery 2(1): 41-51
Hexley, P.; Robinson, C.T.; Osterburg, A.R.; Babcock, G.F. 2012: Circulating microparticles do not all share biophysical light scatter properties with immune complexes when analyzed by flow cytometry. Blood 120(7): 1528-1529
Leonetti, D.; Reimund, J-Marie.; Tesse, A.; Viennot, Séphanie.; Martinez, M.Carmen.; Bretagne, A-Laure.; Andriantsitohaina, R. 2013: Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. Plos one 8(9): E73088
Tual-Chalot, S.; Gagnadoux, Fédéric.; Trzepizur, W.; Priou, P.; Andriantsitohaina, R.; Martinez, M.Carmen. 2014: Circulating microparticles from obstructive sleep apnea syndrome patients induce endothelin-mediated angiogenesis. Biochimica et Biophysica Acta 1842(2): 202-207
Bueno Jiménez, Cóbal. 2012: Circulating microparticles from patients with coronary artery disease cause endothelial dysfunction. Revista Espanola de Cardiologia 65(4): 389; Author Reply 389-90
Tual-Chalot, S.; Fatoumata, K.; Priou, P.; Trzepizur, W.; Gaceb, A.; Contreras, C.; Prieto, D.; Martinez, M.Carmen.; Gagnadoux, Fédéric.; Andriantsitohaina, R. 2012: Circulating microparticles from patients with obstructive sleep apnea enhance vascular contraction: mandatory role of the endothelium. American Journal of Pathology 181(4): 1473-1482
Mostefai, H.Ahmed.; Meziani, F.; Mastronardi, M.Letizia.; Agouni, A.; Heymes, C.; Sargentini, C.; Asfar, P.; Martinez, M.Carmen.; Andriantsitohaina, R. 2008: Circulating microparticles from patients with septic shock exert protective role in vascular function. American Journal of Respiratory and Critical Care Medicine 178(11): 1148-1155
Tual-Chalot, S.; Guibert, C.; Muller, B.; Savineau, J-Pierre.; Andriantsitohaina, R.; Martinez, M.Carmen. 2010: Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. American Journal of Respiratory and Critical Care Medicine 182(2): 261-268
Mastronardi, M.Letizia.; Mostefai, H.Ahmed.; Meziani, F.; Martínez, M.Carmen.; Asfar, P.; Andriantsitohaina, R. 2011: Circulating microparticles from septic shock patients exert differential tissue expression of enzymes related to inflammation and oxidative stress. Critical Care Medicine 39(7): 1739-1748
Shantsila, E.; Kamphuisen, P.W.; Lip, G.Y.H. 2010: Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. Journal of Thrombosis and Haemostasis: Jth 8(11): 2358-2368
Campello, E.; Spiezia, L.; Radu, C.M.; Bon, M.; Gavasso, S.; Zerbinati, P.; Woodhams, B.; Tormene, D.; Prandoni, P.; Simioni, P. 2012: Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. Thrombosis and Haemostasis 108(4): 633-639
Campello, E.; Spiezia, L.; Radu, C.M.; Gavasso, S.; Zerbinati, P.; Woodhams, B.; Simioni, P. 2014: Circulating microparticles in carriers of prothrombin G20210A mutation. Thrombosis and Haemostasis 112(3): 432-437
Falanga, A.; Trinchero, A. 2013: Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin. Haematologica 98(7): 995-997
Kim, J.; Bhattacharjee, R.; Kheirandish-Gozal, L.; Spruyt, K.; Gozal, D. 2011: Circulating microparticles in children with sleep disordered breathing. Chest 140(2): 408-417
Tietjen, G.E. 2015: Circulating microparticles in migraine with aura: cause or consequence, a link to stroke. Cephalalgia: An International Journal of Headache 35(2): 85-87
Crookston, K.P.; Sibbitt, W.L.; Chandler, W.L.; Qualls, C.R.; Roldan, C.A. 2013: Circulating microparticles in neuropsychiatric systemic lupus erythematosus. International Journal of Rheumatic Diseases 16(1): 72-80
Rank, A.; Liebhardt, S.; Zwirner, J.; Burges, A.; Nieuwland, R.; Toth, B. 2012: Circulating microparticles in patients with benign and malignant ovarian tumors. Anticancer Research 32(5): 2009-2014
Cui, Y.; Zheng, L.; Jiang, M.; Jia, R.; Zhang, X.; Quan, Q.; Du, G.; Shen, D.; Zhao, X.; Sun, W.; Xu, H.; Huang, L. 2013: Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein. Molecular Biology Reports 40(11): 6437-6442
Daniel, L.; Dou, L.; Berland, Y.; Lesavre, P.; Mecarelli-Halbwachs, L.; Dignat-George, F. 2008: Circulating microparticles in renal diseases. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(7): 2129-2132
Walenta, K.L.H.; Link, A.; Friedrich, E.B.; Böhm, M. 2009: Circulating microparticles in septic shock. American Journal of Respiratory and Critical Care Medicine 180(1): 100; Author Reply 100-1
Marques, F.K.; Campos, F.M.F.; Filho, O.A.M.; Carvalho, A.T.; Dusse, L.M.S.; Gomes, K.B. 2012: Circulating microparticles in severe preeclampsia. Clinica Chimica Acta; International Journal of Clinical Chemistry 414: 253-258
Nielsen, C.Tandrup. 2012: Circulating microparticles in systemic Lupus Erythematosus. Danish Medical Journal 59(11): B4548
Chironi, G.N.; Simon, A.; Boulanger, C.M.; Dignat-George, Fçoise.; Hugel, Bénédicte.; Megnien, J-Louis.; Lefort, M.; Freyssinet, J-Marie.; Tedgui, A. 2010: Circulating microparticles may influence early carotid artery remodeling. Journal of Hypertension 28(4): 789-796
Sartori, M.Teresa.; Della Puppa, A.; Ballin, A.; Campello, E.; Radu, C.Maria.; Saggiorato, G.; d'Avella, D.; Scienza, R.; Cella, G.; Simioni, P. 2013: Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. Thrombosis and Haemostasis 110(2): 378-385
Sáenz-Cuesta, Mías.; Irizar, H.; Castillo-Triviño, T.; Muñoz-Culla, M.; Osorio-Querejeta, Iñaki.; Prada, A.; Sepúlveda, Lía.; López-Mato, Mía.P.; López de Munain, A.; Comabella, M.; Villar, L.M.; Olascoaga, J.; Otaegui, D. 2014: Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis. Biomarkers in Medicine 8(5): 653-661
van Eijk, I.C.; Tushuizen, M.E.; Sturk, A.; Dijkmans, B.A.C.; Boers, M.; Voskuyl, A.E.; Diamant, M.; Wolbink, G.J.; Nieuwland, R.; Nurmohamed, M.T. 2010: Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Annals of the Rheumatic Diseases 69(7): 1378-1382
Alijotas-Reig, J.; Palacio-Garcia, C.; Vilardell-Tarres, M. 2009: Circulating microparticles, lupus anticoagulant and recurrent miscarriages. European Journal of Obstetrics Gynecology and Reproductive Biology 145(1): 22-26
Bobik, A. 2010: Circulating microparticles. Markers or participants in carotid artery remodelling?. Journal of Hypertension 28(4): 673-675
Shantsila, E.; Montoro-García, S.; Gallego, P.; Lip, G.Y.H. 2014: Circulating microparticles: challenges and perspectives of flow cytometric assessment. Thrombosis and Haemostasis 111(6): 1009-1014
Ghosh, A.K.; Secreto, C.R.; Knox, T.R.; Ding, W.; Mukhopadhyay, D.; Kay, N.E. 2010: Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 115(9): 1755-1764
Krzystek-Korpacka, M.; Neubauer, K.; Matusiewicz, M. 2010: Circulating midkine in Crohn's disease: clinical implications. Inflammatory Bowel Diseases 16(2): 208-215
Budnik, L.T.; Kloth, S.; Baur, X.; Preisser, A.M.; Schwarzenbach, H. 2013: Circulating mitochondrial DNA as biomarker linking environmental chemical exposure to early preclinical lesions elevation of mtDNA in human serum after exposure to carcinogenic halo-alkane-based pesticides. Plos one 8(5): E64413
Nakahira, K.; Kyung, S.-Y.; Rogers, A.J.; Gazourian, L.; Youn, S.; Massaro, A.F.; Quintana, C.; Osorio, J.C.; Wang, Z.; Zhao, Y.; Lawler, L.A.; Christie, J.D.; Meyer, N.J.; Mc Causland, F.R.; Waikar, S.S.; Waxman, A.B.; Chung, R.T.; Bueno, R.; Rosas, I.O.; Fredenburgh, L.E.; Baron, R.M.; Christiani, D.C.; Hunninghake, G.M.; Choi, A.M.K. 2013: Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. Plos Medicine 10(12): E1001577; Discussion E1001577
Ellinger, J.ör.; Müller, D.C.; Müller, S.C.; Hauser, S.; Heukamp, L.C.; von Ruecker, A.; Bastian, P.J.; Walgenbach-Brunagel, G. 2012: Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies. Urologic Oncology 30(4): 509-515
Ellinger, J.ör.; Albers, P.; Müller, S.C.; von Ruecker, A.; Bastian, P.J. 2009: Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker. Bju International 104(1): 48-52
Pinti, M.; Cevenini, E.; Nasi, M.; De Biasi, S.; Salvioli, S.; Monti, D.; Benatti, S.; Gibellini, L.; Cotichini, R.; Stazi, M.A.; Trenti, T.; Franceschi, C.; Cossarizza, A. 2014: Circulating mitochondrial DNA increases with age and is a familiar trait: Implications for "inflamm-aging". European Journal of Immunology 44(5): 1552-1562
Fernandes, J.; Michel, V.ér.; Camorlinga-Ponce, M.; Gomez, A.; Maldonado, C.; De Reuse, H.; Torres, J.; Touati, E. 2014: Circulating mitochondrial DNA level, a noninvasive biomarker for the early detection of gastric cancer. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 23(11): 2430-2438
Jackups, R.; Mehrad, M. 2012: Circulating mitotic figures in CMV-associated hydrops fetalis. Blood 119(14): 3201
Gall, T.M.H.; Frampton, A.E.; Krell, J.; Castellano, L.; Jiao, L.R. 2013: Circulating molecular markers in pancreatic cancer: ready for clinical use?. Future Oncology 9(2): 141-144
Wamae, C.N. 2009: Circulating money is "vector" of common disease causing agents. East African Medical Journal 86(4): 149-150
Telejko, B.; Kuzmicki, M.; Zonenberg, A.; Niedziolko-Bagniuk, K.; Nikolajuk, A.; Szamatowicz, J.; Gorska, M. 2007: Circulating monocyte chemoattractant protein-1 in women with gestational diabetes. Folia Histochemica et Cytobiologica 45(Suppl 1): S153-S156
Dworacka, M.; Krzyżagórska, E.; Wesołowska, A.; Zharmakhanova, G.; Iskakova, S.; Dworacki, G. 2014: Circulating monocyte chemotactic protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1) and angiogenin in type 2 diabetic patients treated with statins in low doses. European Journal of Pharmacology 740: 474-479
Ulrich, C.; Heine, G.H.; Seibert, E.; Fliser, D.; Girndt, M. 2010: Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25(7): 2265-2272
Hristov, M.; Leyendecker, T.; Schuhmann, C.; von Hundelshausen, P.; Heussen, N.; Kehmeier, E.; Krötz, F.; Sohn, H.-Y.; Klauss, V.; Weber, C. 2010: Circulating monocyte subsets and cardiovascular risk factors in coronary artery disease. Thrombosis and Haemostasis 104(2): 412-414
Shantsila, E.; Devitt, A.; Lip, G.Y.H. 2010: Circulating monocytes and atherogenesis: from animal experiments to human studies. Thrombosis and Haemostasis 104(2): 191-193
Gille-Johnson, P.; Smedman, C.; Gudmundsdotter, L.; Somell, A.; Nihlmark, K.; Paulie, S.; Andersson, J.; Gårdlund, B. 2012: Circulating monocytes are not the major source of plasma cytokines in patients with sepsis. Shock 38(6): 577-583
Kim, S.-J.; Kim, J.-S.; Papadopoulos, J.; Wook Kim, S.; Maya, M.; Zhang, F.; He, J.; Fan, D.; Langley, R.; Fidler, I.J. 2009: Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. American Journal of Pathology 174(5): 1972-1980
Medina, A.; Brown, E.; Carr, N.; Ghahary, A. 2009: Circulating monocytes have the capacity to be transdifferentiated into keratinocyte-like cells. Wound Repair and Regeneration: Official Publication of the Wound Healing Society and the European Tissue Repair Society 17(2): 268-277
Giri, M.S.; Nebozyhn, M.; Raymond, A.; Gekonge, B.; Hancock, A.; Creer, S.; Nicols, C.; Yousef, M.; Foulkes, A.S.; Mounzer, K.; Shull, J.; Silvestri, G.; Kostman, J.; Collman, R.G.; Showe, L.; Montaner, L.J. 2009: Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance. Journal of Immunology 182(7): 4459-4470
Caballero, S.; Hazra, S.; Bhatwadekar, A.; Li Calzi, S.; Paradiso, L.J.; Miller, L.P.; Chang, L.-J.; Kern, T.S.; Grant, M.B. 2013: Circulating mononuclear progenitor cells: differential roles for subpopulations in repair of retinal vascular injury. Investigative Ophthalmology and Visual Science 54(4): 3000-3009
Russell, J.S.; Brown, J.M. 2014: Circulating mouse Flk1+/c-Kit+/CD45- cells function as endothelial progenitors cells (EPCs) and stimulate the growth of human tumor xenografts. Molecular Cancer 13: 177
Leung, D.T.; Bhuiyan, T.R.; Nishat, N.S.; Hoq, M.R.; Aktar, A.; Rahman, M.A.; Uddin, T.; Khan, A.I.; Chowdhury, F.; Charles, R.C.; Harris, J.B.; Calderwood, S.B.; Qadri, F.; Ryan, E.T. 2014: Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. Plos Neglected Tropical Diseases 8(8): E3076
Lee, O.-J.; Cho, Y.-N.; Kee, S.-J.; Kim, M.-J.; Jin, H.-M.; Lee, S.-J.; Park, K.-J.; Kim, T.-J.; Lee, S.-S.; Kwon, Y.-S.; Kim, N.; Shin, M.-G.; Shin, J.-H.; Suh, S.-P.; Ryang, D.-W.; Park, Y.-W. 2014: Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults. Experimental Gerontology 49: 47-54
Verschoor, C.P.; Naidoo, A.; Wallace, J.G.; Johnstone, J.; Loeb, M.; Bramson, J.L.; Bowdish, D.M. 2015: Circulating muramyl dipeptide is negatively associated with interleukin-10 in the frail elderly. Inflammation 38(1): 272-277
Miyachi, M.; Tsuchiya, K.; Yoshida, H.; Yagyu, S.; Kikuchi, K.; Misawa, A.; Iehara, T.; Hosoi, H. 2010: Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochemical and Biophysical Research Communications 400(1): 89-93
Kim, K.; Perera, R.; Tan, D.B.A.; Fernandez, S.; Seddiki, N.; Waring, J.; French, M.A. 2014: Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection. Tuberculosis 94(5): 494-501
Menegazzo, L.; Albiero, M.; Millioni, R.; Tolin, S.; Arrigoni, G.; Poncina, N.; Tessari, P.; Avogaro, A.; Fadini, G.Paolo. 2013: Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(11): 4355-4365
Zonghong, S.; Meifeng, T.; Huaquan, W.; Limin, X.; Jun, W.; Rong, F.; Hong, L.; Yuhong, W. 2011: Circulating myeloid dendritic cells are increased in individuals with severe aplastic anemia. International Journal of Hematology 93(2): 156-162
Yamamoto, T.; Yanagimoto, H.; Satoi, S.; Toyokawa, H.; Yamao, J.; Kim, S.; Terakawa, N.; Takahashi, K.; Kwon, A-Hon. 2012: Circulating myeloid dendritic cells as prognostic factors in patients with pancreatic cancer who have undergone surgical resection. Journal of Surgical Research 173(2): 299-308
Yeager, M.E.; Nguyen, C.M.; Belchenko, D.D.; Colvin, K.L.; Takatsuki, S.; Ivy, D.D.; Stenmark, K.R. 2012: Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension. Chest 141(4): 944-952
Ohki, S.; Shibata, M.; Gonda, K.; Machida, T.; Shimura, T.; Nakamura, I.; Ohtake, T.; Koyama, Y.; Suzuki, S.; Ohto, H.; Takenoshita, S. 2012: Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer. Oncology Reports 28(2): 453-458
Romano, A.; Parrinello, N.L.; Vetro, C.; Forte, S.; Chiarenza, A.; Figuera, A.; Motta, G.; Palumbo, G.A.; Ippolito, M.; Consoli, U.; Di Raimondo, F. 2015: Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy. British Journal of Haematology 168(5): 689-700
Santilli, F.; Paloscia, L.; Liani, R.; Di Nicola, M.; Di Marco, M.; Lattanzio, S.; La Barba, S.; Pascale, S.; Mascellanti, M.; Davì, G. 2014: Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. Journal of the American Heart Association 3(4)
Ugarte-Gil, M.F.; Sánchez-Zúñiga, C.és.; Gamboa-Cárdenas, R.ío.V.; Aliaga-Zamudio, M.; Zevallos, F.; Tineo-Pozo, G.; Cucho-Venegas, J.M.; Mosqueira-Riveros, A.; Perich-Campos, R.A.; Alfaro-Lozano, J.é L.; Medina, M.; Rodríguez-Bellido, Z.; Alarcón, G.S.; Pastor-Asurza, C.A. 2015: Circulating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo population. Rheumatology 54(7): 1302-1307
Menaut, P.; Connolly, D.J.; Volk, A.; Pace, C.; Luis Fuentes, V.; Elliott, J.; Syme, H. 2012: Circulating natriuretic peptide concentrations in hyperthyroid cats. Journal of Small Animal Practice 53(12): 673-678
Walford, G.A.; Ma, Y.; Christophi, C.A.; Goldberg, R.B.; Jarolim, P.; Horton, E.; Mather, K.J.; Barrett-Connor, E.; Davis, J.; Florez, J.C.; Wang, T.J.; Bray, G.A.; Culbert, I.W.; Champagne, C.M.; Eberhardt, B.; Greenway, F.; Guillory, F.G.; Herbert, A.A.; Jeffirs, M.L.; Kennedy, B.M.; Lovejoy, J.C.; Morris, L.H.; Melancon, L.E.; Ryan, D.; Sanford, D.A.; Smith, K.G.; Smith, L.L.; St Amant, J.A.; Tulley, R.T.; Vicknair, P.C.; Williamson, D.; Zachwieja, J.J.; Polonsky, K.S.; Tobian, J.; Ehrmann, D.; Matulik, M.J.; Clark, B.; Czech, K.; DeSandre, C.; Hil 2014: Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program. Diabetologia 57(5): 935-939
Maisel, A. 2007: Circulating natriuretic peptide levels in acute heart failure. Reviews in Cardiovascular Medicine 8(Suppl 5): S13-S21
Rodas, J.D.; Cairo, C.; Djavani, M.; Zapata, J.C.; Ruckwardt, T.; Bryant, J.; Pauza, C.D.; Lukashevich, I.S.; Salvato, M.S. 2009: Circulating natural killer and gammadelta T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus. Memorias do Instituto Oswaldo Cruz 104(4): 583-591
Miyoshi, H.; Uchida, K.; Taniguchi, T.; Yazumi, S.; Matsushita, M.; Takaoka, M.; Okazaki, K. 2008: Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 36(2): 133-140
Liu, Y.; Studzinski, C.; Beckett, T.; Murphy, M.P.; Klein, R.L.; Hersh, L.B. 2010: Circulating neprilysin clears brain amyloid. Molecular and Cellular Neurosciences 45(2): 101-107
Klein-Weigel, P.; Gutsche-Petrak, B.; Humpel, C.; Riemekasten, G.; Ivanov, S.; Heidrich, H. 2009: Circulating nerve growth factor in primary and secondary Raynaud's syndrome - results of a pilot study. Vasa. Zeitschrift für Gefasskrankheiten 38(1): 39-45
Geisberg, C.A.; Wang, G.; Safa, R.N.; Smith, H.M.; Anderson, B.; Peng, X.-Y.; Veerkamp, B.; Zhao, D.X.; Blakemore, D.; Yu, C.; Sawyer, D.B. 2011: Circulating neuregulin-1β levels vary according to the angiographic severity of coronary artery disease and ischemia. Coronary Artery Disease 22(8): 577-582
Svendsen, E.R.; Yeatts, K.B.; Peden, D.; Orton, S.; Alexis, N.E.; Creason, J.; Williams, R.; Neas, L. 2007: Circulating neutrophil CD14 expression and the inverse association of ambient particulate matter on lung function in asthmatic children. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 99(3): 244-253
Bermejo-Martín, J.ús.F.; Tamayo, E.; Ruiz, G.; Andaluz-Ojeda, D.; Herrán-Monge, R.én.; Muriel-Bombín, A.; Fe Muñoz, M.; Heredia-Rodríguez, M.ía.; Citores, R.; Gómez-Herreras, J.é; Blanco, J.ús.; Gómez-Sánchez, E.; Gutiérrez, S.; Bobillo, F.; Gandía, F.; Iglesias, V.ón.; Rico, L.; Almansa, R.; de Lejarazu, R.úl.O.; Merino, P.; García-García, M.M.ía.; Pueyo, M.J.ús.L.óp.; Ratero, J.A.F.; Barrios, M.M.; Torre, F.C.; Echeverri, S.O.; Ule, D.C.; Berrot, A.M.D.ín.; Domínguez, F.J.D.ía.; Moradillo, S.; Martínez, B.A.; Albalá, N.; Ballesteros, J.C.; Perez, M.P.; Losada, E.P.; García, R.P.; Cervigón, N.R.G.ía.; Serrano, M.M.G.; Calavia, M.J.é F.án.; Torres, D.M.; Tarancón, C.; Loreto, T.; Carcelen, P. 2014: Circulating neutrophil counts and mortality in septic shock. Critical Care 18(1): 407
Chen, M.; Wang, F.; Zhao, M.-H. 2009: Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis. Rheumatology 48(4): 355-358
Fujimori, K.; Oh-i, K.; Takeuchi, M.; Yamakawa, N.; Hattori, T.; Kezuka, T.; Keino, H.; Suzuki, J.; Goto, H.; Sakai, J.-i.; Usui, M. 2008: Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis. Graefe's Archive for Clinical and Experimental Ophthalmology 246(2): 285-290
Morton, J.; Coles, B.; Wright, K.; Gallimore, A.; Morrow, J.D.; Terry, E.S.; Anning, P.B.; Morgan, B.Paul.; Dioszeghy, V.; Kühn, H.; Chaitidis, P.; Hobbs, A.J.; Jones, S.A.; O'Donnell, V.B. 2008: Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy mice. Blood 111(10): 5187-5194
Fernandes, P.C.; Garcia, C.B.; Micheli, D.C.; Cunha, F.Q.; Murta, E.F.C.; Tavares-Murta, B.M. 2007: Circulating neutrophils may play a role in the host response in cervical cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 17(5): 1068-1074
Charni-Ben Tabassi, N.; Richardot, P.; Toh, L.; Marotte, H.; Bay-Jensen, A.-C.; Miossec, P.; Garnero, P. 2009: Circulating nitrated N-telopeptide of type IIi collagen (IIINys) as a biochemical marker of oxidative-related synovial tissue metabolism in rheumatoid arthritis. Annals of the Rheumatic Diseases 68(3): 451-452
Ozkan, Y.şi.; Firat, H.; Simşek, B.; Torun, M.; Yardim-Akaydin, S. 2008: Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep and Breathing 12(2): 149-154
Jacobsen, S.ør.B.; Hansen, M.N.; Jensen, F.B.; Skovgaard, N.; Wang, T.; Fago, A. 2012: Circulating nitric oxide metabolites and cardiovascular changes in the turtle Trachemys scripta during normoxia, anoxia and reoxygenation. Journal of Experimental Biology 215(Part 15): 2560-2566
Takaki, J. 2013: Circulating nitrite and nitrate are associated with job-related fatigue in women, but not in men. International Journal of Environmental Research and Public Health 10(7): 2813-2824
Rassaf, T.; Totzeck, M.; Hendgen-Cotta, U.B.; Shiva, S.; Heusch, G.; Kelm, M. 2014: Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circulation Research 114(10): 1601-1610
Farr, R.J.; Joglekar, M.V.; Taylor, C.J.; Hardikar, A.A. 2013: Circulating non-coding RNAs as biomarkers of beta cell death in diabetes. Pediatric Endocrinology Reviews: Per 11(1): 14-20
Brittenham, G.M.; Andersson, M.; Egli, I.; Foman, J.Tajeri.; Zeder, C.; Westerman, M.E.; Hurrell, R.F. 2014: Circulating non-transferrin-bound iron after oral administration of supplemental and fortification doses of iron to healthy women: a randomized study. American Journal of Clinical Nutrition 100(3): 813-820
Schlieper, G.; Westenfeld, R.; Krüger, T.; Cranenburg, E.C.; Magdeleyns, E.J.; Brandenburg, V.M.; Djuric, Z.; Damjanovic, T.; Ketteler, M.; Vermeer, C.; Dimkovic, N.; Floege, J.ür.; Schurgers, L.J. 2011: Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. Journal of the American Society of Nephrology: Jasn 22(2): 387-395
Yamasaki, S.; Hashimoto, Y.; Takigami, J.; Terai, S.; Takahashi, M.; Wakitani, S.; Nakamura, H. 2017: Circulating nucleated peripheral blood cells contribute to early-phase meniscal healing. Journal of Tissue Engineering and Regenerative Medicine 11(3): 609-617
Liu, Y. 2012: Circulating nucleic acids and Darwin's gemmules. Expert Opinion on Biological Therapy 12(Suppl 1): S225
Anker, P.; Stroun, M. 2012: Circulating nucleic acids and evolution. Expert Opinion on Biological Therapy 12(Suppl 1): S113-S117
Scalici, E.; Traver, S.; Mullet, T.; Ferrières, A.; Monforte, M.; Vintejoux, E.; Hamamah, S. 2014: Circulating nucleic acids and in vitro fertilization. Gynecologie Obstetrique and Fertilite 42(10): 696-701
Schwarzenbach, H. 2012: Circulating nucleic acids and protease activities in blood of tumor patients. Expert Opinion on Biological Therapy 12(Suppl 1): S163-S169
Vlassov, V.V.; Laktionov, P.P.; Rykova, E.Y. 2010: Circulating nucleic acids as a potential source for cancer biomarkers. Current Molecular Medicine 10(2): 142-165
Schwarzenbach, H. 2013: Circulating nucleic acids as biomarkers in breast cancer. Breast Cancer Research: Bcr 15(5): 211
Sita-Lumsden, A.; Fletcher, C.E.; Dart, D.A.; Brooke, G.N.; Waxman, J.; Bevan, C.L. 2013: Circulating nucleic acids as biomarkers of prostate cancer. Biomarkers in Medicine 7(6): 867-877
Kocić, G.; Radenkovic, S.; Cvetkovic, T.; Cencic, A.; Carluccio, F.; Musovic, D.; Nikolić, G.; Jevtović-Stoimenov, T.; Sokolović, D.; Milojkovic, B.; Basic, J.; Veljkovic, A.; Stojanović, S. 2010: Circulating nucleic acids as possible damage-associated molecular patterns in different stages of renal failure. Renal Failure 32(4): 486-492
Pinzani, P.; Salvianti, F.; Pazzagli, M.; Orlando, C. 2010: Circulating nucleic acids in cancer and pregnancy. Methods 50(4): 302-307
González-Masiá, J.é A.; García-Olmo, D.án.; García-Olmo, D.C. 2013: Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology. Oncotargets and Therapy 6: 819-832
Gahan, P.B.; Swaminathan, R. 2008: Circulating nucleic acids in plasma and serum. Recent developments. Annals of the new York Academy of Sciences 1137: 1-6
García-Olmo, D.C.; García-Olmo, D.án. 2012: Circulating nucleic acids in plasma and serum: an intriguing phenomenon. Expert Opinion on Biological Therapy 12(Suppl 1): S1-S2
Gahan, P.B. 2013: Circulating nucleic acids in plasma and serum: applications in diagnostic techniques for noninvasive prenatal diagnosis. International Journal of Women's Health 5: 177-186
Gahan, P.B. 2010: Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer. Epma Journal 1(3): 503-512
Gahan, P.B. 2008: Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer. Infectious Disorders Drug Targets 8(2): 100-108
Kocic, G.; Pavlovic, V.; Saranac, L.J.; Kocic, R.; Zivic, S.; Sokolovic, D.; Jevtovic, T.; Nikolic, G.; Stojanovic, S.; Damnjanovic, I. 2010: Circulating nucleic acids in type 1 diabetes may modulate the thymocyte turnover rate. Cellular Immunology 266(1): 76-82
Stoetzer, O.J.; Wittwer, C.; Lehner, J.; Fahmueller, Y.N.; Kohles, N.; Fersching, D.M.I.; Leszinski, G.; Roessner, J.; Holdenrieder, S. 2012: Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy. Expert Opinion on Biological Therapy 12(Suppl 1): S217-S224
Wittwer, C.; Boeck, S.; Heinemann, V.; Haas, M.; Stieber, P.; Nagel, D.; Holdenrieder, S. 2013: Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy. International Journal of Cancer 133(11): 2619-2630
Zeerleder, S.; Stephan, F.; Emonts, M.; de Kleijn, E.D.; Esmon, C.T.; Varadi, K.; Hack, C.E.; Hazelzet, J.A. 2012: Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C. Critical Care Medicine 40(12): 3224-3229
Chen, Q.; Ye, L.; Jin, Y.; Zhang, N.; Lou, T.; Qiu, Z.; Jin, Y.; Cheng, B.; Fang, X. 2012: Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 16(7): E558-E564
Huang, J.; Zhang, Y.; Yu, S.; Gan, X.; Su, Y.; Yuan, J.; An, R. 2012: Circulating obestatin concentration is lowered by insulin in rats. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 120(1): 56-58
Shao, L.; Zhao, Y.-T.; Teng, L.-L.; Li, M.-Z.; Jiang, H. 2014: Circulating obestatin levels correlate with fasting insulin and HOMA-IR but not with hypertension in elderly men. Cell Biochemistry and Biophysics 69(1): 89-92
St-Pierre, D.H.; Settanni, F.; Olivetti, I.; Gramaglia, E.; Tomelini, M.; Granata, R.; Prodam, F.; Benso, A.; Ghigo, E.; Broglio, F. 2010: Circulating obestatin levels in normal and Type 2 diabetic subjects. Journal of Endocrinological Investigation 33(4): 211-214
Merle, B.én.éd.M.J.; Benlian, P.; Puche, N.; Bassols, A.; Delcourt, C.éc.; Souied, E.H.; Allaire, C.; Bassols, A.; Belabbas, K.; Brault, D.; Brouquet, Y.; Castagnet, S.ép.; Crié, A.; Gaudino, I.; Gawrilow, P.; Lablache-Combier, M.èl.; Leveziel, N.; Mechai, N.; Morineau, G.; Orlic-Pleyer, N.; Paccou, B.; Pumariega, N.; Querques, G.; Siou-Mermet, R.ël.; Turquois, I. 2014: Circulating omega-3 Fatty acids and neovascular age-related macular degeneration. Investigative Ophthalmology and Visual Science 55(3): 2010-2019
Virtanen, J.K.; Siscovick, D.S.; Lemaitre, R.N.; Longstreth, W.T.; Spiegelman, D.; Rimm, E.B.; King, I.B.; Mozaffarian, D. 2013: Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRi in older adults: the Cardiovascular Health Study. Journal of the American Heart Association 2(5): E000305
Wu, J.H.Y.; Lemaitre, R.N.; King, I.B.; Song, X.; Psaty, B.M.; Siscovick, D.S.; Mozaffarian, D. 2014: Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation 130(15): 1245-1253
Moreno-Navarrete, J.é M.ía.; Catalán, V.; Ortega, F.; Gómez-Ambrosi, J.; Ricart, W.; Frühbeck, G.; Fernández-Real, J.é M. 2010: Circulating omentin concentration increases after weight loss. Nutrition and Metabolism 7: 27
Borger, D.R.; Goyal, L.; Yau, T.; Poon, R.T.; Ancukiewicz, M.; Deshpande, V.; Christiani, D.C.; Liebman, H.M.; Yang, H.; Kim, H.; Yen, K.; Faris, J.E.; Iafrate, A.J.; Kwak, E.L.; Clark, J.W.; Allen, J.N.; Blaszkowsky, L.S.; Murphy, J.E.; Saha, S.K.; Hong, T.S.; Wo, J.Y.; Ferrone, C.R.; Tanabe, K.K.; Bardeesy, N.; Straley, K.S.; Agresta, S.; Schenkein, D.P.; Ellisen, L.W.; Ryan, D.P.; Zhu, A.X. 2014: Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(7): 1884-1890
Carney, W.P. 2007: Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers. Expert Review of Molecular Diagnostics 7(3): 309-319
Fernández-Real, J.M.; Ortega, F.; Gómez-Ambrosi, J.; Salvador, J.; Frühbeck, G.; Ricart, W. 2010: Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 21(12): 2101-2107
Aoki, A.; Muneyuki, T.; Yoshida, M.; Munakata, H.; Ishikawa, S.-e.; Sugawara, H.; Kawakami, M.; Kakei, M. 2011: Circulating osteocalcin is increased in early-stage diabetes. Diabetes Research and Clinical Practice 92(2): 181-186
Undale, A.; Srinivasan, B.; Drake, M.; McCready, L.; Atkinson, E.; Peterson, J.; Riggs, B.L.; Amin, S.; Modder, U.I.; Moedder, U.I.; Khosla, S. 2010: Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women. Bone 47(1): 83-92
Pignolo, R.J.; Shore, E.M. 2010: Circulating osteogenic precursor cells. Critical Reviews in Eukaryotic Gene Expression 20(2): 171-180
Suda, R.K.; Billings, P.C.; Egan, K.P.; Kim, J.-H.; McCarrick-Walmsley, R.; Glaser, D.L.; Porter, D.L.; Shore, E.M.; Pignolo, R.J. 2009: Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells 27(9): 2209-2219
Cheng, J.M.; Akkerhuis, K.Martijn.; Meilhac, O.; Oemrawsingh, R.M.; Garcia-Garcia, H.M.; van Geuns, R-Jan.; Piquer, D.; Merle, D.; du Paty, E.; Galéa, P.; Jaisser, F.; Rossignol, P.; Serruys, P.W.; Boersma, E.; Fareh, J.; Kardys, I. 2014: Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography. Arteriosclerosis Thrombosis and Vascular Biology 34(5): 1078-1084
Motovska, Z.; Vichova, T.; Tousek, P.; Dusek, L.; Widimsky, P. 2012: Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. International Journal of Cardiology 158(2): 300-301
Albu, A.; Bondor, C.I.; Crăciun, A.M.; Fodor, D. 2014: Circulating osteoprotegerin and asymptomatic carotid atherosclerosis in postmenopausal non diabetic women. Advances in Medical Sciences 59(2): 293-298
Briana, D.D.; Boutsikou, M.; Baka, S.; Hassiakos, D.; Gourgiotis, D.; Malamitsi-Puchner, A. 2009: Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. the impact of intrauterine growth restriction. Neonatology 96(2): 132-136
Dovio, A.; Data, V.; Carignola, R.; Calzolari, G.; Vitetta, R.; Ventura, M.; Saba, L.; Severino, A.; Angeli, A. 2008: Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. Journal of Rheumatology 35(11): 2206-2213
Pepene, C.E.; Ilie, I.R.; Marian, I.; Duncea, I. 2011: Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. European Journal of Endocrinology 164(1): 61-68
Uemura, H.; Yasui, T.; Miyatani, Y.; Yamada, M.; Hiyoshi, M.; Arisawa, K.; Irahara, M. 2008: Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women. Menopause 15(1): 180-184
Pérez de Ciriza, C.; Moreno, M.ía.; Restituto, P.; Bastarrika, G.; Simón, I.; Colina, I.; Varo, N. 2014: Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification. Clinical Biochemistry 47(18): 272-278
Kwok, S.K.; Shin, Y.J.; Kim, H.J.; Kim, H.S.; Kim, J.Y.; Yoo, S.A.; Choi, J.J.; Kim, W.U.; Cho, C.S. 2009: Circulating osteoprotegerin levels are elevated and correlated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Lupus 18(2): 133-138
Ramírez-Expósito, M.ía.J.ús.; Sánchez-López, E.ía.; Cueto-Ureña, C.; Dueñas, B.; Carrera-González, P.; Navarro-Cecilia, J.ín.; Mayas, M.ía.D.; Arias de Saavedra, J.é M.; Sánchez-Agesta, R.; Martínez-Martos, J.é M. 2014: Circulating oxidative stress parameters in pre- and post-menopausal healthy women and in women suffering from breast cancer treated or not with neoadjuvant chemotherapy. Experimental Gerontology 58: 34-42
Saleh, M.A.; Mahran, O.M.; Bassam Al-Salahy, M. 2011: Circulating oxidative stress status in dromedary camels infested with sarcoptic mange. Veterinary Research Communications 35(1): 35-45
Linna, M.; Ahotupa, M.; Löppönen, M.K.; Irjala, K.; Vasankari, T. 2013: Circulating oxidised LDL lipids, when proportioned to HDL-c, emerged as a risk factor of all-cause mortality in a population-based survival study. Age and Ageing 42(1): 110-113
Sigurdardottir, V.; Fagerberg, B.; Wikstrand, J.; Schmidt, C.; Hulthe, J. 2008: Circulating oxidized LDL is associated with the occurrence of echolucent plaques in the carotid artery in 61-year-old men. Scandinavian Journal of Clinical and Laboratory Investigation 68(4): 292-297
Kassi, E.; Dalamaga, M.; Faviou, E.; Hroussalas, G.; Kazanis, K.; Nounopoulos, C.; Dionyssiou-Asteriou, A. 2009: Circulating oxidized LDL levels, current smoking and obesity in postmenopausal women. Atherosclerosis 205(1): 279-283
Ueba, T.; Nomura, S.; Nishikawa, T.; Kajiwara, M.; Yamashita, K. 2009: Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese. Atherosclerosis 203(1): 243-248
Ishigaki, Y.; Oka, Y.; Katagiri, H. 2009: Circulating oxidized LDL: a biomarker and a pathogenic factor. Current Opinion in Lipidology 20(5): 363-369
van der Zwan, L.P.; Teerlink, T.; Dekker, J.M.; Henry, R.M.A.; Stehouwer, C.D.A.; Jakobs, C.; Heine, R.J.; Scheffer, P.G. 2009: Circulating oxidized LDL: determinants and association with brachial flow-mediated dilation. Journal of Lipid Research 50(2): 342-349
Verhoye, E.; Langlois, M.R.; Rietzchel, E.; De Buyzere, M.; Gillebert, T.; De Bacquer, D.; De Backer, G.; Bekaert, S.; van Oostveldt, P.; Segers, P.; Verdonck, P.; Langlois, M. 2009: Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?. Clinical Chemistry and Laboratory Medicine 47(2): 128-137
Pohjantähti-Maaroos, H.; Palomäki, A.; Kankkunen, P.äi.; Laitinen, R.; Husgafvel, S.; Oksanen, K. 2010: Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts. Cardiovascular Diabetology 9: 41
Dincer, Y.; Himmetoglu, S.; Bozcali, E.; Vural, V.A.; Akcay, T. 2010: Circulating p53 and cytochrome c levels in acute myocardial infarction patients. Journal of Thrombosis and Thrombolysis 29(1): 41-45
Evans, S.; Mann, D.L. 2013: Circulating p53-responsive micro RNAs as predictive biomarkers in heart failure after acute myocardial infarction: the long and arduous road from scientific discovery to clinical utility. Circulation Research 113(3): 242-244
Katsila, T.; Juliachs, M.è; Gregori, J.; Macarulla, T.; Villarreal, L.; Bardelli, A.; Torrance, C.; Elez, E.; Tabernero, J.; Villanueva, J. 2014: Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(24): 6346-6356
Mozaffarian, D.; Cao, H.; King, I.B.; Lemaitre, R.N.; Song, X.; Siscovick, D.S.; Hotamisligil, G.ök.S. 2010: Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. American Journal of Clinical Nutrition 92(6): 1350-1358
Jönsson, H.; Eyjolfsson, A.; Scicluna, S.; Paulsson, P.; Johnsson, P. 2009: Circulating particles during cardiac surgery. Interactive Cardiovascular and Thoracic Surgery 8(5): 538-542
Jialal, I.; Rajamani, U.; Adams-Huet, B.; Kaur, H. 2014: Circulating pathogen-associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity. Atherosclerosis 236(1): 182-187
Zhang, Y.; Ji, Y.-X.; Zhu, Z. 2009: Circulating pattern analysis for endemic measles viruses in mainland of China. Zhongguo Yi Miao he Mian Yi 15(2): 97-103
Zanetti, M.; Bosutti, A.; Ferreira, C.; Vinci, P.; Biolo, G.; Fonda, M.; Valente, M.; Cattin, L.; Guarnieri, G.; Barazzoni, R. 2009: Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. Clinical and Experimental Medicine 9(3): 243-248
Sakellariou, G.T.; Anastasilakis, A.D.; Bisbinas, I.; Oikonomou, D.; Gerou, S.; Polyzos, S.A.; Sayegh, F.E. 2015: Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation. Rheumatology 54(5): 908-914
Frampton, A.E.; Fletcher, C.E.; Gall, T.M.; Castellano, L.; Bevan, C.L.; Stebbing, J.; Krell, J. 2013: Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer. Expert Review of Molecular Diagnostics 13(5): 425-430
Mancuso, P.; Martin-Padura, I.; Calleri, A.; Marighetti, P.; Quarna, J.; Rabascio, C.; Braidotti, P.; Bertolini, F. 2011: Circulating perivascular progenitors: a target of PDGFR inhibition. International Journal of Cancer 129(6): 1344-1350
Reiser, J. 2013: Circulating permeability factor suPAR: from concept to discovery to clinic. Transactions of the American Clinical and Climatological Association 124: 133-138
McCarthy, E.T.; Sharma, M.; Savin, V.J. 2010: Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clinical Journal of the American Society of Nephrology: Cjasn 5(11): 2115-2121
Wada, T.; Nangaku, M. 2014: Circulating permeability factors in primary focal segmental glomerulosclerosis. Nihon Jinzo Gakkai Shi 56(4): 478-485
Abbasi, A.; Corpeleijn, E.; Gansevoort, R.T.; Gans, R.O.B.; Struck, J.; Schulte, J.; Hillege, H.L.; van der Harst, P.; Stolk, R.P.; Navis, G.; Bakker, S.J.L. 2014: Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. Diabetologia 57(9): 1842-1849
Turbadkar, S.D.; Ghadge, D.P.; Patil, S.; Chowdhary, A.S.; Bharadwaj, R. 2007: Circulating phage type of Vibrio cholerae in Mumbai. Indian Journal of Medical Microbiology 25(2): 177-178
Srirangaraj, S.; Venkatesha, D. 2009: Circulating phage type of Vibrio cholerae in Mysore. Indian Journal of Medical Microbiology 27(2): 166-167
Kraljevic, K.; Wong, S.; Fulcher, D.A. 2013: Circulating phenotypic B-1 cells are decreased in common variable immunodeficiency and correlate with immunoglobulin M levels. Clinical and Experimental Immunology 171(3): 278-282
Sabater, M.òn.; Moreno-Navarrete, J.M.; Ortega, F.J.é; Pardo, G.; Salvador, J.; Ricart, W.; Frühbeck, G.; Fernández-Real, J.é M. 2010: Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. Journal of Clinical Endocrinology and Metabolism 95(10): 4720-4728
Dhakal, P.; Hirama, A.; Nambo, Y.; Harada, T.; Sato, F.; Nagaoka, K.; Watanabe, G.; Taya, K. 2012: Circulating pituitary and gonadal hormones in spring-born Thoroughbred fillies and colts from birth to puberty. Journal of Reproduction and Development 58(5): 522-530
Ellis, E.; Sidhu, S. 2014: Circulating plakin autoantibodies in a patient with erythema multiforme major: are they pathogenic or a manifestation of epitope spreading?. Australasian Journal of Dermatology 55(4): 266-269
Lehner, J.; Stötzer, O.J.; Fersching, D.; Nagel, D.; Holdenrieder, S. 2013: Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy. Clinica Chimica Acta; International Journal of Clinical Chemistry 425: 206-211
Paci, M.; Maramotti, S.; Bellesia, E.; Formisano, D.; Albertazzi, L.; Ricchetti, T.; Ferrari, G.; Annessi, V.; Lasagni, D.; Carbonelli, C.; De Franco, S.; Brini, M.; Sgarbi, G.; Lodi, R. 2009: Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 64(1): 92-97
Cheng, H.; Zhang, L.; Cogdell, D.E.; Zheng, H.; Schetter, A.J.; Nykter, M.; Harris, C.C.; Chen, K.; Hamilton, S.R.; Zhang, W. 2011: Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. Plos one 6(3): E17745
Bhattacharyya, S.; Jagroop, A.; Gujral, D.M.; Hayward, C.; Toumpanakis, C.; Caplin, M.; Mikhailidis, D.P.; Davar, J. 2013: Circulating plasma and platelet 5-hydroxytryptamine in carcinoid heart disease: a pilot study. Journal of Heart Valve Disease 22(3): 400-407
Riccioni, G.; D Orazio, N.; Scotti, L.; Petruzzelli, R.; Latino, A.; Bucciarelli, V.; Pennelli, A.; Cicolini, G.; Di Ilio, E.; Bucciarelli, T. 2010: Circulating plasma antioxidants, inflammatory markers and asymptomatic carotid atherosclerosis in end-stage renal disease patients: a case control study. International Journal of Immunopathology and Pharmacology 23(1): 327-334
Peceliunas, V.; Janiulioniene, A.; Matuzeviciene, R.; Zvirblis, T.; Griskevicius, L. 2012: Circulating plasma cells predict the outcome of relapsed or refractory multiple myeloma. Leukemia and Lymphoma 53(4): 641-647
Chen, M.; Green, R. 2013: Circulating plasma cells with Russell bodies in osteosclerotic myeloma. Blood 122(2): 160
Zachariah, J.P.; Pencina, M.J.; Lyass, A.; Kaur, G.; D'Agostino, R.B.; Ordovas, J.M.; Vasan, R.S. 2011: Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community. Journal of Hypertension 29(5): 863-868
Reynolds, R.M.; Ilyas, B.; Price, J.F.; Fowkes, F.G.R.; Newby, D.E.; Webb, D.J.; Walker, B.R. 2009: Circulating plasma cortisol concentrations are not associated with coronary artery disease or peripheral vascular disease. Qjm: Monthly Journal of the Association of Physicians 102(7): 469-475
Mariano, F.; Cantaluppi, V.; Stella, M.; Romanazzi, G.M.; Assenzio, B.; Cairo, M.; Biancone, L.; Triolo, G.; Ranieri, V.M.; Camussi, G. 2008: Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Critical Care 12(2): R42
Ruge, T.; Södergren, A.; Wållberg-Jonsson, S.; Larsson, A.; Arnlöv, J. 2014: Circulating plasma levels of cathepsin S and L are not associated with disease severity in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 43(5): 371-373
Dubois-Deruy, E.; Belliard, A.; Mulder, P.; Chwastyniak, M.; Beseme, O.; Henry, J.-P.; Thuillez, C.; Amouyel, P.; Richard, V.; Pinet, F. 2013: Circulating plasma serine208-phosphorylated troponin T levels are indicator of cardiac dysfunction. Journal of Cellular and Molecular Medicine 17(10): 1335-1344
Magrì, D.; Brioschi, M.; Banfi, C.; Schmid, J.P.; Palermo, P.; Contini, M.; Apostolo, A.; Bussotti, M.; Tremoli, E.; Sciomer, S.; Cattadori, G.; Fiorentini, C.; Agostoni, P. 2009: Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure. CIRCULATION. Heart Failure 2(3): 175-180
Mansour, H.; Laird, M.E.; Saleh, R.; Casrouge, A.; Eldin, N.S.; El Kafrawy, S.; Hamdy, M.; Decalf, J.ér.ém.; Rosenberg, B.R.; Fontanet, A.; Abdel-Hamid, M.; Mohamed, M.K.; Albert, M.L.; Rafik, M. 2010: Circulating plasmacytoid dendritic cells in acutely infected patients with hepatitis C virus genotype 4 are normal in number and phenotype. Journal of Infectious Diseases 202(11): 1671-1675
Saito, A.; Yokohama, A.; Osaki, Y.; Ogawa, Y.; Nakahashi, H.; Toyama, K.; Mitsui, T.; Hashimoto, Y.; Koiso, H.; Uchiumi, H.; Saitoh, T.; Handa, H.; Sawamura, M.; Karasawa, M.; Murakami, H.; Tsukamoto, N.; Nojima, Y. 2012: Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia. European Journal of Haematology 88(4): 340-349
Wood, P.L.; Mankidy, R.; Ritchie, S.; Heath, D.; Wood, J.A.; Flax, J.; Goodenowe, D.B. 2010: Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients. Journal of Psychiatry and Neuroscience: Jpn 35(1): 59-62
Alm, J.J.; Koivu, H.M.A.; Heino, T.J.; Hentunen, T.A.; Laitinen, S.; Aro, H.T. 2010: Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 28(12): 1634-1642
Tantawy, A.Abdel.Gawad.; Adly, A.Abdel.Moneam.; Ismail, E.Abdel.Rahman.; Habeeb, N.Mamdouh.; Farouk, A. 2013: Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications. Platelets 24(8): 605-614
Rautou, P-Emmanuel.; Vion, A-Clémence.; Valla, D.; Boulanger, C.M. 2013: Circulating platelet derived microparticles are not increased in patients with cirrhosis. Journal of Hepatology 59(4): 912
Liu, J.; Chen, R.; Marathe, G.K.; Febbraio, M.; Zou, W.; McIntyre, T.M. 2011: Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase. Circulation Research 108(4): 469-477
Lok, C.A.R.; Böing, A.N.; Sargent, I.L.; Sooranna, S.R.; van der Post, J.A.M.; Nieuwland, R.; Sturk, A. 2008: Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia. Reproductive Sciences 15(10): 1002-1010
Kang, P.; Shen, B.; Yang, J.; Pei, F. 2008: Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head. Thrombosis Research 123(2): 367-373
Koiou, E.; Tziomalos, K.; Katsikis, I.; Kalaitzakis, E.; Kandaraki, E.A.; Tsourdi, E.A.; Delkos, D.; Papadakis, E.; Panidis, D. 2011: Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels. European Journal of Endocrinology 165(1): 63-68
Kornerup, K.N.; Salmon, G.P.; Pitchford, S.C.; Liu, W.L.; Page, C.P. 2010: Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration. Journal of Applied Physiology 109(3): 758-767
Maugeri, N.; Franchini, S.; Campana, L.; Baldini, M.; Ramirez, G.A.; Sabbadini, M.G.; Rovere-Querini, P.; Manfredi, A.A. 2012: Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity 45(8): 584-587
Baxendale, H.E.; Johnson, M.; Keating, S.M.; Ashton, L.; Burbidge, P.; Woodgate, S.; Southern, J.; Miller, E.; Goldblatt, D. 2010: Circulating pneumococcal specific plasma and memory B cells in the elderly two years after pneumococcal conjugate versus polysaccharide vaccination. Vaccine 28(42): 6915-6922
Tan, L.; Dickens, J.A.; Demeo, D.L.; Miranda, E.; Perez, J.; Rashid, S.T.; Day, J.; Ordoñez, A.; Marciniak, S.J.; Haq, I.; Barker, A.F.; Campbell, E.J.; Eden, E.; McElvaney, N.G.; Rennard, S.I.; Sandhaus, R.A.; Stocks, J.M.; Stoller, J.K.; Strange, C.; Turino, G.; Rouhani, F.N.; Brantly, M.; Lomas, D.A. 2014: Circulating polymers in α1-antitrypsin deficiency. European Respiratory Journal 43(5): 1501-1504
He, J.; Tsai, L.M.; Leong, Y.A.; Hu, X.; Ma, C.S.; Chevalier, N.; Sun, X.; Vandenberg, K.; Rockman, S.; Ding, Y.; Zhu, L.; Wei, W.; Wang, C.; Karnowski, A.; Belz, G.T.; Ghali, J.R.; Cook, M.C.; Riminton, D.S.; Veillette, A.é; Schwartzberg, P.L.; Mackay, F.; Brink, R.; Tangye, S.G.; Vinuesa, C.G.; Mackay, C.R.; Li, Z.; Yu, D. 2013: Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39(4): 770-781
Stark, J.R.; Li, H.; Kraft, P.; Kurth, T.; Giovannucci, E.L.; Stampfer, M.J.; Ma, J.; Mucci, L.A. 2009: Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. International Journal of Cancer 124(11): 2683-2689
Kronenberg, D.; Knight, R.R.; Estorninho, M.; Ellis, R.J.; Kester, M.G.; de Ru, A.; Eichmann, M.; Huang, G.C.; Powrie, J.; Dayan, C.M.; Skowera, A.; van Veelen, P.A.; Peakman, M. 2012: Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells. Diabetes 61(7): 1752-1759
Yang, G.; Li, L.; Chen, W.; Liu, H.; Boden, G.; Li, K. 2009: Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Annals of Medicine 41(1): 52-56
Masson, S.; Caironi, P.; Fanizza, C.; Thomae, R.; Bernasconi, R.; Noto, A.; Oggioni, R.; Pasetti, G.S.; Romero, M.; Tognoni, G.; Latini, R.; Gattinoni, L. 2015: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Intensive Care Medicine 41(1): 12-20
Talaat, R.M.; Salem, T.A.; El-Masry, S.; Imbarek, A.; Mokhles, M.; Abdel-Aziz, A. 2014: Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma. Journal of Medical Virology 86(7): 1120-1129
Donnelly, J.C.; Cooley, S.M.; Walsh, T.A.; Smith, O.P.; Gillan, J.; McMahon, C.; Geary, M.P. 2013: Circulating pro- and anticoagulant levels in normal and complicated primigravid pregnancies and their relationship to placental pathology. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 33(3): 264-268
Oudemans-van Straaten, H.M. 2008: Circulating pro-apoptotic mediators in burn septic acute renal failure. Critical Care 12(2): 126
Betjes, M.G.H.; de Wit, E.E.A.; Weimar, W.; Litjens, N.H.R. 2010: Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25(11): 3640-3646
Su, S.-C.; Pei, D.; Hsieh, C.-H.; Hsiao, F.-C.; Wu, C.-Z.; Hung, Y.-J. 2011: Circulating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes. Acta Diabetologica 48(2): 113-119
Taguchi, A.; Hanash, S.; Rundle, A.; McKeague, I.W.; Tang, D.; Darakjy, S.; Gaziano, J.M.; Sesso, H.D.; Perera, F. 2013: Circulating pro-surfactant protein B as a risk biomarker for lung cancer. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 22(10): 1756-1761
Mavromatis, K.; Aznaouridis, K.; Al Mheid, I.; Veledar, E.; Dhawan, S.; Murrow, J.R.; Forghani, Z.; Sutcliffe, D.J.; Ghasemzadeh, N.; Alexander, R.W.; Taylor, W.R.; Quyyumi, A.A. 2012: Circulating proangiogenic cell activity is associated with cardiovascular disease risk. Journal of Biomolecular Screening 17(9): 1163-1170
Giovanella, L.; Suriano, S.; Ricci, R.; Ravani, P.; Ceriani, L. 2010: Circulating procalcitonin in aseptic carcinoma patients: a specificity study with (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography as benchmark. Clinical Chemistry and Laboratory Medicine 48(8): 1163-1165
Bal, L.; Ederhy, Séphane.; Di Angelantonio, E.; Toti, F.; Zobairi, F.; Dufaitre, G.; Meuleman, C.; Mallat, Z.; Boccara, F.; Tedgui, A.; Freyssinet, J.Marie.; Cohen, A. 2010: Circulating procoagulant microparticles in acute pulmonary embolism: a case-control study. International Journal of Cardiology 145(2): 321-322
Thaler, J.; Ay, C.; Weinstabl, H.; Dunkler, D.; Simanek, R.; Vormittag, R.; Freyssinet, J-Marie.; Zielinski, C.; Pabinger, I. 2011: Circulating procoagulant microparticles in cancer patients. Annals of Hematology 90(4): 447-453
Ay, C.; Freyssinet, J-Marie.; Sailer, T.; Vormittag, R.; Pabinger, I. 2009: Circulating procoagulant microparticles in patients with venous thromboembolism. Thrombosis Research 123(5): 724-726
Shimoni, S.; Bar, I.; Zilberman, L.; Goland, S.; Edri, O.; Gandelman, G.; Afek, A.; Shamiss, A.; George, J. 2013: Circulating progenitor and apoptotic progenitor cells in patients with aortic regurgitation. Circulation Journal: Official Journal of the Japanese Circulation Society 77(3): 764-771
Alessio, A.M.; Beltrame, M.P.; Nascimento, M.C.F.; Vicente, C.P.; de Godoy, J.A.P.; Silva, J.C.R.S.; Bittar, L.F.; Lorand-Metze, I.; de Paula, E.V.; Annichino-Bizzacchi, J.M. 2013: Circulating progenitor and mature endothelial cells in deep vein thrombosis. International Journal of Medical Sciences 10(12): 1746-1754
Fadini, G.P.; Maruyama, S.; Ozaki, T.; Taguchi, A.; Meigs, J.; Dimmeler, S.; Zeiher, A.M.; de Kreutzenberg, S.; Avogaro, A.; Nickenig, G.; Schmidt-Lucke, C.; Werner, N. 2010: Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. Plos one 5(7): E11488
Coppolino, G.; Bolignano, D.; Campo, S.; Loddo, S.; Teti, D.; Buemi, M. 2008: Circulating progenitor cells after cold pressor test in hypertensive and uremic patients. Hypertension Research: Official Journal of the Japanese Society of Hypertension 31(4): 717-724
Gomer, R.H. 2008: Circulating progenitor cells and scleroderma. Current Rheumatology Reports 10(3): 183-188
Mandraffino, G.; Sardo, M.A.; Riggio, S.; D'Ascola, A.; Alibrandi, A.; Saitta, C.; Versace, A.; Castaldo, M.; Mormina, E.; Imbalzano, E.; Cinquegrani, M.; Bonaiuto, M.; David, A.; Saitta, A. 2012: Circulating progenitor cells and the elderly: a seven-year observational study. Experimental Gerontology 47(5): 394-400
Pizarro, S.; García-Lucio, J.és.; Peinado, V.íc.I.; Tura-Ceide, O.; Díez, M.; Blanco, I.; Sitges, M.; Petriz, J.; Torralba, Y.; Marín, P.; Roca, J.; Barberà, J.A. 2014: Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease. Plos one 9(8): E106163
Ghasemzadeh, N.; Zhang, L.; Al Mheid, I.; Li, Q.; Sperling, L.; Waller, E.K.; Taylor, W.R.; Guest, J.; Quyyumi, A.A.; Mavromatis, K. 2014: Circulating progenitor cells are reduced in HIV-positive, anti-retroviral naïve patients. International Journal of Cardiology 176(3): 1150-1152
Tilokee, E.L.; Davis, D.R. 2013: Circulating progenitor cells as a heart failure biomarker: does a failing marrow predict a failing heart?. Canadian Journal of Cardiology 29(6): 662-663
Adams, V.; Linke, A.; Breuckmann, F.; Leineweber, K.; Erbs, S.; Kränkel, N.; Bröcker-Preuss, M.; Woitek, F.; Erbel, R.; Heusch, G.; Hambrecht, R.; Schuler, G.; Möhlenkamp, S. 2008: Circulating progenitor cells decrease immediately after marathon race in advanced-age marathon runners. European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology Working Groups on Epidemiology and Prevention and Cardiac Rehabilitation and Exercise Physiology 15(5): 602-607
Corral, L.; Conde, L.; Guillamó, E.; Blasi, J.; Juncadella, M.; Javierre, C.; Viscor, G.és.; Ventura, J.L. 2014: Circulating progenitor cells during exercise, muscle electro-stimulation and intermittent hypobaric hypoxia in patients with traumatic brain injury: a pilot study. Neurorehabilitation 35(4): 763-769
Mehrad, B.; Keane, M.P.; Gomperts, B.N.; Strieter, R.M. 2007: Circulating progenitor cells in chronic lung disease. Expert Review of Respiratory Medicine 1(1): 157-165
Rochefort, G.Y. 2008: Circulating progenitor cells in coronary heart disease. Heart 94(6): 793
Watson, T.; Shantsila, E.; Blann, A.; Lip, G.Y.H. 2010: Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis. Thrombosis and Haemostasis 104(2): 327-334
Lo Gullo, A.; Mandraffino, G.; Sardo, M.A.; D'Ascola, A.; Mamone, F.; Loddo, S.; Alibrandi, A.; Imbalzano, E.; Mandraffino, R.; Mormina, E.; Saitta, C.; Lo Gullo, R.; David, A.; Saitta, A. 2014: Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. Scandinavian Journal of Rheumatology 43(3): 184-193
Burnham, E.L. 2008: Circulating progenitors in lung injury: a novel therapy for acute respiratory distress syndrome?. Anesthesiology 108(3): 354-356
Bosch, E.; Labarta, E.; Crespo, J.; Simón, C.; Remohí, J.; Jenkins, J.; Pellicer, A. 2010: Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Human Reproduction 25(8): 2092-2100
Solassol, J.ér.ôm.; Guillot, B.; Maudelonde, T. 2011: Circulating prognosis markers in melanoma: proteomic profiling and clinical studies. Annales de Biologie Clinique 69(2): 151-157
Ghidoni, R.; Paterlini, A.; Benussi, L. 2012: Circulating progranulin as a biomarker for neurodegenerative diseases. American Journal of Neurodegenerative Disease 1(2): 180-190
Tanaka, Y.; Takahashi, T.; Tamori, Y. 2014: Circulating progranulin level is associated with visceral fat and elevated liver enzymes: significance of serum progranulin as a useful marker for liver dysfunction. Endocrine Journal 61(12): 1191-1196
Galcheva, S.V.; Iotova, V.M.; Yotov, Y.T.; Bernasconi, S.; Street, M.E. 2011: Circulating proinflammatory peptides related to abdominal adiposity and cardiometabolic risk factors in healthy prepubertal children. European Journal of Endocrinology 164(4): 553-558
Tikk, K.; Sookthai, D.; Johnson, T.; Rinaldi, S.; Romieu, I.; Tjønneland, A.; Olsen, A.; Overvad, K.; Clavel-Chapelon, F.; Baglietto, L.; Boeing, H.; Trichopoulou, A.; Lagiou, P.; Trichopoulos, D.; Palli, D.; Pala, V.; Tumino, R.; Rosso, S.; Panico, S.; Agudo, A.; Menéndez, V.; Sánchez, M.-J.; Amiano, P.; Huerta Castaño, J.M.; Ardanaz, E.; Bueno-de-Mesquita, H.B.; Monninkhof, E.; Onland-Moret, C.; Andersson, A.; Sund, M.; Weiderpass, E.; Khaw, K.-T.; Key, T.J.; Travis, R.C.; Gunter, M.J.; Riboli, E.; Dossus, L.; Kaaks, R. 2014: Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort. Annals of Oncology: Official Journal of the European Society for Medical Oncology 25(7): 1422-1428
Wang, T.; Lu, J.; Xu, Y.; Li, M.; Sun, J.; Zhang, J.; Xu, B.; Xu, M.; Chen, Y.; Bi, Y.; Wang, W.; Ning, G. 2013: Circulating prolactin associates with diabetes and impaired glucose regulation: a population-based study. Diabetes Care 36(7): 1974-1980
Consiglio, A.R.; Bridges, R.S. 2009: Circulating prolactin, MPOA prolactin receptor expression and maternal aggression in lactating rats. Behavioural Brain Research 197(1): 97-102
Bourrel, A-Sophie.; Clauser, S. 2013: Circulating proplatelet. Blood 122(22): 3559
Persson, L.; Cao, G.; Ståhle, L.; Sjöberg, B.G.; Troutt, J.S.; Konrad, R.J.; Gälman, C.; Wallén, H.åk.; Eriksson, M.; Hafström, I.äl.; Lind, S.; Dahlin, M.; Amark, P.; Angelin, B.; Rudling, M. 2010: Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans. Arteriosclerosis Thrombosis and Vascular Biology 30(12): 2666-2672
Roubtsova, A.; Munkonda, M.N.; Awan, Z.; Marcinkiewicz, J.; Chamberland, A.; Lazure, C.; Cianflone, K.; Seidah, N.G.; Prat, A. 2011: Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue. Arteriosclerosis Thrombosis and Vascular Biology 31(4): 785-791
Helo, P.; Cronin, A.M.; Danila, D.C.; Wenske, S.; Gonzalez-Espinoza, R.; Anand, A.; Koscuiszka, M.; Väänänen, R-Minna.; Pettersson, K.; Chun, F.K-H.; Steuber, T.; Huland, H.; Guillonneau, B.D.; Eastham, J.A.; Scardino, P.T.; Fleisher, M.; Scher, H.I.; Lilja, H. 2009: Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Clinical Chemistry 55(4): 765-773
Tylicka, M.; Matuszczak, E.; Dębek, W.; Hermanowicz, A.; Ostrowska, H. 2014: Circulating proteasome activity following mild head injury in children. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 30(7): 1191-1196
Majetschak, M.; Zedler, S.; Romero, J.; Albright, J.M.; Kraft, R.; Kovacs, E.J.; Faist, E.; Gamelli, R.L. 2010: Circulating proteasomes after burn injury. Journal of Burn Care and Research: Official Publication of the American Burn Association 31(2): 243-250
Deprimo, S.E.; Bello, C.L.; Smeraglia, J.; Baum, C.M.; Spinella, D.; Rini, B.I.; Michaelson, M.D.; Motzer, R.J. 2007: Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins. Journal of Translational Medicine 5: 32
Bay-Jensen, A.C.; Wichuk, S.; Byrjalsen, I.; Leeming, D.J.; Morency, N.; Christiansen, C.; Karsdal, M.A.; Maksymowych, W.P. 2013: Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis. Plos one 8(1): E54504
Harmon, C.S.; DePrimo, S.E.; Figlin, R.A.; Hudes, G.R.; Hutson, T.E.; Michaelson, M.D.; Négrier, S.; Kim, S.T.; Huang, X.; Williams, J.A.; Eisen, T.; Motzer, R.J. 2014: Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma. Cancer ChemoTherapy and Pharmacology 73(1): 151-161
Sauter, E.R.; Patel, N. 2010: Circulating proteins predict liver fibrosis in hepatitis C infection. Biomarkers in Medicine 4(5): 751-752
Li, Y.; Li, Y.; Chen, T.; Kuklina, A.S.; Bernard, P.; Esteva, F.J.; Shen, H.; Ferrari, M.; Hu, Y. 2014: Circulating proteolytic products of carboxypeptidase N for early detection of breast cancer. Clinical Chemistry 60(1): 233-242
Wiita, A.P.; Hsu, G.W.; Lu, C.M.; Esensten, J.H.; Wells, J.A. 2014: Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling. Proceedings of the National Academy of Sciences of the United States of America 111(21): 7594-7599
Qian, X.; Moss, N.G.; Fellner, R.C.; Goy, M.F. 2008: Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules. Endocrinology 149(9): 4499-4509
Boban, M.; Kocic, G.; Radenkovic, S.; Pavlovic, R.; Cvetkovic, T.; Deljanin-Ilic, M.; Ilic, S.; Bobana, M.D.; Djindjic, B.; Stojanovic, D.; Sokolovic, D.; Jevtovic-Stoimenov, T. 2014: Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease. Renal Failure 36(4): 613-618
Wang, Y.; Qian, C.; Roks, A.J.M.; Westermann, D.; Schumacher, S.-M.; Escher, F.; Schoemaker, R.G.; Reudelhuber, T.L.; van Gilst, W.H.; Schultheiss, H.-P.; Tschöpe, C.; Walther, T. 2010: Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction. CIRCULATION. Heart Failure 3(2): 286-293
Wang, W.; Noel, J.; Kaplan, H.J.; Dean, D.C. 2011: Circulating reactive oxidant causes apoptosis of retinal pigment epithelium and cone photoreceptors in the mouse central retina. Ophthalmology and Eye Diseases 3: 45-54
Nantakomol, D.; Dondorp, A.M.; Krudsood, S.; Udomsangpetch, R.; Pattanapanyasat, K.; Combes, V.; Grau, G.E.; White, N.J.; Viriyavejakul, P.; Day, N.P.J.; Chotivanich, K. 2011: Circulating red cell-derived microparticles in human malaria. Journal of Infectious Diseases 203(5): 700-706
Yang, C.; Hu, Y.; Cao, L.; Yang, J. 2012: Circulating regeneration and resource recovery of flue gas desulfurization residuals using a membrane electroreactor: from lab concept to commercial scale. Environmental Science and Technology 46(20): 11273-11279
Gates, J.D.; Clifton, G.T.; Benavides, L.C.; Sears, A.K.; Carmichael, M.G.; Hueman, M.T.; Holmes, J.P.; Jama, Y.H.; Mursal, M.; Zacharia, A.; Ciano, K.; Khoo, S.; Stojadinovic, A.; Ponniah, S.; Peoples, G.E. 2010: Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class Ii HER2/neu (AE37) peptide. Vaccine 28(47): 7476-7482
D'Arena, G.; Rossi, G.; Minervini, M.M.; Savino, L.; D'Auria, F.; Laurenti, L.; Del Principe, M.I.; Deaglio, S.; Biagi, A.; De Martino, L.; De Feo, V.; Statuto, T.; Musto, P.; Del Poeta, G. 2011: Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis. International Journal of Immunopathology and Pharmacology 24(4): 915-923
Sawan, S.; Burt, D.J.; Stern, P.L.; Holland, C.; Elkord, E. 2011: Circulating regulatory T cells in endometrial cancer: a role for age and menopausal status. Immunological Investigations 40(1): 62-75
Sandager, P.; Uldbjerg, N.; Henriksen, T.B.; Goldsmith, L.T.; Thorsen, P.; Weiss, G.; Vogel, I. 2009: Circulating relaxin and cervical length in midpregnancy are independently associated with spontaneous preterm birth. American Journal of Obstetrics and Gynecology 201(2): 169.E1-6
Senateş, E.; Colak, Y.; Yeşil, A.; Coşkunpinar, E.; Sahin, O.; Kahraman, O.T.; Erkalma Şenateş, B.; Tuncer, I. 2012: Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. Minerva Medica 103(5): 369-376
Kawamura, R.; Doi, Y.; Osawa, H.; Ninomiya, T.; Hata, J.; Yonemoto, K.; Tanizaki, Y.; Iida, M.; Makino, H.; Kiyohara, Y. 2010: Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25(10): 3236-3240
Owecki, M.; El Ali, Z.; Waśko, R.; Nikisch, E.; Sowiński, J. 2008: Circulating resistin levels are lower in hypothyroid women but independent from thyroid hormones concentrations. Neuro Endocrinology Letters 29(1): 131-136
Koch, A.; Weiskirchen, R.; Sanson, E.; Zimmermann, H.W.; Voigt, S.; Dückers, H.; Trautwein, C.; Tacke, F. 2010: Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation. Critical Care 14(5): R179
Mostafaie, N.; Sebesta, C.; Zehetmayer, S.; Jungwirth, S.; Huber, K.R.; Hinterberger, M.; Leitha, T.; Hofman, J.ör.; Hejtman, M.; Schrattbauer, K.; Krugluger, W.; Tragl, K.-H.; Fischer, P. 2011: Circulating retinol-binding protein 4 and metabolic syndrome in the elderly. Wiener Medizinische Wochenschrift 161(21-22): 505-510
Ingelsson, E.; Lind, L. 2009: Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care 32(4): 733-735
Ingelsson, E.; Sundström, J.; Melhus, H.åk.; Michaëlsson, K.; Berne, C.; Vasan, R.S.; Risérus, U.; Blomhoff, R.; Lind, L.; Arnlöv, J. 2009: Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 206(1): 239-244
Fernández-Real, J.é M.; Moreno, J.é M.ía.; Ricart, W. 2008: Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload. Diabetes 57(7): 1918-1925
Kocic, G.; Pavlovic, R.; Najman, S.; Nikolic, G.; Sokolovic, D.; Jevtovic-Stoimenov, T.; Musovic, D.; Veljkovic, A.; Kocic, R.; Djindjic, N. 2011: Circulating ribonucleic acids and metabolic stress parameters may reflect progression of autoimmune or inflammatory conditions in juvenile type 1 diabetes. Thescientificworldjournal 11: 1496-1508
Parra, M.; Herrera, D.; Jácome, M.ía.F.; Mesa, M.C.; Rodríguez, L.-S.; Guzmán, C.; Angel, J.; Franco, M.A. 2014: Circulating rotavirus-specific T cells have a poor functional profile. Virology 468-470: 340-350
Marchetti, G.; Nasta, P.; Bai, F.; Gatti, F.; Bellistrì, G.M.; Tincati, C.; Borghi, F.; Carosi, G.; Puoti, M.; Monforte, A.d.'A. 2012: Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients. Plos one 7(2): E32028
De Pablo, R.úl.; Monserrat, J.; Reyes, E.; Díaz, D.; Rodríguez-Zapata, M.; de la Hera, A.; Prieto, A.; Álvarez-Mon, M. 2013: Circulating sICAM-1 and sE-Selectin as biomarker of infection and prognosis in patients with systemic inflammatory response syndrome. European Journal of Internal Medicine 24(2): 132-138
Jelić-Ivanović, Z.; Bujisić, N.; Spasić, S.; Bogavac-Stanojević, N.; Spasojević-Kalimanovska, V.; Kotur-Stevuljević, J. 2009: Circulating sTWEAK improves the prediction of coronary artery disease. Clinical Biochemistry 42(13-14): 1381-1386
Rinelli, S.; Spadafranca, A.; Fiorillo, G.; Cocucci, M.; Bertoli, S.; Battezzati, A. 2012: Circulating salicylic acid and metabolic and inflammatory responses after fruit ingestion. Plant Foods for Human Nutrition 67(1): 100-104
Shimizu, M.; Kishimoto, K.; Yamaguchi, T.; Nakano, Y.; Hara, A.; Dickhoff, W.W. 2011: Circulating salmon 28- and 22-kDa insulin-like growth factor binding proteins (IGFBPs) are co-orthologs of IGFBP-1. General and Comparative Endocrinology 174(2): 97-106
Shimizu, M.; Suzuki, S.; Horikoshi, M.; Hara, A.; Dickhoff, W.W. 2011: Circulating salmon 41-kDa insulin-like growth factor binding protein (IGFBP) is not IGFBP-3 but an IGFBP-2 subtype. General and Comparative Endocrinology 171(3): 326-331
Klangjareonchai, T.; Nimitphong, H.; Saetung, S.; Bhirommuang, N.; Samittarucksa, R.; Chanprasertyothin, S.; Sudatip, R.; Ongphiphadhanakul, B. 2014: Circulating sclerostin and irisin are related and interact with gender to influence adiposity in adults with prediabetes. International Journal of Endocrinology 2014: 261545
Ma, Y.-H.V.; Schwartz, A.V.; Sigurdsson, S.; Hue, T.F.; Lang, T.F.; Harris, T.B.; Rosen, C.J.; Vittinghoff, E.; Eiriksdottir, G.; Hauksdottir, A.M.; Siggeirsdottir, K.; Sigurdsson, G.; Oskarsdottir, D.; Napoli, N.; Palermo, L.; Gudnason, V.; Li, X. 2014: Circulating sclerostin associated with vertebral bone marrow fat in older men but not women. Journal of Clinical Endocrinology and Metabolism 99(12): E2584-E2590
Palomo, T.; Glorieux, F.H.; Rauch, F. 2014: Circulating sclerostin in children and young adults with heritable bone disorders. Journal of Clinical Endocrinology and Metabolism 99(5): E920-E925
Battaglino, R.A.; Sudhakar, S.; Lazzari, A.A.; Garshick, E.; Zafonte, R.; Morse, L.R. 2012: Circulating sclerostin is elevated in short-term and reduced in long-term SCi. Bone 51(3): 600-605
Costa, A.G.; Walker, M.D.; Zhang, C.A.; Cremers, S.; Dworakowski, E.; McMahon, D.J.; Liu, G.; Bilezikian, J.P. 2013: Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women. Journal of clinical endocrinology and metabolism 98(12): 4736-4743
Lu, Y-Chuan.; Wang, C-Ping.; Hsu, C-Chang.; Chiu, C-An.; Yu, T-Hung.; Hung, W-Chin.; Lu, L-Fen.; Chung, F-Mei.; Tsai, I-Ting.; Lin, H-Chang.; Lee, Y-Jiunn. 2013: Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews 29(7): 551-556
Velmurugan, S.; Brunton, P.J.; Leng, G.; Russell, J.A. 2010: Circulating secretin activates supraoptic nucleus oxytocin and vasopressin neurons via noradrenergic pathways in the rat. Endocrinology 151(6): 2681-2688
Ao, C.; Qi, L.; Xiong, Z.; Kang, A.; Guo, H.; Xue, L.; Huo, Y. 2008: Circulating secretory type IIA phospholipase A2, lipoprotein (a) and soluble cellular adhesion molecule levels in patients with angina pectoris. Clinical Biochemistry 41(18): 1423-1428
Roy, C.N.; Semba, R.D.; Sun, K.; Bandinelli, S.; Varadhan, R.; Patel, K.V.; Guralnik, J.M.; Ferrucci, L. 2012: Circulating selenium and carboxymethyl-lysine, an advanced glycation endproduct, are independent predictors of anemia in older community-dwelling adults. Nutrition 28(7-8): 762-766
Anastasilakis, A.D.; Polyzos, S.A.; Makras, P.; Gkiomisi, A.; Sakellariou, G.; Savvidis, M.; Papatheodorou, A.; Kokkoris, P.; Terpos, E. 2015: Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment. Expert Opinion on Therapeutic Targets 19(3): 299-306
Koliou, M.; Ioannou, Y.; Efstratiou, A.; Hannidou, N.; Pieri, V.; Alexandrou, M.; Soteriades, E.S. 2007: Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 13(6): 645-647
Patel, J.V.; Abraheem, A.; Dotsenko, O.; Creamer, J.; Gunning, M.; Hughes, E.A.; Lip, G.Y.H. 2008: Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. Journal of Internal Medicine 264(6): 593-598
Landgren, O.; Goedert, J.J.; Rabkin, C.S.; Wilson, W.H.; Dunleavy, K.; Kyle, R.A.; Katzmann, J.A.; Rajkumar, S.V.; Engels, E.A. 2010: Circulating serum free light chains as predictive markers of AIDS-related lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(5): 773-779
Shao, Q.; Liu, H.; Ng, C.Y.; Xu, G.; Liu, E.; Li, G.; Liu, T. 2014: Circulating serum levels of growth differentiation factor-15 and neuregulin-1 in patients with paroxysmal non-valvular atrial fibrillation. International Journal of Cardiology 172(2): E311-E313
Clark, E.H.; Marks, M.A.; Gilman, R.H.; Fernandez, A.B.; Crawford, T.C.; Samuels, A.M.; Hidron, A.I.; Galdos-Cardenas, G.; Menacho-Mendez, G.S.; Bozo-Gutierrez, R.W.; Martin, D.L.; Bern, C. 2015: Circulating serum markers and QRS scar score in Chagas cardiomyopathy. American Journal of Tropical Medicine and Hygiene 92(1): 39-44
Zákovičová, E.; Charvat, J.; Kukacka, J.; Chlumsky, J.; Svab, P.; Kvapil, M. 2010: Circulating serum matrix metalloproteinase-3 and metalloproteinase-9 are not associated with echocardiographic parameters of diastolic function in asymptomatic type 2 diabetic patients. Journal of International Medical Research 38(6): 2093-2099
Syring, I.; Bartels, J.; Holdenrieder, S.; Kristiansen, G.; Müller, S.C.; Ellinger, J.ör. 2015: Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer. Journal of Urology 193(1): 331-337
Kubiczkova, L.; Kryukov, F.; Slaby, O.; Dementyeva, E.; Jarkovsky, J.; Nekvindova, J.; Radova, L.; Greslikova, H.; Kuglik, P.; Vetesnikova, E.; Pour, L.; Adam, Z.; Sevcikova, S.; Hajek, R. 2014: Circulating serum micro RNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance. Haematologica 99(3): 511-518
Jakimovska, M.; Cerne, K.; Verdenik, I.; Kobal, B. 2014: Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites. Radiology and Oncology 48(3): 307-313
Du, T.-y.; Luo, H.-m.; Qin, H.-c.; Wang, F.; Wang, Q.; Xiang, Y.; Zhang, Y. 2013: Circulating serum trefoil factor 3 (TFF3) is dramatically increased in chronic kidney disease. Plos one 8(11): E80271
Samson, M.Hessellund.; Vestergaard, E.M.; Milman, N.; Poulsen, S.Seier.; Nexo, E. 2008: Circulating serum trefoil factors increase dramatically during pregnancy. Scandinavian Journal of Clinical and Laboratory Investigation 68(5): 369-374
Chakra, M.; Pujol, J.L.; Lamy, P.-J.; Bozonnat, M.C.; Quantin, X.; Jacot, W.; Daurès, J.-P. 2008: Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 3(10): 1119-1126
Nakhai Pour, H.R.; Grobbee, D.E.; Bots, M.L.; Verhaar, H.J.J.; Muller, M.; van der Schouw, Y.T. 2007: Circulating sex hormone levels and aortic stiffness in men. Journal of the American Geriatrics Society 55(4): 621-622
Andersen, O.; Pedersen, S.B.; Svenstrup, B.; Hansen, B.R.; Paulsen, S.ør.K.; Rathje, G.S.; Richelsen, B.ør.; Nielsen, J.O.; Madsbad, S.; Iversen, J.; Haugaard, S.B. 2007: Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution. Clinical Endocrinology 67(2): 250-258
Sprague, B.L.; Trentham-Dietz, A.; Gangnon, R.E.; Buist, D.S.M.; Burnside, E.S.; Bowles, E.J.A.; Stanczyk, F.Z.; Sisney, G.S. 2011: Circulating sex hormones and mammographic breast density among postmenopausal women. Hormones and Cancer 2(1): 62-72
Secreto, G.; Meneghini, E.; Venturelli, E.; Cogliati, P.; Agresti, R.; Ferraris, C.; Gion, M.; Zancan, M.; Fabricio, A.S.C.; Berrino, F.; Cavalleri, A.; Micheli, A. 2011: Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study. International Journal of Biological Markers 26(4): 241-246
Keung, W.; Man, R.Y.K. 2011: Circulating sex hormones modulate vascular contractions and acute response to 17β-estradiol in rat mesenteric arteries. Pharmacology 88(1-2): 55-64
Ahmadi, H.; Allameh, F.; Baradaran, N.; Montaser-Kouhsari, L.; Bazargan-Hejazi, S.; Salem, S.; Mehrsai, A.; Pourmand, G. 2011: Circulating sex hormones play no role in the association between sexual activity and the risk of prostate cancer. Journal of Sexual Medicine 8(3): 905-913
Hankinson, S.E.; Eliassen, A.H. 2010: Circulating sex steroids and breast cancer risk in premenopausal women. Hormones and Cancer 1(1): 2-10
Salonia, A.; Abdollah, F.; Capitanio, U.; Suardi, N.; Gallina, A.; Castagna, G.; Clementi, M.C.; Briganti, A.; Rigatti, P.; Montorsi, F. 2013: Circulating sex steroids and prostate cancer: introducing the time-dependency theory. World Journal of Urology 31(2): 267-273
Chen, T.; Surcel, H.-M.; Lundin, E.; Kaasila, M.; Lakso, H.-A.; Schock, H.; Kaaks, R.; Koskela, P.; Grankvist, K.; Hallmans, G.; Pukkala, E.; Zeleniuch-Jacquotte, A.; Toniolo, P.; Lehtinen, M.; Lukanova, A. 2011: Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 20(2): 324-336
Bjørnerem, A.; Emaus, N.; Berntsen, G.K.R.; Joakimsen, R.M.; Fønnebø, V.; Wilsgaard, T.; Oian, P.ål.; Seeman, E.; Straume, B.ør. 2007: Circulating sex steroids, sex hormone-binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausal women and men: the Tromsø study. Calcified Tissue International 81(2): 65-72
George, J.W.; Holmberg, T.A.; Riggs, S.M.; Hawkins, M.G. 2008: Circulating siderophagocytes and erythrophagocytes in a corn snake (Elaphe guttata) after coelomic surgery. Veterinary Clinical Pathology 37(3): 308-311
Smith, P.M.; Ferguson, A.V. 2010: Circulating signals as critical regulators of autonomic state--central roles for the subfornical organ. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 299(2): R405-R415
Dhahbi, J.M. 2014: Circulating small noncoding RNAs as biomarkers of aging. Ageing Research Reviews 17: 86-98
Few, M. 2010: Circulating smallpox knowledge: Guatemalan doctors, Maya Indians and designing Spain's smallpox vaccination expedition, 1780-1803. British journal for the history of science 43(159 Pt 4): 519-537
Daniel, J.-M.; Sedding, D.G. 2011: Circulating smooth muscle progenitor cells in arterial remodeling. Journal of Molecular and Cellular Cardiology 50(2): 273-279
Bentzon, J.F.; Falk, E. 2010: Circulating smooth muscle progenitor cells in atherosclerosis and plaque rupture: current perspective and methods of analysis. Vascular Pharmacology 52(1-2): 11-20
Satoh, K.; Berk, B.C. 2008: Circulating smooth muscle progenitor cells: novel players in plaque stability. Cardiovascular Research 77(3): 445-447
Albiero, M.; Menegazzo, L.; Fadini, G.P. 2010: Circulating smooth muscle progenitors and atherosclerosis. Trends in Cardiovascular Medicine 20(4): 133-140
Saberi Hosnijeh, F.; Portengen, L.üt.; Bueno-de-Mesquita, H.B.; Heederik, D.; Vermeulen, R. 2013: Circulating soluble CD27 and CD30 in workers exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD). Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 22(12): 2420-2424
Vermeulen, R.; Hosnijeh, F.S.; Portengen, L.üt.; Krogh, V.; Palli, D.; Panico, S.; Tumino, R.; Sacredote, C.; Purdue, M.; Lan, Q.; Rothman, N.; Vineis, P. 2011: Circulating soluble CD30 and future risk of lymphoma; evidence from two prospective studies in the general population. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 20(9): 1925-1927
Fernández-Real, J.-M.; Handberg, A.; Ortega, F.; Højlund, K.; Vendrell, J.; Ricart, W. 2009: Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance. Journal of Nutritional Biochemistry 20(6): 477-484
Handberg, A.; Lopez-Bermejo, A.; Bassols, J.; Vendrell, J.; Ricart, W.; Fernandez-Real, J.M. 2009: Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men. Diabetes and Vascular Disease Research 6(1): 15-20
Setianto, B.Y.; Hartopo, A.B.; Gharini, P.P.R.; Anggrahini, D.W.; Irawan, B. 2010: Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome. Heart and Vessels 25(4): 282-287
Sakthivel, P.; Wermeling, F.; Elmgren, A.; Hulthe, J.; Kakoulidou, M.; Lefvert, A.K.; Lind, L. 2010: Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population. Scandinavian Journal of Clinical and Laboratory Investigation 70(4): 237-243
Erfani, N.; Razmkhah, M.; Ghaderi, A. 2010: Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer. Cancer Investigation 28(8): 828-832
Bielinski, S.J.; Pankow, J.S.; Foster, C.L.; Miller, M.B.; Hopkins, P.N.; Eckfeldt, J.H.; Hixson, J.; Liu, Y.; Register, T.; Myers, R.H.; Arnett, D.K. 2008: Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: the NHLBi Family Heart Study follow-up examination. Atherosclerosis 199(1): 172-178
Menini, T.; Ikeda, H.; Kimura, S.; Gugliucci, A. 2014: Circulating soluble RAGE increase after a cerebrovascular event. Clinical Chemistry and Laboratory Medicine 52(1): 109-116
Mitsuoka, H.; Toyohara, M.; Kume, N.; Hayashida, K.; Jinnai, T.; Tanaka, M.; Kita, T. 2009: Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein. Journal of Atherosclerosis and Thrombosis 16(5): 586-593
He, L.; Bao, H.; Xue, J.; Zheng, L.; Zhang, Q.; Sun, L.; Pan, H. 2014: Circulating soluble advanced glycation end product is inversely associated with the significant risk of developing cancer: evidence from a meta-analysis. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(9): 8749-8755
Ho, G.Y.F.; Wang, T.; Zheng, S.L.; Tinker, L.; Xu, J.; Rohan, T.E.; Wassertheil-Smoller, S.; Xue, X.; Augenlicht, L.H.; Peters, U.; Phipps, A.I.; Strickler, H.D.; Gunter, M.J.; Cushman, M. 2014: Circulating soluble cytokine receptors and colorectal cancer risk. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 23(1): 179-188
Signore, C.; Mills, J.L.; Qian, C.; Yu, K.F.; Rana, S.; Karumanchi, S.A.; Levine, R.J. 2008: Circulating soluble endoglin and placental abruption. Prenatal Diagnosis 28(9): 852-858
Silver, K.L.; Conroy, A.L.; Leke, R.G.F.; Leke, R.J.I.; Gwanmesia, P.; Molyneux, M.E.; Taylor, D.Wallace.; Wallace, D.Taylor.; Rogerson, S.J.; Kain, K.C. 2011: Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction. Plos one 6(9): E24985
Zhao, Z.-W.; Zhu, X.-L.; Luo, Y.-K.; Lin, C.-G.; Chen, L.-L. 2011: Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with angiographic coronary lesion complexity in patients with coronary artery disease. Clinical Cardiology 34(3): 172-177
Kobat, M.A.; Fırdolas, F.; Balin, M.; Çelik, A.; Bentli, R.; Baydas, A. 2013: Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with erectile dysfunction in patients without known coronary artery disease. Journal of Sexual Medicine 10(11): 2782-2789
Branchetti, E.; Bavaria, J.E.; Grau, J.B.; Shaw, R.E.; Poggio, P.; Lai, E.K.; Desai, N.D.; Gorman, J.H.; Gorman, R.C.; Ferrari, G. 2014: Circulating soluble receptor for advanced glycation end product identifies patients with bicuspid aortic valve and associated aortopathies. Arteriosclerosis Thrombosis and Vascular Biology 34(10): 2349-2357
Norata, G.D.; Garlaschelli, K.; Grigore, L.; Tibolla, G.; Raselli, S.; Redaelli, L.; Buccianti, G.; Catapano, A.L. 2009: Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 19(2): 129-134
Kotani, K.; Caccavello, R.; Taniguchi, N.; Gugliucci, A. 2012: Circulating soluble receptor for advanced glycation end products is inversely correlated to oxidized low-density lipoproteins in asymptomatic subjects. Journal of International Medical Research 40(5): 1878-1883
Basta, G.; Corciu, A.I.; Vianello, A.; Del Turco, S.; Foffa, I.; Navarra, T.; Chiappino, D.; Berti, S.; Mazzone, A. 2010: Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis. Atherosclerosis 210(2): 614-618
Adly, A.A.M.; Ismail, E.A.; Andrawes, N.G.; El-Saadany, M.A. 2014: Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis. Cytokine 65(2): 184-191
Bisgin, A.; Yalcin, A.D.; Gorczynski, R.M. 2012: Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients. Diabetes Research and Clinical Practice 96(3): E84-E86
Koch, A.; Voigt, S.; Kruschinski, C.; Sanson, E.; Dückers, H.; Horn, A.; Yagmur, E.; Zimmermann, H.; Trautwein, C.; Tacke, F. 2011: Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Critical Care 15(1): R63
Eugen-Olsen, J.; Andersen, O.; Linneberg, A.; Ladelund, S.; Hansen, T.W.; Langkilde, A.; Petersen, J.; Pielak, T.; Møller, L.N.; Jeppesen, J.; Lyngbaek, S.; Fenger, M.; Olsen, M.H.; Hildebrandt, P.R.; Borch-Johnsen, K.; Jørgensen, T.; Haugaard, S.B. 2010: Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. Journal of Internal Medicine 268(3): 296-308
Dalmeijer, G.W.; van der Schouw, Y.T.; Magdeleyns, E.J.; Vermeer, C.; Elias, S.G.; Velthuis, B.K.; de Jong, P.A.; Beulens, J.W.J. 2013: Circulating species of matrix Gla protein and the risk of vascular calcification in healthy women. International Journal of Cardiology 168(6): E168-E170
Wang, L.; Yao, M.; Dong, Z.; Zhang, Y.; Yao, D. 2014: Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(1): 9-20
Fox, T.E.; Bewley, M.C.; Unrath, K.A.; Pedersen, M.M.; Anderson, R.E.; Jung, D.Y.; Jefferson, L.S.; Kim, J.K.; Bronson, S.K.; Flanagan, J.M.; Kester, M. 2011: Circulating sphingolipid biomarkers in models of type 1 diabetes. Journal of Lipid Research 52(3): 509-517
Pchejetski, D.; Nunes, J.; Sauer, L.; Sidhu, J.; Sharma, A.; Keun, H.C.; Waxman, J.; Stebbing, J. 2010: Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer. Breast Cancer Research and Treatment 124(2): 543-549
Machalinska, A.; Modrzejewska, M.; Kotowski, M.; Dziedziejko, V.; Kucia, M.; Kawa, M.; Safranow, K.; Baskiewicz-Masiuk, M.; Modrzejewska, A.; Karczewicz, D.; Rudnicki, J.; Machalinski, B. 2010: Circulating stem cell populations in preterm infants: implications for the development of retinopathy of prematurity. Archives of Ophthalmology 128(10): 1311-1319
Fortini, C.; Toffoletto, B.; Fucili, A.; Puppato, E.; Olivares, A.; Beltrami, A.P.; Fiorelli, V.; Bergamin, N.; Cesselli, D.; Morelli, C.; Francolini, G.; Ferrari, R.; Beltrami, C.A. 2011: Circulating stem cell vary with NYHA stage in heart failure patients. Journal of Cellular and Molecular Medicine 15(8): 1726-1736
Sun, Y-Fan.; Xu, Y.; Yang, X-Rong.; Guo, W.; Zhang, X.; Qiu, S-Jian.; Shi, R-Yu.; Hu, B.; Zhou, J.; Fan, J. 2013: Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 57(4): 1458-1468
Bershteĭn, L.M. 2009: Circulating stem cells: a comparison of breast cancer and cardiovascular pathology. Voprosy Onkologii 55(5): 528-533
Baglietto, L.; English, D.R.; Hopper, J.L.; MacInnis, R.J.; Morris, H.A.; Tilley, W.D.; Krishnan, K.; Giles, G.G. 2009: Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition. Breast Cancer Research and Treatment 115(1): 171-179
Baglietto, L.; Severi, G.; English, D.R.; Krishnan, K.; Hopper, J.L.; McLean, C.; Morris, H.A.; Tilley, W.D.; Giles, G.G. 2010: Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 19(2): 492-502
Sovero, M.; Garcia, J.; Kochel, T.; Laguna-Torres, V.Alberto.; Gomez, J.; Chicaiza, W.; Barrantes, M.; Sanchez, F.; Jimenez, M.; Comach, G.; de Rivera, I.Lorenzana.; Arango, A.E.; Agudo, R.; Halsey, E.S. 2011: Circulating strains of human respiratory syncytial virus in central and south America. Plos one 6(8): E22111
Woo, I.Sook.; Hong, S.Hee.; Byun, J.Ho.; Kang, J-Hyung.; Jeon, H-Myung.; Choi, M.Gyu. 2008: Circulating stromal cell derived factor-1alpha (SDF-1alpha) is predictive of distant metastasis in gastric carcinoma. Cancer Investigation 26(3): 256-261
Barutcu, I.; Karakaya, O.; Esen, A.M.; Dogan, S.; Saglam, M.; Kargin, R.; Karapinar, H.; Karavelioglu, Y.; Akgun, T.; Esen, O.; Ozdemir, N.; Turkmen, S.; Kaymaz, C. 2009: Circulating stromelysin concentration is elevated in hypertensive aortic root dilatation. Heart and Vessels 24(2): 138-141
Kelly, D.; Khan, S.; Cockerill, G.; Ng, L.L.; Thompson, M.; Samani, N.J.; Squire, I.B. 2008: Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. European Journal of Heart Failure 10(2): 133-139
Wei, C.; Trachtman, H.; Li, J.; Dong, C.; Friedman, A.L.; Gassman, J.J.; McMahan, J.L.; Radeva, M.; Heil, K.M.; Trautmann, A.; Anarat, A.; Emre, S.; Ghiggeri, G.M.; Ozaltin, F.; Haffner, D.; Gipson, D.S.; Kaskel, F.; Fischer, D.-C.; Schaefer, F.; Reiser, J. 2012: Circulating suPAR in two cohorts of primary FSGS. Journal of the American Society of Nephrology: Jasn 23(12): 2051-2059
Musetti, C.; Quaglia, M.; Cena, T.; Chiocchetti, A.; Monti, S.; Clemente, N.; Magnani, C.; Dianzani, U.; Stratta, P. 2015: Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis. Journal of Nephrology 28(3): 299-305
Sanvito, L.; Makowska, A.; Gregson, N.; Nemni, R.; Hughes, R.A.C. 2009: Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy. Autoimmunity 42(8): 667-677
Franceschi, F.; Longo, U.G.; Ruzzini, L.; Morini, S.; Battistoni, F.; Dicuonzo, G.; Maffulli, N.; Denaro, V. 2008: Circulating substance P levels and shoulder joint contracture after arthroscopic repair of the rotator cuff. British Journal of Sports Medicine 42(9): 742-745
Christensen, A.F.; Sørensen, G.L.; Hørslev-Petersen, K.; Holmskov, U.; Lindegaard, H.M.; Junker, K.; Hetland, M.L.; Stengaard-Pedersen, K.; Jacobsen, S.ør.; Lottenburger, T.; Ellingsen, T.; Andersen, L.S.; Hansen, I.; Skjødt, H.; Pedersen, J.K.; Lauridsen, U.B.; Svendsen, A.; Tarp, U.; Pødenphant, J.; Vestergaard, A.; Jurik, A.G.; Østergaard, M.; Junker, P. 2010: Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis. Arthritis Research and Therapy 12(2): R39
Fernández-Real, J.é M.; Chico, B.; Shiratori, M.; Nara, Y.; Takahashi, H.; Ricart, W. 2008: Circulating surfactant protein a (SP-A), a marker of lung injury, is associated with insulin resistance. Diabetes Care 31(5): 958-963
Sin, D.D.; Leung, R.; Gan, W.Q.; Man, S.P. 2007: Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. Bmc Pulmonary Medicine 7: 13
Hoegh, S.V.; Voss, A.; Sorensen, G.L.; Høj, A.; Bendixen, C.; Junker, P.; Holmskov, U. 2009: Circulating surfactant protein D is decreased in systemic lupus erythematosus. Journal of Rheumatology 36(11): 2449-2453
Galeotti, L.; Adrian, K.; Berg, S.; Tarkowski, A.; Bokarewa, M. 2008: Circulating survivin indicates severe course of juvenile idiopathic arthritis. Clinical and Experimental Rheumatology 26(2): 373-378
Bikov, A.; Bocskei, R.; Eszes, N.; Bohacs, A.; Losonczy, G.; Rigo, J.; Horvath, I.; Tamasi, L. 2014: Circulating survivin levels in healthy and asthmatic pregnancy. Reproductive Biology and Endocrinology: Rb&e 12: 93
Hirt, C.; Weitmann, K.; Schüler, F.; Kiefer, T.; Rabkin, C.S.; Hoffmann, W.; Dölken, G. 2013: Circulating t(14;18)-positive cells in healthy individuals: association with age and sex but not with smoking. Leukemia and Lymphoma 54(12): 2678-2684
Rydlewska, A.; Maj, J.; Katkowski, B.; Biel, B.; Ponikowska, B.; Banasiak, W.; Ponikowski, P.; Jankowska, E.A. 2013: Circulating testosterone and estradiol, autonomic balance and baroreflex sensitivity in middle-aged and elderly men with heart failure. Aging Male: the Official Journal of the International Society for the Study of the Aging Male 16(2): 58-66
Katsumata, E.; Ueda, Y.; Arai, K.; Katsumata, H.; Kishimoto, M.; Watanabe, G.; Taya, K. 2012: Circulating testosterone and inhibin levels at different ages in the male beluga (Delphinapterus leucas). Journal of Veterinary Medical Science 74(3): 293-300
Siu, K.L.; Cai, H. 2014: Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm. American Journal of Physiology. Heart and Circulatory Physiology 307(11): H1559-H1564
Yao, G.H.; Liu, Z.H.; Zhang, X.; Zheng, C.X.; Chen, H.P.; Zeng, C.H.; Li, L.S. 2008: Circulating thrombomodulin and vascular cell adhesion molecule-1 and renal vascular lesion in patients with lupus nephritis. Lupus 17(8): 720-726
Lansiaux, A.él.; Salingue, S.; Dewitte, A.él.; Clisant, S.ép.; Penel, N. 2012: Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapy. Investigational new Drugs 30(1): 403-404
Hanatani, S.; Izumiya, Y.; Takashio, S.; Kimura, Y.; Araki, S.; Rokutanda, T.; Tsujita, K.; Yamamoto, E.; Tanaka, T.; Yamamuro, M.; Kojima, S.; Tayama, S.; Kaikita, K.; Hokimoto, S.; Ogawa, H. 2014: Circulating thrombospondin-2 reflects disease severity and predicts outcome of heart failure with reduced ejection fraction. Circulation Journal: Official Journal of the Japanese Circulation Society 78(4): 903-910
Shalia, K.K.; Shah, V.K.; Mashru, M.R.; Soneji, S.L.; Vasvani, J.B.; Payannavar, S.S.; Walvalkar, A.P.; Mokal, R.A.; Mithbawkar, S.M.; Kudalkar, K.V.; Abraham, A.; Thakur, P.K. 2010: Circulating thrombotic and haemostatic components in patients with coronary artery disease. Indian Journal of Clinical Biochemistry: Ijcb 25(1): 20-28
Lombardi, C.P.; Bossola, M.; Princi, P.; Boscherini, M.; La Torre, G.; Raffaelli, M.; Traini, E.; Salvatori, M.; Pontecorvi, A.; Bellantone, R. 2008: Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer. American Journal of Surgery 196(3): 326-332
Gupta, M.; Chia, S.-Y. 2007: Circulating thyroid cancer markers. Current Opinion in Endocrinology Diabetes and Obesity 14(5): 383-388
Emerson, C.H. 2009: Circulating thyroid stimulating hormones: why, when, and what to measure. Thyroid: Official Journal of the American Thyroid Association 19(1): 1-3
Milas, M.; Shin, J.; Gupta, M.; Novosel, T.; Nasr, C.; Brainard, J.; Mitchell, J.; Berber, E.; Siperstein, A. 2010: Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples. Annals of Surgery 252(4): 643-651
Gutnick, J.; Soldes, O.; Gupta, M.; Milas, M. 2012: Circulating thyrotropin receptor messenger RNA for evaluation of thyroid nodules and surveillance of thyroid cancer in children. Journal of Pediatric Surgery 47(1): 171-176
Mondul, A.M.; Weinstein, S.J.; Bosworth, T.; Remaley, A.T.; Virtamo, J.; Albanes, D. 2012: Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer. Plos one 7(10): E47730
Steppich, B.A.; Hassenpflug, M.; Braun, S.L.; Schömig, K.; von Beckerath, O.; von Beckerath, N.; Eckstein, H-H.; Ott, I. 2011: Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis. Vasa. Zeitschrift für Gefasskrankheiten 40(2): 117-122
Ye, R.; Ye, C.; Huang, Y.; Liu, L.; Wang, S. 2012: Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. Thrombosis Research 130(2): 253-258
Vaidyula, V.R.; Criner, G.J.; Grabianowski, C.; Rao, A.K. 2009: Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease. Thrombosis Research 124(3): 259-261
Lechner, D.; Weltermann, A. 2008: Circulating tissue factor-exposing microparticles. Thrombosis Research 122 Suppl. 1: S47-S54
Elias, G.J.; Ioannis, M.; Theodora, P.; Dimitrios, P.P.; Despoina, P.; Kostantinos, V.; Charalampos, K.; Vassilios, V.; Petros, S.P. 2008: Circulating tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) in systemic sclerosis patients with elevated pulmonary arterial pressure. Mediators of Inflammation 2008: 164134
Park, M.H.; Moon, J. 2012: Circulating total glutathione in normal tension glaucoma patients: comparison with normal control subjects. Korean Journal of Ophthalmology: Kjo 26(2): 84-91
Ogawa, N.; Imai, Y.; Nishimura, H.; Kato, M.; Takeda, N.; Nawata, K.; Taketani, T.; Morota, T.; Takamoto, S.; Nagai, R.; Hirata, Y. 2013: Circulating transforming growth factor β-1 level in Japanese patients with Marfan syndrome. International Heart Journal 54(1): 23-26
Matt, P.; Schoenhoff, F.; Habashi, J.; Holm, T.; Van Erp, C.; Loch, D.; Carlson, O.D.; Griswold, B.F.; Fu, Q.; De Backer, J.; Loeys, B.; Huso, D.L.; McDonnell, N.B.; Van Eyk, J.E.; Dietz, H.C. 2009: Circulating transforming growth factor-beta in Marfan syndrome. Circulation 120(6): 526-532
Suzuki, T.; Trimarchi, S.; Sawaki, D.; Grassi, V.; Costa, E.; Rampoldi, V.; Nagai, R.; Eagle, K. 2011: Circulating transforming growth factor-beta levels in acute aortic dissection. Journal of the American College of Cardiology 58(7): 775
Grau, A.M.; Wen, W.; Ramroopsingh, D.S.; Gao, Y.-T.; Zi, J.; Cai, Q.; Shu, X.-O.; Zheng, W. 2008: Circulating transforming growth factor-beta-1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study. Breast Cancer Research and Treatment 112(2): 335-341
Divella, R.; Daniele, A.; Gadaleta, C.; Tufaro, A.; Venneri, M.T.; Paradiso, A.; Quaranta, M. 2012: Circulating transforming growth factor-β and epidermal growth factor receptor as related to virus infection in liver carcinogenesis. Anticancer Research 32(1): 141-145
Nyamache, A.K.; Muigai, A.W.T.; Khamadi, S.A. 2013: Circulating trends of non-B HIV type 1 subtypes among Kenyan individuals. Aids Research and Human Retroviruses 29(2): 400-403
Hyysalo, J.; Gopalacharyulu, P.; Bian, H.; Hyötyläinen, T.; Leivonen, M.; Jaser, N.; Juuti, A.; Honka, M.-J.; Nuutila, P.; Olkkonen, V.M.; Oresic, M.; Yki-Järvinen, H. 2014: Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity. Diabetes 63(1): 312-322
Karatayev, O.; Gaysinskaya, V.; Chang, G.-Q.; Leibowitz, S.F. 2009: Circulating triglycerides after a high-fat meal: predictor of increased caloric intake, orexigenic peptide expression, and dietary obesity. Brain Research 1298: 111-122
Moreno, M.ía.; Puig, J.; Serrano, M.; Moreno-Navarrete, J.é M.ía.; Ortega, F.; Ricart, W.; Fernandez-Real, J.M. 2014: Circulating tryptase as a marker for subclinical atherosclerosis in obese subjects. Plos one 9(5): E97014
Madic, J.; Kiialainen, A.; Bidard, F.-C.; Birzele, F.; Ramey, G.; Leroy, Q.; Rio Frio, T.; Vaucher, I.; Raynal, V.; Bernard, V.; Lermine, A.; Clausen, I.; Giroud, N.; Schmucki, R.; Milder, M.; Horn, C.; Spleiss, O.; Lantz, O.; Stern, M.-H.; Pierga, J.-Y.; Weisser, M.; Lebofsky, R. 2015: Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients. International Journal of Cancer 136(9): 2158-2165
Zhong, S.; Yang, M.; Johnson, P.J. 2001: Circulating tumor DNA and its application on tumor researches. Zhongguo Fei Ai Za Zhi 4(2): 112-115
Heitzer, E.; Ulz, P.; Geigl, J.B. 2015: Circulating tumor DNA as a liquid biopsy for cancer. Clinical Chemistry 61(1): 112-123
Qiu, M.; Wang, J.; Xu, Y.; Ding, X.; Li, M.; Jiang, F.; Xu, L.; Yin, R. 2015: Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 24(1): 206-212
Sausen, M.; Parpart, S.; Diaz, L.A. 2014: Circulating tumor DNA moves further into the spotlight. Genome Medicine 6(5): 35
Cristofanilli, M.; Fortina, P. 2013: Circulating tumor DNA to monitor metastatic breast cancer. New England Journal of Medicine 369(1): 93
Lippman, M.; Osborne, C.Kent. 2013: Circulating tumor DNA--ready for prime time?. New England Journal of Medicine 368(13): 1249-1250
Nisman, B.; Yutkin, V.; Nechushtan, H.; Gofrit, O.N.; Peretz, T.; Gronowitz, S.; Pode, D. 2010: Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy. Urology 76(2): 513.E1-6
Kuboki, Y.; Matsusaka, S.; Minowa, S.; Shibata, H.; Suenaga, M.; Shinozaki, E.; Mizunuma, N.; Ueno, M.; Yamaguchi, T.; Hatake, K. 2013: Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer. Anticancer Research 33(9): 3905-3910
Shaffer, D.R.; Leversha, M.A.; Danila, D.C.; Lin, O.; Gonzalez-Espinoza, R.; Gu, B.; Anand, A.; Smith, K.; Maslak, P.; Doyle, G.V.; Terstappen, L.W.M.M.; Lilja, H.; Heller, G.; Fleisher, M.; Scher, H.I. 2007: Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(7): 2023-2029
Allan, A.L.; Keeney, M. 2010: Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. Journal of Oncology 2010: 426218
Tanaka, F.; Yoneda, K.; Kondo, N.; Hashimoto, M.; Takuwa, T.; Matsumoto, S.; Okumura, Y.; Rahman, S.; Tsubota, N.; Tsujimura, T.; Kuribayashi, K.; Fukuoka, K.; Nakano, T.; Hasegawa, S. 2009: Circulating tumor cell as a diagnostic marker in primary lung cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(22): 6980-6986
Davis, J.W. 2009: Circulating tumor cell assays for the prognosis of prostate and colon cancers. Expert Opinion on Medical Diagnostics 3(3): 293-301
Aceto, N.; Bardia, A.; Miyamoto, D.T.; Donaldson, M.C.; Wittner, B.S.; Spencer, J.A.; Yu, M.; Pely, A.; Engstrom, A.; Zhu, H.; Brannigan, B.W.; Kapur, R.; Stott, S.L.; Shioda, T.; Ramaswamy, S.; Ting, D.T.; Lin, C.P.; Toner, M.; Haber, D.A.; Maheswaran, S. 2014: Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158(5): 1110-1122
Nel, I.; Gauler, T.; Hoffmann, A.-C. 2014: Circulating tumor cell composition and outcome in patients with solid tumors. International Journal of Clinical Pharmacology and Therapeutics 52(1): 74-75
Ide, H.; Lu, Y.; Tanaka, T.; Wakumoto, Y.; Kitamura, K.; Muto, S.; Yamaguchi, R.; Masumori, N.; Horie, S. 2014: Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study. Prostate International 2(3): 147-151
Sastre, J.; Maestro, M.L.; Gómez-España, A.; Rivera, F.; Valladares, M.; Massuti, B.; Benavides, M.; Gallén, M.; Marcuello, E.; Abad, A.; Arrivi, A.; Fernández-Martos, C.; González, E.ón.; Tabernero, J.M.; Vidaurreta, M.; Aranda, E.; Díaz-Rubio, E. 2012: Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. Oncologist 17(7): 947-955
Goldkorn, A.; Ely, B.; Quinn, D.I.; Tangen, C.M.; Fink, L.M.; Xu, T.; Twardowski, P.; Van Veldhuizen, P.J.; Agarwal, N.; Carducci, M.A.; Monk, J.P.; Datar, R.H.; Garzotto, M.; Mack, P.C.; Lara, P.; Higano, C.S.; Hussain, M.; Thompson, I.M.; Cote, R.J.; Vogelzang, N.J. 2014: Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase IIi trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32(11): 1136-1142
Marsland, T.; Schuur, E.R. 2014: Circulating tumor cell data: integration with imaging and serum tumor markers for metastatic breast cancer patient management. Case Reports in Oncology 7(1): 175-181
Reyal, F.; Valet, F.; de Cremoux, P.; Mathiot, C.; Decraene, C.; Asselain, B.; Brain, E.; Delaloge, S.; Giacchetti, S.; Marty, M.; Pierga, J.Y.; Bidard, F.C. 2011: Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(6): 1458-1459
Loh, J.; Jovanovic, L.; Lehman, M.; Capp, A.; Pryor, D.; Harris, M.; Nelson, C.; Martin, J. 2014: Circulating tumor cell detection in high-risk non-metastatic prostate cancer. Journal of Cancer Research and Clinical Oncology 140(12): 2157-2162
Pierga, J.-Y.; Bidard, F.ço.-C.ém.; Mathiot, C.; Brain, E.; Delaloge, S.; Giachetti, S.; de Cremoux, P.; Salmon, R.ém.; Vincent-Salomon, A.; Marty, M. 2008: Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase Ii randomized trial. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(21): 7004-7010
Harouaka, R.A.; Nisic, M.; Zheng, S.-Y. 2013: Circulating tumor cell enrichment based on physical properties. Journal of Laboratory Automation 18(6): 455-468
Satelli, A.; Brownlee, Z.; Mitra, A.; Meng, Q.H.; Li, S. 2015: Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response. Clinical Chemistry 61(1): 259-266
Lianidou, E.S. 2014: Circulating tumor cell isolation: a marathon race worth running. Clinical Chemistry 60(2): 287-289
Kim, S.; Han, S.-I.; Park, M.-J.; Jeon, C.-W.; Joo, Y.-D.; Choi, I.-H.; Han, K.-H. 2013: Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads. Analytical Chemistry 85(5): 2779-2786
Danila, D.C.; Heller, G.; Gignac, G.A.; Gonzalez-Espinoza, R.; Anand, A.; Tanaka, E.; Lilja, H.; Schwartz, L.; Larson, S.; Fleisher, M.; Scher, H.I. 2007: Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(23): 7053-7058
Goldkorn, A.; Ely, B.; Tangen, C.M.; Tai, Y.-C.; Xu, T.; Li, H.; Twardowski, P.; Veldhuizen, P.J.V.; Agarwal, N.; Carducci, M.A.; Monk, J.P.; Garzotto, M.; Mack, P.C.; Lara, P.; Higano, C.S.; Hussain, M.; Vogelzang, N.J.; Thompson, I.M.; Cote, R.J.; Quinn, D.I. 2015: Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase IIi metastatic castration resistant prostate cancer trial. International Journal of Cancer 136(8): 1856-1862
Cai, L.-L.; Ye, H.-M.; Zheng, L.-M.; Ruan, R.-S.; Tzeng, C.-M. 2014: Circulating tumor cells (CTCs) as a liquid biopsy material and drug target. Current Drug Targets 15(10): 965-972
Wang, S.; Zheng, G.; Cheng, B.; Chen, F.; Wang, Z.; Chen, Y.; Wang, Y.; Xiong, B. 2014: Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature. Plos one 9(6): E99259
Green, T.L.; Cruse, J.M.; Lewis, R.E.; Craft, B.S. 2013: Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment. Experimental and Molecular Pathology 95(2): 174-179
Dong, X.; Alpaugh, K.R.; Cristofanilli, M. 2012: Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis. Chinese Journal of Cancer Research 24(4): 388-398
Yoneda, K.; Tanaka, F.; Kondo, N.; Hashimoto, M.; Takuwa, T.; Matsumoto, S.; Okumura, Y.; Tsubota, N.; Sato, A.; Tsujimura, T.; Kuribayashi, K.; Fukuoka, K.; Tabata, C.; Nakano, T.; Hasegawa, S. 2014: Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM). Annals of Surgical Oncology 21(Suppl 4): S472-S480
Gradilone, A.; Naso, G.; Raimondi, C.; Cortesi, E.; Gandini, O.; Vincenzi, B.; Saltarelli, R.; Chiapparino, E.; Spremberg, F.; Cristofanilli, M.; Frati, L.; Aglianò, A.M.; Gazzaniga, P. 2011: Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(1): 86-92
Magnowski, P.; Bochyński, H.; Nowak-Markwitz, E.; Zabel, M.; Spaczyński, M. 2012: Circulating tumor cells (CTCs)--clinical significance in patients with ovarian cancer. Ginekologia Polska 83(4): 291-294
Mostert, B.; Sleijfer, S.; Foekens, J.A.; Gratama, J.W. 2009: Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treatment Reviews 35(5): 463-474
Heitzer, E.; Auer, M.; Ulz, P.; Geigl, J.B.; Speicher, M.R. 2013: Circulating tumor cells and DNA as liquid biopsies. Genome Medicine 5(8): 73
Khan, M.S.; Tsigani, T.; Rashid, M.; Rabouhans, J.S.; Yu, D.; Luong, T.V.; Caplin, M.; Meyer, T. 2011: Circulating tumor cells and EpCAM expression in neuroendocrine tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(2): 337-345
De Giorgi, U.; Valero, V.; Rohren, E.; Dawood, S.; Ueno, N.T.; Miller, M.C.; Doyle, G.V.; Jackson, S.; Andreopoulou, E.; Handy, B.C.; Reuben, J.M.; Fritsche, H.A.; Macapinlac, H.A.; Hortobagyi, G.N.; Cristofanilli, M. 2009: Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(20): 3303-3311
Murez, T.; Droupy, S.ép.; Rebillard, X.; Alix-Panabieres, C. 2012: Circulating tumor cells and advanced prostate cancer. Bulletin du Cancer 99(Suppl 1): S4-15
Reuben, J.M.; Lee, B.-N.; Li, C.; Gao, H.; Broglio, K.R.; Valero, V.; Jackson, S.A.; Ueno, N.T.; Krishnamurthy, S.; Hortobagyi, G.N.; Cristofanilli, M. 2010: Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer. Breast Journal 16(3): 327-330
Alix-Panabières, C.; Riethdorf, S.; Pantel, K. 2008: Circulating tumor cells and bone marrow micrometastasis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(16): 5013-5021
De Giorgi, U.; Valero, V.; Rohren, E.; Mego, M.; Doyle, G.V.; Miller, M.C.; Ueno, N.T.; Handy, B.C.; Reuben, J.M.; Macapinlac, H.A.; Hortobagyi, G.N.; Cristofanilli, M. 2010: Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 21(1): 33-39
Pierga, J.-Y.; Bidard, F.-C.; Cropet, C.; Tresca, P.; Dalenc, F.; Romieu, G.; Campone, M.; Mahier Aït-Oukhatar, C.; Le Rhun, E.; Gonçalves, A.; Leheurteur, M.; Dômont, J.; Gutierrez, M.; Curé, H.; Ferrero, J.-M.; Labbe-Devilliers, C.; Bachelot, T. 2013: Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial. Annals of Oncology: Official Journal of the European Society for Medical Oncology 24(12): 2999-3004
Bidard, F.-C.; Saliba, A.-E.; Saias, L.; Degeorges, A.; Cremoux, P.d.; Viovy, J.-L.; Vincent-Salomon, A.; Mathiot, C.; Pierga, J.-Y.; de Gramont, A. 2009: Circulating tumor cells and breast cancer: detection techniques and clinical results. Bulletin du Cancer 96(1): 73-86
Consoli, F.; Arcangeli, G.; Ferrari, V.; Grisanti, S.; Almici, C.; Bordonali, T.; Simoncini, E. 2011: Circulating tumor cells and cardiac metastasis from esophageal cancer: a case report. Case Reports in Oncology 4(2): 299-303
Alix-Panabières, C.; Schwarzenbach, H.; Pantel, K. 2012: Circulating tumor cells and circulating tumor DNA. Annual Review of Medicine 63: 199-215
Ignatiadis, M.; Dawson, S.-J. 2014: Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 25(12): 2304-2313
Criscitiello, C.; Sotiriou, C.; Ignatiadis, M. 2010: Circulating tumor cells and emerging blood biomarkers in breast cancer. Current Opinion in Oncology 22(6): 552-558
Yu, S.-R.; Wei, J.; Qian, X.-P.; Liu, B.-R. 2009: Circulating tumor cells and individualized chemotherapy. Ai Zheng 28(11): 1225-1232
Shaw, J.A.; Brown, J.; Coombes, R.C.; Jacob, J.; Payne, R.; Lee, B.; Page, K.; Hava, N.; Stebbing, J. 2011: Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer. Biomarkers in Medicine 5(1): 87-91
Capoun, O.; Soukup, V.; Mikulová, V.; Jančíková, M.ét.; Honová, H.; Kološtová, K.ín.; Zima, T.áš; Hanuš, T.áš 2014: Circulating tumor cells and prostate cancer prognosis. Casopis Lekaru Ceskych 153(2): 72-77
Smerage, J.B.; Barlow, W.E.; Hortobagyi, G.N.; Winer, E.P.; Leyland-Jones, B.; Srkalovic, G.; Tejwani, S.; Schott, A.F.; O'Rourke, M.A.; Lew, D.L.; Doyle, G.V.; Gralow, J.R.; Livingston, R.B.; Hayes, D.F. 2014: Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32(31): 3483-3489
Azim, H.A.; Rothé, F.; Aura, C.M.; Bavington, M.; Maetens, M.; Rouas, G.; Gebhart, G.; Gamez, C.; Eidtmann, H.; Baselga, J.é; Piccart-Gebhart, M.; Ellis, C.; Vuylsteke, P.; Cure, H.é; Domont, J.; Ferro, A.; Toral-Peña, J.C.; de Azambuja, E.; Sotiriou, C.; Di Cosimo, S.; Ignatiadis, M. 2013: Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase IIi trial. Breast 22(6): 1060-1065
Lalmahomed, Z.S.; Kraan, J.; Gratama, J.W.; Mostert, B.; Sleijfer, S.; Verhoef, C. 2010: Circulating tumor cells and sample size: the more, the better. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(17): E288
Gradilone, A.; Iacovelli, R.; Cortesi, E.; Raimondi, C.; Gianni, W.; Nicolazzo, C.; Petracca, A.; Palazzo, A.; Longo, F.; Frati, L.; Gazzaniga, P. 2011: Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma. Anticancer Research 31(12): 4219-4221
Cheng, M.; Liu, L.; Yang, H.-S.; Liu, G.-F. 2014: Circulating tumor cells are associated with bone metastasis of lung cancer. Asian Pacific Journal of Cancer Prevention: Apjcp 15(15): 6369-6374
Kaifi, J.T.; Kunkel, M.; Zhu, J.; Dicker, D.T.; Gusani, N.; Yang, Z.; Sarwani, N.E.; Li, G.; Kimchi, E.T.; Staveley-O'Carroll, K.F.; El-Deiry, W.S. 2013: Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients. Cancer Biology and Therapy 14(12): 1174-1181
Helzer, K.T.; Barnes, H.E.; Day, L.; Harvey, J.; Billings, P.R.; Forsyth, A. 2009: Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model. Cancer Research 69(19): 7860-7866
Torphy, R.J.; Tignanelli, C.J.; Kamande, J.W.; Moffitt, R.A.; Herrera Loeza, S.G.; Soper, S.A.; Yeh, J.J. 2014: Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma. Plos one 9(2): E89474
Okegawa, T.; Itaya, N.; Hara, H.; Tambo, M.; Nutahara, K. 2014: Circulating tumor cells as a biomarker predictive of sensitivity to docetaxel chemotherapy in patients with castration-resistant prostate cancer. Anticancer Research 34(11): 6705-6710
Pinton, G.; Manente, A.G.; Moro, L.; Mutti, L. 2012: Circulating tumor cells as a diagnostic test for malignant pleural mesothelioma. Expert Opinion on Medical Diagnostics 6(3): 171-173
Economos, C.; Morrissey, C.; Vessella, R.L. 2012: Circulating tumor cells as a marker of response: implications for determining treatment efficacy and evaluating new agents. Current Opinion in Urology 22(3): 190-196
Hashimoto, M.; Tanaka, F.; Yoneda, K.; Kondo, N.; Takuwa, T.; Matsumoto, S.; Kuroda, A.; Noda, M.; Tomita, N.; Hasegawa, S. 2012: Circulating tumor cells as a potential biomarker in selecting patients for pulmonary metastasectomy from colorectal cancer: report of a case. Case Reports in Oncology 5(3): 542-545
Taneja, S.S. 2009: Circulating tumor cells as a potential efficacy end point in clinical trials of hormone-resistant prostate cancer. Current Urology Reports 10(1): 4-5
Goodman, O.B.; Symanowski, J.T.; Loudyi, A.; Fink, L.M.; Ward, D.C.; Vogelzang, N.J. 2011: Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer. Clinical Genitourinary Cancer 9(1): 31-38
Igawa, S.; Gohda, K.; Fukui, T.; Ryuge, S.; Otani, S.; Masago, A.; Sato, J.; Murakami, K.; Maki, S.; Katono, K.; Takakura, A.; Sasaki, J.; Satoh, Y.; Masuda, N. 2014: Circulating tumor cells as a prognostic factor in patients with small cell lung cancer. Oncology Letters 7(5): 1469-1473
Matsusaka, S.; Suenaga, M.; Mishima, Y.; Kuniyoshi, R.; Takagi, K.; Terui, Y.; Mizunuma, N.; Hatake, K. 2011: Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer. Cancer Science 102(6): 1188-1192
Matsusaka, S.; Chìn, K.; Ogura, M.; Suenaga, M.; Shinozaki, E.; Mishima, Y.; Terui, Y.; Mizunuma, N.; Hatake, K. 2010: Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Science 101(4): 1067-1071
Hou, J.-M.; Krebs, M.; Ward, T.; Sloane, R.; Priest, L.; Hughes, A.; Clack, G.; Ranson, M.; Blackhall, F.; Dive, C. 2011: Circulating tumor cells as a window on metastasis biology in lung cancer. American Journal of Pathology 178(3): 989-996
Danila, D.C.; Fleisher, M.; Scher, H.I. 2011: Circulating tumor cells as biomarkers in prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(12): 3903-3912
Giuliano, M.; Giordano, A.; Jackson, S.; De Giorgi, U.; Mego, M.; Cohen, E.N.; Gao, H.; Anfossi, S.; Handy, B.C.; Ueno, N.T.; Alvarez, R.H.; De Placido, S.; Valero, V.; Hortobagyi, G.N.; Reuben, J.M.; Cristofanilli, M. 2014: Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination. Breast Cancer Research: Bcr 16(5): 440
Lianidou, E.S.; Markou, A. 2011: Circulating tumor cells as emerging tumor biomarkers in breast cancer. Clinical Chemistry and Laboratory Medicine 49(10): 1579-1590
Cho, E.H. 2012: Circulating tumor cells as emerging tumor biomarkers in lung cancer. Journal of Thoracic Disease 4(5): 444-445
Wong, M.P. 2012: Circulating tumor cells as lung cancer biomarkers. Journal of Thoracic Disease 4(6): 631-634
Kasimir-Bauer, S. 2009: Circulating tumor cells as markers for cancer risk assessment and treatment monitoring. Molecular Diagnosis and Therapy 13(4): 209-215
Consoli, F.; Grisanti, S.; Amoroso, V.; Almici, C.; Verardi, R.; Marini, M.; Simoncini, E. 2011: Circulating tumor cells as predictors of prognosis in metastatic breast cancer: clinical application outside a clinical trial. Tumori 97(6): 737-742
Boutrus, R.R.; Abi Raad, R.F.; Kuter, I.; Ancukiewicz, M.; Roberts, L.; Solomon, N.; Ngo, T.; Borick, H.; Ryan, P.; Moy, B.; Gadd, M.; Chien, J.; Younger, J.; Smith, B.; Taghian, A.G.; Harris, L. 2013: Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy. International Journal of Biological Markers 28(1): 17-23
Kiyohara, E.; Hata, K.; Lam, S.; Hoon, D.S.B. 2014: Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients. Methods in Molecular Biology 1102: 513-522
Andreopoulou, E.; Cristofanilli, M. 2010: Circulating tumor cells as prognostic marker in metastatic breast cancer. Expert Review of Anticancer Therapy 10(2): 171-177
Lianidou, E.S.; Strati, A.; Markou, A. 2014: Circulating tumor cells as promising novel biomarkers in solid cancers. Critical Reviews in Clinical Laboratory Sciences 51(3): 160-171
Van Dalum, G.; van der Stam, G.J.; Tibbe, A.G.J.; Franken, B.; Mastboom, W.J.B.; Vermes, I.; de Groot, M.R.; Terstappen, L.W.M.M. 2015: Circulating tumor cells before and during follow-up after breast cancer surgery. International Journal of Oncology 46(1): 407-413
Fu, L.; Liu, F.; Fu, H.; Liu, L.; Yuan, S.; Gao, Y.; Fu, Z.; Yu, J. 2014: Circulating tumor cells correlate with recurrence in stage IIi small-cell lung cancer after systemic chemoradiotherapy and prophylactic cranial irradiation. Japanese Journal of Clinical Oncology 44(10): 948-955
Gazzaniga, P.; Naso, G.; Raimondi, C.; Gradilone, A.; Palazzo, A.; Gandini, O.; Petracca, A.; Nicolazzo, C.; Cortesi, E.; Frati, L. 2011: Circulating tumor cells count and characterization in a male breast cancer patient. Cancer Biology and Therapy 12(5): 379-382
Romiti, A.; Raffa, S.; Di Rocco, R.; Roberto, M.; Milano, A.; Zullo, A.; Leone, L.; Ranieri, D.; Mazzetta, F.; Medda, E.; Sarcina, I.; Barucca, V.; D'Antonio, C.; Durante, V.; Ferri, M.; Torrisi, M.R.; Marchetti, P. 2014: Circulating tumor cells count predicts survival in colorectal cancer patients. Journal of Gastrointestinal and Liver Diseases: Jgld 23(3): 279-284
Mazzini, C.; Pinzani, P.; Salvianti, F.; Scatena, C.; Paglierani, M.; Ucci, F.; Pazzagli, M.; Massi, D. 2014: Circulating tumor cells detection and counting in uveal melanomas by a filtration-based method. Cancers 6(1): 323-332
Gazzaniga, P.; de Berardinis, E.; Raimondi, C.; Gradilone, A.; Busetto, G.M.; De Falco, E.; Nicolazzo, C.; Giovannone, R.; Gentile, V.; Cortesi, E.; Pantel, K. 2014: Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer. International Journal of Cancer 135(8): 1978-1982
Pavese, J.M.; Bergan, R.C. 2014: Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. Cancer Letters 352(2): 179-186
Mishra, D.K.; Scott, K.L.; Wardwell-Ozgo, J.M.; Thrall, M.J.; Kim, M.P. 2015: Circulating tumor cells from 4D model have less integrin beta 4 expression. Journal of Surgical Research 193(2): 745-753
Vishnoi, M.; Mishra, D.K.; Thrall, M.J.; Kurie, J.M.; Kim, M.P. 2014: Circulating tumor cells from a 4-dimensional lung cancer model are resistant to cisplatin. Journal of Thoracic and Cardiovascular Surgery 148(3): 1056-1063; Discussion: 1063-1064
Gakhar, G.; Navarro, V.N.; Jurish, M.; Lee, G.Y.; Tagawa, S.T.; Akhtar, N.H.; Seandel, M.; Geng, Y.; Liu, H.; Bander, N.H.; Giannakakou, P.; Christos, P.J.; King, M.R.; Nanus, D.M. 2013: Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow. Plos one 8(12): E85143
Marrinucci, D.; Bethel, K.; Luttgen, M.; Bruce, R.H.; Nieva, J.; Kuhn, P. 2009: Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. Archives of Pathology and Laboratory Medicine 133(9): 1468-1471
Nunes, R.A.; Li, X.; Kang, S.P.; Burstein, H.; Roberts, L.; Carney, W.; Blackwell, K.; Ryan, P.; Borges, V.; Iglehart, J.D.; Friedman, P.; Harris, L.N. 2009: Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy. International Journal of Biological Markers 24(1): 1-10
Gharbaran, R.; Park, J.; Kim, C.; Goy, A.; Suh, K.S. 2014: Circulating tumor cells in Hodgkin's lymphoma - a review of the spread of HL tumor cells or their putative precursors by lymphatic and hematogenous means, and their prognostic significance. Critical Reviews in Oncology/Hematology 89(3): 404-417
Budd, G.T. 2012: Circulating tumor cells in biliary cancer: first step or false step?. Journal of Gastrointestinal Oncology 3(2): 82-83
Schmitt, M.; Foekens, J.A. 2009: Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells. Breast Cancer Research: Bcr 11(5): 109
Pukazhendhi, G.; Glück, S. 2014: Circulating tumor cells in breast cancer. Journal of Carcinogenesis 13: 8
Liao, Y.; Wang, S-Yi.; Meng, X-Yu.; Yang, J.; Shi, M-Jun.; Liu, H-Long.; Chen, F-Fang.; Xiong, B. 2014: Circulating tumor cells in breast cancer and its association with tumor clinicopathological characteristics: a meta-analysis. Medical Oncology 31(12): 343
Graves, H.; Czerniecki, B.J. 2011: Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression. Pathology Research International 2011: 621090
Cristofanilli, M.; Reuben, J.; Uhr, J. 2008: Circulating tumor cells in breast cancer: fiction or reality?. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 26(21): 3656-7; author reply 3657-8
Gasent Blesa, J.M.; Alberola Candel, V.; Esteban González, E.; Vidal Martínez, J.; Gisbert Criado, R.; Provencio Pulla, M.; Laforga Canales, J.; Pachmann, K. 2008: Circulating tumor cells in breast cancer: methodology and clinical repercussions. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 10(7): 399-406
Sastre, J.; Maestro, M.L.; Puente, J.; Veganzones, S.; Alfonso, R.; Rafael, S.; García-Saenz, J.A.; Vidaurreta, M.; Martín, M.; Arroyo, M.; Sanz-Casla, M.T.; Díaz-Rubio, E. 2008: Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Annals of Oncology: Official Journal of the European Society for Medical Oncology 19(5): 935-938
Tsouma, A.; Aggeli, C.; Pissimissis, N.; Lembessis, P.; Zografos, G.N.; Koutsilieris, M. 2008: Circulating tumor cells in colorectal cancer: detection methods and clinical significance. Anticancer Research 28(6b): 3945-3960
Negin, B.P.; Cohen, S.J. 2010: Circulating tumor cells in colorectal cancer: past, present, and future challenges. Current Treatment Options in Oncology 11(1-2): 1-13
Raimondi, C.; Gradilone, A.; Gazzaniga, P. 2014: Circulating tumor cells in early bladder cancer: insight into micrometastatic disease. Expert Review of Molecular Diagnostics 14(4): 407-409
Sinha, G. 2012: Circulating tumor cells in early-stage breast cancer. Journal of the National Cancer Institute 104(22): 1693-1694
Takeuchi, H.; Kitagawa, Y. 2010: Circulating tumor cells in gastrointestinal cancer. Journal of Hepato-Biliary-Pancreatic Sciences 17(5): 577-582
Lurje, G.; Schiesser, M.; Claudius, A.; Schneider, P.M. 2010: Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. Journal of Oncology 2010: 392652
Gazzaniga, P.; Gianni, W.; Raimondi, C.; Gradilone, A.; Lo Russo, G.; Longo, F.; Gandini, O.; Tomao, S.; Frati, L. 2013: Circulating tumor cells in high-risk nonmetastatic colorectal cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 34(5): 2507-2509
Kolostova, K.; Broul, M.; Schraml, J.; Cegan, M.; Matkowski, R.; Fiutowski, M.; Bobek, V. 2014: Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score. Anticancer Research 34(7): 3641-3646
Young, R.; Pailler, E.; Billiot, F.; Drusch, F.ço.; Barthelemy, A.él.; Oulhen, M.; Besse, B.; Soria, J.-C.; Farace, F.ço.; Vielh, P. 2012: Circulating tumor cells in lung cancer. Acta Cytologica 56(6): 655-660
Clawson, G.A.; Kimchi, E.; Patrick, S.D.; Xin, P.; Harouaka, R.; Zheng, S.; Berg, A.; Schell, T.; Staveley-O'Carroll, K.F.; Neves, R.I.; Mosca, P.J.; Thiboutot, D. 2012: Circulating tumor cells in melanoma patients. Plos one 7(7): E41052
Steen, S.; Nemunaitis, J.; Fisher, T.; Kuhn, J. 2008: Circulating tumor cells in melanoma: a review of the literature and description of a novel technique. Proceedings 21(2): 127-132
Cristofanilli, M.; Broglio, K.R.; Guarneri, V.; Jackson, S.; Fritsche, H.A.; Islam, R.; Dawood, S.; Reuben, J.M.; Kau, S.-W.; Lara, J.M.; Krishnamurthy, S.; Ueno, N.T.; Hortobagyi, G.N.; Valero, V. 2007: Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clinical Breast Cancer 7(6): 471-479
Dawood, S.; Broglio, K.; Valero, V.; Reuben, J.; Handy, B.; Islam, R.; Jackson, S.; Hortobagyi, G.N.; Fritsche, H.; Cristofanilli, M. 2008: Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?. Cancer 113(9): 2422-2430
De Mattos-Arruda, L.; Elattar, I.; Azim, H.A. 2011: Circulating tumor cells in metastatic breast cancer: the need for a standardized approach. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(1): 234
Martín, M.; García-Sáenz, J.é A.; Maestro De las Casas, M.L.; Vidaurreta, M.; Puente, J.; Veganzones, S.; Rodríguez-Lajusticia, L.; De la Orden, V.; Oliva, B.én.; De la Torre, J.-C.és.; López-Tarruella, S.; Casado, A.; Sastre, J.; Díaz-Rubio, E. 2009: Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis. Anticancer Research 29(10): 4185-4187
Rini, B.I. 2009: Circulating tumor cells in metastatic castration-resistant prostate cancer. Current Oncology Reports 11(3): 163-164
Königsberg, R.; Gneist, M.; Jahn-Kuch, D.; Pfeiler, G.; Hager, G.; Hudec, M.; Dittrich, C.; Zeillinger, R. 2010: Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods. Cancer Letters 293(1): 117-123
Mego, M.; De Giorgi, U.; Hsu, L.; Ueno, N.T.; Valero, V.; Jackson, S.; Andreopoulou, E.; Kau, S.-W.; Reuben, J.M.; Cristofanilli, M. 2009: Circulating tumor cells in metastatic inflammatory breast cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 20(11): 1824-1828
Karhade, M.; Hall, C.; Mishra, P.; Anderson, A.; Kuerer, H.; Bedrosian, I.; Krishnamurthy, S.; Lucci, A. 2014: Circulating tumor cells in non-metastatic triple-negative breast cancer. Breast Cancer Research and Treatment 147(2): 325-333
Boshuizen, R.; Kuhn, P.; van den Heuvel, M. 2012: Circulating tumor cells in non-small cell lung carcinoma. Journal of Thoracic Disease 4(5): 456-458
Papavasiliou, P.; Fisher, T.; Kuhn, J.; Nemunaitis, J.; Lamont, J. 2010: Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Proceedings 23(1): 11-14
Biggers, B.; Knox, S.; Grant, M.; Kuhn, J.; Nemunatitis, J.; Fisher, T.; Lamont, J. 2009: Circulating tumor cells in patients undergoing surgery for primary breast cancer: preliminary results of a pilot study. Annals of Surgical Oncology 16(4): 969-971
Ušiaková, Z.; Mikulová, V.; Pintérová, D.; Brychta, M.; Valchář, J.; Kubecová, M.; Tesařová, P.; Bobek, V.ír.; Kološtová, K.ín. 2014: Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success. In Vivo 28(4): 605-614
Goodman, O.B.; Fink, L.M.; Symanowski, J.T.; Wong, B.; Grobaski, B.; Pomerantz, D.; Ma, Y.; Ward, D.C.; Vogelzang, N.J. 2009: Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 18(6): 1904-1913
Seeberg, L.T.; Waage, A.; Brunborg, C.; Hugenschmidt, H.; Renolen, A.; Stav, I.; Bjørnbeth, B.ør.A.; Brudvik, K.W.; Borgen, E.F.; Naume, B.ør.; Wiedswang, G. 2015: Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival. Annals of Surgery 261(1): 164-171
Fosså, S.D.; Hess, S.L.; Paus, E.; Borgen, E. 2014: Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital. Research and Reports in Urology 6: 121-126
Grisanti, S.; Almici, C.; Consoli, F.; Buglione, M.; Verardi, R.; Bolzoni-Villaret, A.; Bianchetti, A.; Ciccarese, C.; Mangoni, M.; Ferrari, L.; Biti, G.; Marini, M.; Ferrari, V.D.; Nicolai, P.; Magrini, S.M.; Berruti, A. 2014: Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance. Plos one 9(8): E103918
Nastały, P.; Ruf, C.; Becker, P.; Bednarz-Knoll, N.; Stoupiec, M.łg.; Kavsur, R.; Isbarn, H.; Matthies, C.; Wagner, W.; Höppner, D.; Fisch, M.; Bokemeyer, C.; Ahyai, S.; Honecker, F.; Riethdorf, S.; Pantel, K. 2014: Circulating tumor cells in patients with testicular germ cell tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(14): 3830-3841
Liu, Z.; Jiang, M.; Zhao, J.; Ju, H. 2007: Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(10): 2992-2997
Sawabata, N.; Okumura, M.; Utsumi, T.; Inoue, M.; Shiono, H.; Minami, M.; Nishida, T.; Sawa, Y. 2007: Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. General Thoracic and Cardiovascular Surgery 55(5): 189-192
Hu, B.; Rochefort, H.; Goldkorn, A. 2013: Circulating tumor cells in prostate cancer. Cancers 5(4): 1676-1690
Galletti, G.; Portella, L.; Tagawa, S.T.; Kirby, B.J.; Giannakakou, P.; Nanus, D.M. 2014: Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential. Molecular Diagnosis and Therapy 18(4): 389-402
Hu, B.; Goldkorn, A. 2014: Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen?. Expert Review of Anticancer Therapy 14(11): 1257-1260
Doyen, J.ér.ôm.; Alix-Panabières, C.; Hofman, P.; Parks, S.K.; Chamorey, E.; Naman, H.é; Hannoun-Lévi, J.-M. 2012: Circulating tumor cells in prostate cancer: a potential surrogate marker of survival. Critical Reviews in Oncology/Hematology 81(3): 241-256
Okumura, Y.; Tanaka, F.; Yoneda, K.; Hashimoto, M.; Takuwa, T.; Kondo, N.; Hasegawa, S. 2009: Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Annals of Thoracic Surgery 87(6): 1669-1675
Bertazza, L.; Mocellin, S.; Nitti, D. 2008: Circulating tumor cells in solid cancer: tumor marker of clinical relevance?. Current Oncology Reports 10(2): 137-146
Maestro, L.M.; Sastre, J.; Rafael, S.B.; Veganzones, S.B.; Vidaurreta, M.; Martín, M.; Olivier, C.; DE La Orden, V.B.; Garcia-Saenz, J.A.; Alfonso, R.; Arroyo, M.; Diaz-Rubio, E. 2009: Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Research 29(11): 4839-4843
Fang, Z.-T.; Zhang, W.; Wang, G.-Z.; Zhou, B.; Yang, G.-W.; Qu, X.-D.; Liu, R.; Qian, S.; Zhu, L.; Liu, L.-X.; Wang, J.-H. 2014: Circulating tumor cells in the central and peripheral venous compartment - assessing hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Oncotargets and Therapy 7: 1311-1318
Faltas, B. 2011: Circulating tumor cells in the cerebrospinal fluid: "tapping" into diagnostic and predictive potential. Oncotarget 2(11): 822
Nagaiah, G.; Abraham, J. 2010: Circulating tumor cells in the management of breast cancer. Clinical Breast Cancer 10(3): 209-216
Torres, V.; Triozzi, P.; Eng, C.; Tubbs, R.; Schoenfiled, L.; Crabb, J.W.; Saunthararajah, Y.; Singh, A.D. 2011: Circulating tumor cells in uveal melanoma. Future Oncology 7(1): 101-109
Gazzaniga, P.; Gianni, W.; Gradilone, A.; Raimondi, C.; Cortesi, E.; Frati, L. 2012: Circulating tumor cells in young and elderly patients with colorectal cancer: "lupus et agnus". Aging Clinical and Experimental Research 24(6): 722-723
Chiappini, F. 2012: Circulating tumor cells measurements in hepatocellular carcinoma. International Journal of Hepatology 2012: 684802
De Bono, J.S.; Scher, H.I.; Montgomery, R.B.; Parker, C.; Miller, M.C.; Tissing, H.; Doyle, G.V.; Terstappen, L.W.W.M.; Pienta, K.J.; Raghavan, D. 2008: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(19): 6302-6309
Rack, B.; Schindlbeck, C.; Jückstock, J.; Andergassen, U.; Hepp, P.; Zwingers, T.; Friedl, T.W.P.; Lorenz, R.; Tesch, H.; Fasching, P.A.; Fehm, T.; Schneeweiss, A.; Lichtenegger, W.; Beckmann, M.W.; Friese, K.; Pantel, K.; Janni, W. 2014: Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. Journal of the National Cancer Institute 106(5)
Cristofanilli, M.; Braun, S. 2010: Circulating tumor cells revisited. JAMA 303(11): 1092-1093
Kidess, E.; Jeffrey, S.S. 2013: Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?. Genome Medicine 5(8): 70
Theodoropoulos, P.A.; Polioudaki, H.; Agelaki, S.; Kallergi, G.; Saridaki, Z.; Mavroudis, D.; Georgoulias, V. 2010: Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Letters 288(1): 99-106
Gazzaniga, P.; Raimondi, C.; Gradilone, A.; Di Seri, M.; Longo, F.; Cortesi, E.; Frati, L. 2011: Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(8): 1929-1930
Hou, J.-M.; Krebs, M.; Ward, T.; Morris, K.; Sloane, R.; Blackhall, F.; Dive, C. 2010: Circulating tumor cells, enumeration and beyond. Cancers 2(2): 1236-1250
Lianidou, E.S. 2012: Circulating tumor cells--new challenges ahead. Clinical Chemistry 58(5): 805-807
Yap, T.A.; Lorente, D.; Omlin, A.; Olmos, D.; de Bono, J.S. 2014: Circulating tumor cells: a multifunctional biomarker. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(10): 2553-2568
Séronie-Vivien, S. 2014: Circulating tumor cells: a new challenge for laboratory medicine. Annales de Biologie Clinique 72(2): 153-177
García, E.D.ía.-R. 2011: Circulating tumor cells: a new efficacy marker in the treatment of metastatic colorectal cancer. Anales de la Real Academia Nacional de Medicina 128(3): 455-469; Discussion: 469-475
Millner, L.M.; Linder, M.W.; Valdes, R. 2013: Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes. Annals of Clinical and Laboratory Science 43(3): 295-304
Liu, M.C.; Shields, P.G.; Warren, R.D.; Cohen, P.; Wilkinson, M.; Ottaviano, Y.L.; Rao, S.B.; Eng-Wong, J.; Seillier-Moiseiwitsch, F.; Noone, A.-M.; Isaacs, C. 2009: Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(31): 5153-5159
Sun, Y.-F.; Yang, X.-R.; Zhou, J.; Qiu, S.-J.; Fan, J.; Xu, Y. 2011: Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. Journal of Cancer Research and Clinical Oncology 137(8): 1151-1173
Harouaka, R.; Kang, Z.; Zheng, S.-Y.; Cao, L. 2014: Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications. Pharmacology and Therapeutics 141(2): 209-221
Bao, H.; Burke, P.A.; Huang, J.; Chen, X.; Brohawn, P.Z.; Yao, Y.; Lechleider, R.J.; Sikorski, R.S.; Buzoianu, M.; Zhang, J.; Shi, X.; Richman, L.K.; Lavallee, T.M. 2013: Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase i clinical study. Plos one 8(8): E58557
Yu, M.; Stott, S.; Toner, M.; Maheswaran, S.; Haber, D.A. 2011: Circulating tumor cells: approaches to isolation and characterization. Journal of Cell Biology 192(3): 373-382
Winer-Jones, J.P.; Vahidi, B.; Arquilevich, N.; Fang, C.; Ferguson, S.; Harkins, D.; Hill, C.; Klem, E.; Pagano, P.C.; Peasley, C.; Romero, J.; Shartle, R.; Vasko, R.C.; Strauss, W.M.; Dempsey, P.W. 2014: Circulating tumor cells: clinically relevant molecular access based on a novel CTC flow cell. Plos one 9(1): E86717
Rafii, A.; Vidal, F.; Rathat, G.; Alix-Panabières, C. 2014: Circulating tumor cells: cornerstone of personalized medicine. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 43(9): 640-648
Gilles, C.; Collignon, J.; Noël, A.; Jerusalem, G.; Foidart, J.-M. 2011: Circulating tumor cells: detection, characterization and clinical impact. Revue Medicale de Liege 66(5-6): 279-284
Jacob, K.; Sollier, C.; Jabado, N. 2007: Circulating tumor cells: detection, molecular profiling and future prospects. Expert Review of Proteomics 4(6): 741-756
Li, Q. 2010: Circulating tumor cells: determining its number and what it means. CYTOMETRY. Part A: the Journal of the International Society for Analytical Cytology 77(3): 211-212
Dotan, E.; Cohen, S.J.; Alpaugh, K.R.; Meropol, N.J. 2009: Circulating tumor cells: evolving evidence and future challenges. Oncologist 14(11): 1070-1082
Raimondi, C.; Nicolazzo, C.; Gradilone, A.; Giannini, G.; De Falco, E.; Chimenti, I.; Varriale, E.; Hauch, S.; Plappert, L.; Cortesi, E.; Gazzaniga, P. 2014: Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer. Cancer Biology and Therapy 15(5): 496-503
Zhe, X.; Cher, M.L.; Bonfil, R.D. 2011: Circulating tumor cells: finding the needle in the haystack. American Journal of Cancer Research 1(6): 740-751
Balic, M.; Williams, A.; Lin, H.; Datar, R.; Cote, R.J. 2013: Circulating tumor cells: from bench to bedside. Annual Review of Medicine 64: 31-44
Gazzaniga, P.; Raimondi, C.; Gradilone, A.; Naso, G.; Cortesi, E.; Frati, L. 2012: Circulating tumor cells: highlight on practical implications. Molecular Diagnosis and Therapy 16(1): 7-11
Gehrig, P.A. 2011: Circulating tumor cells: is this gold or pyrite?. Obstetrics and Gynecology 117(5): 1037-1039
Olivier Gómez, C.; Carballido Rodríguez, J. 2010: Circulating tumor cells: isolation, quantification, and relevance of their translation into clinical practice. Actas Urologicas Espanolas 34(1): 3-5
Alix-Panabières, C.; Pierga, J.-Y. 2014: Circulating tumor cells: liquid biopsy. Bulletin du Cancer 101(1): 17-23
Wicha, M.S.; Hayes, D.F. 2011: Circulating tumor cells: not all detected cells are bad and not all bad cells are detected. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29(12): 1508-1511
Hofman, P. 2009: Circulating tumor cells: pitfalls and new promises in clinical oncology. Annales de Pathologie 29(Special Issue 1): S25-S27
Fischer, A.H. 2009: Circulating tumor cells: seeing is believing. Archives of Pathology and Laboratory Medicine 133(9): 1367-1369
Den Toonder, J. 2011: Circulating tumor cells: the Grand Challenge. Lab on a Chip 11(3): 375-377
Greene, B.T.; Hughes, A.D.; King, M.R. 2012: Circulating tumor cells: the substrate of personalized medicine?. Frontiers in Oncology 2: 69
Mata, M.; Raponi, M. 2009: Circulating tumor cells: utility for predicting response to anti-EGFR therapies?. Expert Review of Molecular Diagnostics 9(2): 115-119
Conteduca, V.; Zamarchi, R.; Rossi, E.; Condelli, V.; Troiani, L.; Aieta, M. 2013: Circulating tumor cells: utopia or reality?. Future Oncology 9(9): 1337-1352
Schwartz, A.M.; Nolan, N. 2014: Circulating tumor cells: what goes around, comes around. Journal of the National Cancer Institute 106(5)
Nelson, N.J. 2010: Circulating tumor cells: will they be clinically useful?. Journal of the National Cancer Institute 102(3): 146-148
Carlsson, A.; Nair, V.S.; Luttgen, M.S.; Keu, K.V.; Horng, G.; Vasanawala, M.; Kolatkar, A.; Jamali, M.; Iagaru, A.H.; Kuschner, W.; Loo, B.W.; Shrager, J.B.; Bethel, K.; Hoh, C.K.; Bazhenova, L.; Nieva, J.; Kuhn, P.; Gambhir, S.S. 2014: Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9(8): 1111-1119
Taenzer, A.; Alix-Panabières, C.; Wikman, H.; Pantel, K. 2012: Circulating tumor-derived biomarkers in lung cancer. Journal of Thoracic Disease 4(5): 448-449
Uzawa, K.; Baba, T.; Uchida, F.; Yamatoji, M.; Kasamatsu, A.; Sakamoto, Y.; Ogawara, K.; Shiiba, M.; Bukawa, H.; Tanzawa, H. 2012: Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma. Oncotarget 3(7): 670-677
Danila, D.C.; Pantel, K.; Fleisher, M.; Scher, H.I. 2011: Circulating tumors cells as biomarkers: progress toward biomarker qualification. Cancer Journal 17(6): 438-450
Olmos, D.; Arkenau, H.-T.; Ang, J.E.; Ledaki, I.; Attard, G.; Carden, C.P.; Reid, A.H.M.; A'Hern, R.; Fong, P.C.; Oomen, N.B.; Molife, R.; Dearnaley, D.; Parker, C.; Terstappen, L.W.M.M.; de Bono, J.S. 2009: Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Annals of Oncology: Official Journal of the European Society for Medical Oncology 20(1): 27-33
Garrigós, N.; Gallego, J.; Guillén-Ponce, C.; Guaraz, P.; García-Bautista, M.; Castillejo, A.; Gómez-Martínez, A.; Carrato, A.; Rodríguez-Lescure, A.; Soto, J.é L. 2010: Circulating tumour cell analysis as an early marker for relapse in stage Ii and IIi colorectal cancer patients: a pilot study. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 12(2): 142-147
Strijbos, M.H. 2011: Circulating tumour cells and circulating endothelial cells as biomarkers in oncology. Acta Clinica Belgica 66(5): 332-336
Lim, S.H.; Becker, T.M.; Chua, W.; Caixeiro, N.J.; Ng, W.L.; Kienzle, N.; Tognela, A.; Lumba, S.; Rasko, J.E.J.; de Souza, P.; Spring, K.J. 2014: Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer. Cancer Letters 346(1): 24-33
Lim, S.H.S.; Becker, T.M.; Chua, W.; Ng, W.L.; de Souza, P.; Spring, K.J. 2014: Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer. Journal of Clinical Pathology 67(10): 848-853
Mego, M.; Zuo, Z.; Gao, H.; Cohen, E.N.; Giordano, A.; Tin, S.; Anfossi, S.; Jackson, S.; Woodward, W.; Ueno, N.T.; Valero, V.; Alvarez, R.H.; Hortobagyi, G.N.; Khoury, J.D.; Cristofanilli, M.; Reuben, J.M. 2015: Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer. Thrombosis and Haemostasis 113(3): 593-598
Lankiewicz, S.; Zimmermann, S.; Hollmann, C.; Hillemann, T.; Greten, T.F. 2008: Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer. Molecular Oncology 2(4): 349-355
Krell, J.; Stebbing, J. 2012: Circulating tumour cells as biomarkers in early breast cancer. LANCET. Oncology 13(7): 653-654
Stebbing, J.; Jiao, L.R. 2009: Circulating tumour cells as more than prognostic markers. LANCET. Oncology 10(12): 1138-1139
Scher, H.I.; Jia, X.; de Bono, J.S.; Fleisher, M.; Pienta, K.J.; Raghavan, D.; Heller, G. 2009: Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. LANCET. Oncology 10(3): 233-239
Bjartell, A. 2011: Circulating tumour cells as surrogate biomarkers in castration-resistant prostate cancer trials. European Urology 60(5): 905-907
Khoja, L.; Lorigan, P.; Dive, C.; Keilholz, U.; Fusi, A. 2015: Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance. Annals of Oncology: Official Journal of the European Society for Medical Oncology 26(1): 33-39
Wind, J.; Tuynman, J.B.; Tibbe, A.G.J.; Swennenhuis, J.F.; Richel, D.J.; van Berge Henegouwen, M.I.; Bemelman, W.A. 2009: Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 35(9): 942-950
Tol, J.; Koopman, M.; Miller, M.C.; Tibbe, A.; Cats, A.; Creemers, G.J.M.; Vos, A.H.; Nagtegaal, I.D.; Terstappen, L.W.M.M.; Punt, C.J.A. 2010: Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Annals of Oncology: Official Journal of the European Society for Medical Oncology 21(5): 1006-1012
Hoffman, R.M. 2015: Circulating tumour cells go green. Gut 64(4): 528-530
Krawczyk, N.; Banys, M.; Hartkopf, A.; Hagenbeck, C.; Melcher, C.; Fehm, T. 2013: Circulating tumour cells in breast cancer. Ecancermedicalscience 7: 352
Vertakova, K.B.; Sanislo, L.; Spanik, S.; Svec, J.; Ondrus, D. 2010: Circulating tumour cells in breast cancer--review. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 23(2): 86-91
Hogan, B.V.; Peter, M.B.; Shenoy, H.; Horgan, K.; Hughes, T.A. 2008: Circulating tumour cells in breast cancer: Prognostic indicators, metastatic intermediates, or irrelevant bystanders? (Review). Molecular Medicine Reports 1(6): 775-779
Pantel, K.; Alix-Panabières, C. 2010: Circulating tumour cells in cancer patients: challenges and perspectives. Trends in Molecular Medicine 16(9): 398-406
Alunni-Fabbroni, M.; Sandri, M.T. 2010: Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods 50(4): 289-297
Nagarajan, C.; Barbieri, A.; Mittal, S. 2012: Circulating tumour cells in disseminated malignant melanoma. British Journal of Haematology 156(6): 692
De Mattos-Arruda, L.; Tabernero, J.; Seoane, J.; Cortes, J. 2012: Circulating tumour cells in early breast cancer. Lancet. Oncology 13(9): e370; author reply e370
García-Sáenz, J.é A.; Martín, M.; Maestro, M.ía.L.; Vidaurreta, M.; Veganzones, S.; Rafael, S.; Casado, A.; Bobokova, J.; Sastre, J.; De la Orden, V.; Arroyo, M.; Díaz-Rubio, E. 2009: Circulating tumour cells in locally advanced breast cancer. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 11(8): 544-547
Pshenay-Severin, D.A.; Ivanov, Y.V.; Burkov, A.A.; Burkov, A.T. 2018: Band structure and unconventional electronic topology of CoSi. Journal of physics. Condensed matter: an Institute of Physics journal 30(13): 135501
Kulasinghe, A.; Perry, C.; Jovanovic, L.; Nelson, C.; Punyadeera, C. 2015: Circulating tumour cells in metastatic head and neck cancers. International Journal of Cancer 136(11): 2515-2523
Kolostova, K.; Cegan, M.; Bobek, V. 2014: Circulating tumour cells in patients with urothelial tumours: Enrichment and in vitro culture. Canadian Urological Association Journal 8(9-10): E715-E720
Okholm, C.; Thorsteinsson, M.; Achiam, M.P. 2014: Circulating tumour cells is a promising prognostic and predictive marker of gastric cancer. Ugeskrift for Laeger 176(32): 1490-1493
Gradilone, A.; Raimondi, C.; Nicolazzo, C.; Petracca, A.; Gandini, O.; Vincenzi, B.; Naso, G.; Aglianò, A.M.; Cortesi, E.; Gazzaniga, P. 2011: Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal. Journal of Cellular and Molecular Medicine 15(5): 1066-1070
Caixeiro, N.J.; Kienzle, N.; Lim, S.H.; Spring, K.J.; Tognela, A.; Scott, K.F.; de Souza, P.; Becker, T.M. 2014: Circulating tumour cells--a bona fide cause of metastatic cancer. Cancer Metastasis Reviews 33(2-3): 747-756
Cristofanilli, M. 2014: Circulating tumour cells: telling the truth about metastasis. LANCET. Oncology 15(4): 365-366
Grover, P.K.; Cummins, A.G.; Price, T.J.; Roberts-Thomson, I.C.; Hardingham, J.E. 2014: Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research. Annals of Oncology: Official Journal of the European Society for Medical Oncology 25(8): 1506-1516
Krebs, M.G.; Hou, J.-M.; Ward, T.H.; Blackhall, F.H.; Dive, C. 2010: Circulating tumour cells: their utility in cancer management and predicting outcomes. Therapeutic Advances in Medical Oncology 2(6): 351-365
Kats-Ugurlu, G.; Roodink, I.; de Weijert, M.; Tiemessen, D.; Maass, C.; Verrijp, K.; van der Laak, J.; de Waal, R.; Mulders, P.; Oosterwijk, E.; Leenders, W. 2009: Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma. Journal of Pathology 219(3): 287-293
Baran, J.; Baj-Krzyworzeka, M.; Weglarczyk, K.; Szatanek, R.; Zembala, M.; Barbasz, J.; Czupryna, A.; Szczepanik, A.; Zembala, M. 2010: Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunology Immunotherapy: Cii 59(6): 841-850
Hodgson, D.R.; Wellings, R.; Orr, M.C.M.; McCormack, R.; Malone, M.; Board, R.E.; Cantarini, M.V. 2010: Circulating tumour-derived predictive biomarkers in oncology. Drug Discovery Today 15(3-4): 98-101
Liu, Y.; Ma, T.; Liu, J.; Zhao, X.; Cheng, Z.; Guo, H.; Xu, R.; Wang, S. 2015: Circulating type 1 vaccine-derived poliovirus may evolve under the pressure of adenosine deaminases acting on RNA. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 28(17): 2096-2099
Van den Heuvel, E.G.H.M.; van Schoor, N.M.; Lips, P.; Magdeleyns, E.J.P.; Deeg, D.J.H.; Vermeer, C.; den Heijer, M. 2014: Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. Maturitas 77(2): 137-141
Shea, M.K.; O'Donnell, C.J.; Vermeer, C.; Magdeleyns, E.J.P.; Crosier, M.D.; Gundberg, C.M.; Ordovas, J.é M.; Kritchevsky, S.B.; Booth, S.L. 2011: Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. Journal of Nutrition 141(8): 1529-1534
Kâ, K.; Rousseau, M.-C.; Tran, S.D.; Kaartinen, M.T.; Myneni, V.D.; Henderson, M.él.; Nicolau, B. 2014: Circulating undercarboxylated osteocalcin and gingival crevicular fluid tumour necrosis factor-α in children. Journal of Clinical Periodontology 41(5): 467-472
Tam, C.; O'Connor, D.; Koren, G. 2012: Circulating unmetabolized folic Acid: relationship to folate status and effect of supplementation. Obstetrics and Gynecology International 2012: 485179
Morris, M.Savaria.; Jacques, P.F.; Rosenberg, I.H.; Selhub, J. 2010: Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. American journal of clinical nutrition 91(6): 1733-1744
Shiue, I.; Starr, J. 2012: Circulating urine phthalates are not associated with a decline in cognition in adults and the elderly: NHANES, 1999-2002. Neuroepidemiology 39(2): 143-144
Fernandes, B.F.; Belfort, R.N.; Di Cesare, S.; Burnier, M.N. 2008: Circulating uveal melanoma cells: should we test for them?. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 43(2): 155-158
Davis, R.; Wright, P.F. 2012: Circulating vaccine derived poliovirus and the polio eradication endgame. Pan African Medical Journal 12: 109
Kusumanto, Y.H.; Meijer, C.; Dam, W.; Mulder, N.H.; Hospers, G.A.P. 2007: Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical ischemia. Drug Target Insights 2: 105-109
Abdelmoaty, M.Ahmed.; Bogdady, A.Mohamed.; Attia, M.Mohamed.; Zaky, N.Abdelhamed. 2009: Circulating vascular endothelial growth factor and nitric oxide in patients with liver cirrhosis: A possible association with liver function impairment. Indian journal of clinical biochemistry: IJCB 24(4): 398-403
Valipour, A.; Schreder, M.; Wolzt, M.; Saliba, S.; Kapiotis, S.; Eickhoff, P.; Burghuber, O.C. 2008: Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clinical Science 115(7): 225-232
Senel, K.; Baykal, T.; Seferoglu, B.; Altas, E.U.; Baygutalp, F.; Ugur, M.; Kiziltunc, A. 2013: Circulating vascular endothelial growth factor concentrations in patients with postmenopausal osteoporosis. Archives of Medical Science: Ams 9(4): 709-712
Schiavetti, A.; Ingrosso, A.; Antenucci, A.; Federici, T.; Megaro, G.; De Luca, L.; Conti, L. 2012: Circulating vascular endothelial growth factor in childhood solid tumors: plasma and serum measurements. Anticancer Research 32(8): 3565-3569
Kubisz, P.; Chudý, P.; Stasko, J.án.; Galajda, P.; Hollý, P.; Vysehradský, R.; Mokán, M.án. 2010: Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus. Acta Diabetologica 47(2): 119-124
Katsuura, S.; Kamezaki, Y.; Yamagishi, N.; Kuwano, Y.; Nishida, K.; Masuda, K.; Tanahashi, T.; Kawai, T.; Arisawa, K.; Rokutan, K. 2011: Circulating vascular endothelial growth factor is independently and negatively associated with trait anxiety and depressive mood in healthy Japanese university students. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 81(1): 38-43
Dullaart, R.P.F.; Oomen, P.H.N.; Sluiter, W.J. 2007: Circulating vascular endothelial growth factor is unaffected by acute hyperglycemia and hyperinsulinemia in type 1 diabetes mellitus. European Journal of Internal Medicine 18(3): 193-195
Kuemmel, S.; Thomas, A.; Landt, S.; Fuger, A.; Schmid, P.; Kriner, M.; Blohmer, J.-U.; Sehouli, J.; Schaller, G.; Lichtenegger, W.; Köninger, A.; Fuchs, I. 2009: Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer. Anticancer Research 29(2): 641-645
Dessapt-Baradez, C.; Reza, M.; Sivakumar, G.; Hernandez-Fuentes, M.; Markakis, K.; Gnudi, L.; Karalliedde, J. 2011: Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndrome. Plos one 6(5): E20317
Dessapt, C.; Karalliedde, J.; Hernandez-Fuentes, M.; Prieto Martin, P.; Maltese, G.; Dattani, N.; Atkar, R.; Viberti, G.; Gnudi, L. 2010: Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria. Diabetes Care 33(4): 875-877
Genc, H.; Dogru, T.; Tapan, S.; Kara, M.; Ercin, C.N.; Aslan, F.; Kantarcioglu, M.; Karslioglu, Y.; Sertoglu, E.; Erbil, M.K.; Bagci, S. 2011: Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. Scandinavian Journal of Gastroenterology 46(11): 1355-1361
Von Loeffelholz, C.; Möhlig, M.; Arafat, A.M.; Isken, F.; Spranger, J.; Mai, K.; Randeva, H.S.; Pfeiffer, A.F.H.; Weickert, M.O. 2010: Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. European Journal of Endocrinology 162(3): 507-513
Yilmaz, Y.; Kurt, R.; Gurdal, A.; Alahdab, Y.O.; Yonal, O.; Senates, E.; Polat, N.; Eren, F.; Imeryuz, N.; Oflaz, H. 2011: Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 217(1): 125-129
Lemaitre, F.; Carturan, D.; Tourney-Chollet, C.; Gardette, B. 2009: Circulating venous bubbles in children after diving. Pediatric Exercise Science 21(1): 77-85
Jialal, I.; Devaraj, S. 2012: Circulating versus cellular biomarkers of inflammation in Type 1 diabetes: the superiority of C-reactive protein. Cytokine 60(1): 318-320
Krop, M.; Danser, A.H.J. 2008: Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin. Current Hypertension Reports 10(2): 112-118
Wojakowski, W.; Kucia, M.; Liu, R.; Zuba-Surma, E.; Jadczyk, T.; Bachowski, R.; Nabiałek, E.; Kaźmierski, M.; Ratajczak, M.Z.; Tendera, M.ł 2011: Circulating very small embryonic-like stem cells in cardiovascular disease. Journal of Cardiovascular Translational Research 4(2): 138-144
Zago, V.; Lucero, D.; Macri, E.V.; Cacciagiú, L.; Gamba, C.A.; Miksztowicz, V.; Berg, G.; Wikinski, R.; Friedman, S.; Schreier, L. 2010: Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model. Annals of Nutrition and Metabolism 56(3): 198-206
Gutiérrez, S.ín.; Yvon, M.; Pirolles, E.; Garzo, E.; Fereres, A.; Michalakis, Y.; Blanc, S.ép. 2012: Circulating virus load determines the size of bottlenecks in viral populations progressing within a host. Plos Pathogens 8(11): E1003009
Wang, Y.-C.; Cheng, H.-B.; Chen, H.-H.; Liu, C.-M.; Chou, C.-H.T.; Sung, F.-C. 2010: Circulating viruses associated with severe complicated enterovirus infection in Taiwan: a multi-year analysis. Pediatric Infectious Disease Journal 29(4): 334-339
Liu, X.; Ji, Y.; Chen, J.; Li, S.; Luo, F. 2009: Circulating visfatin in chronic obstructive pulmonary disease. Nutrition 25(4): 373-378
de Luis, D.A.; Sagrado, M.Gonzalez.; Aller, R.; Conde, R.; Izaola, O. 2010: Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle. Nutrition 26(11-12): 1130-1133
Olszanecka-Glinianowicz, M.; Kocełak, P.; Nylec, M.; Chudek, J.; Zahorska-Markiewicz, B. 2012: Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome. Archives of Medical Science: Ams 8(2): 214-218
Oki, K.; Yamane, K.; Kamei, N.; Nojima, H.; Kohno, N. 2007: Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clinical Endocrinology 67(5): 796-800
Siahanidou, T.; Margeli, A.; Kappis, A.; Papassotiriou, I.; Mandyla, H. 2011: Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids. Metabolism, Clinical and Experimental 60(3): 389-393
Takahashi, R.; Mizoue, T.; Otake, T.; Fukumoto, J.; Tajima, O.; Tabata, S.; Abe, H.; Ohnaka, K.; Kono, S. 2010: Circulating vitamin D and colorectal adenomas in Japanese men. Cancer Science 101(7): 1695-1700
Schwartz, G.G. 2012: Circulating vitamin D and risk of prostate cancer--letter. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 21(1): 246; Author Reply 247
Smolders, J.; Peelen, E.; Thewissen, M.ël.; Menheere, P.; Damoiseaux, J.; Hupperts, R. 2014: Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis. Multiple Sclerosis 20(4): 433-437
Merhi, Z.O.; Seifer, D.B.; Weedon, J.; Adeyemi, O.; Holman, S.; Anastos, K.; Golub, E.T.; Young, M.; Karim, R.; Greenblatt, R.; Minkoff, H. 2012: Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study. Fertility and Sterility 98(1): 228-234
Bajaj, A.; Stone, K.L.; Peters, K.; Parimi, N.; Barrett-Connor, E.; Bauer, D.; Cawthon, P.M.; Ensrud, K.E.; Hoffman, A.R.; Orwoll, E.; Schernhammer, E.S. 2014: Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS Sleep Study. Journal of Clinical Endocrinology and Metabolism 99(9): 3256-3262
Arslan, A.A.; Clendenen, T.V.; Koenig, K.L.; Hultdin, J.; Enquist, K.; Agren, A.; Lukanova, A.; Sjodin, H.; Zeleniuch-Jacquotte, A.; Shore, R.E.; Hallmans, G.ör.; Toniolo, P.; Lundin, E. 2009: Circulating vitamin d and risk of epithelial ovarian cancer. Journal of Oncology 2009: 672492
He, J.; Le, D.S.; Xu, X.; Scalise, M.; Ferrante, A.W.; Krakoff, J. 2010: Circulating white blood cell count and measures of adipose tissue inflammation predict higher 24-h energy expenditure. European Journal of Endocrinology 162(2): 275-280
Zhang, D.; Zhang, L.; Zheng, Y.; Yue, F.; Russell, R.D.; Zeng, Y. 2014: Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diabetes Research and Clinical Practice 106(2): 312-318
Moreno-Navarrete, Jé.María.; Sabater, Mònica.; Ortega, F.; Ricart, W.; Fernández-Real, Jé.Manuel. 2012: Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. Plos one 7(5): E37160
Smith, R.C.; O'Bryan, L.M.; Farrow, E.G.; Summers, L.J.; Clinkenbeard, E.L.; Roberts, J.L.; Cass, T.A.; Saha, J.; Broderick, C.; Ma, Y.L.; Zeng, Q.Q.; Kharitonenkov, A.; Wilson, J.M.; Guo, Q.; Sun, H.; Allen, M.R.; Burr, D.B.; Breyer, M.D.; White, K.E. 2012: Circulating αKlotho influences phosphate handling by controlling FGF23 production. Journal of Clinical Investigation 122(12): 4710-4715
Banzato, A.; Frasson, R.; Acquasaliente, L.; Bison, E.; Bracco, A.; Denas, G.; Cuffaro, S.; Hoxha, A.; Ruffatti, A.; Iliceto, S.; De Filippis, V.; Pengo, V. 2012: Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein i immunocomplexes in patients with definite antiphospholipid syndrome. Lupus 21(7): 784-786
Ueda-Hayakawa, I.; Hasegawa, M.; Hamaguchi, Y.; Takehara, K.; Fujimoto, M. 2013: Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts. Journal of Dermatological Science 69(1): 54-60
Rossini, M.; Adami, S.; Viapiana, O.; Ortolani, R.; Vella, A.; Fracassi, E.; Gatti, D. 2012: Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 27(1): 227-230
Perez-Protto, S.; Sessler, D.I.; Reynolds, L.F.; Bakri, M.H.; Mascha, E.; Cywinski, J.; Parker, B.; Argalious, M. 2010: Circulating-water garment or the combination of a circulating-water mattress and forced-air cover to maintain core temperature during major upper-abdominal surgery. British Journal of Anaesthesia 105(4): 466-470
Mitchell, H. 1887: Circulation of the Sea through new York Harbor. Science 9(213): 204-205
Marian, A.J.; Bolli, R. 2010: Circulation Research and human genetic studies. Circulation Research 107(1): 6-8
Bolli, R. 2013: Circulation Research launches a clinical track for studies in humans. Circulation Research 113(12): 1266-1267
Bose, J.C. 1924: Circulation and Assimilation in Plants. Proceedings of the Royal Society of Medicine 17(Gen Rep): 19-24
Ghrist, D.G. 1933: Circulation and Postural Change: Adjustments in Health and Disease. California and Western Medicine 39(3): 161-164
Terentyuk, G.S.; Maslyakova, G.N.; Suleymanova, L.V.; Khlebtsov, B.N.; Kogan, B.Ya.; Akchurin, G.G.; Shantrocha, A.V.; Maksimova, I.L.; Khlebtsov, N.G.; Tuchin, V.V. 2009: Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery. Journal of Biophotonics 2(5): 292-302
Milton, S. 2009: Circulation and invasive monitoring: back to basics. Journal of Perioperative Practice 19(7): 213-220
Hampton, M.; Nelson, B.T.; Andrews, M.T. 2010: Circulation and metabolic rates in a natural hibernator: an integrative physiological model. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 299(6): R1478-R1488
Fleck, E.Cristina.Deckmann.; Poletto, R. 2012: Circulation and production of knowledge and scientific practices in southern America in the eighteenth century: an analysis of Materia medica misionera, a manuscript by Pedro Montenegro (1710). Historia Ciencias Saude--Manguinhos 19(4): 1121-1138
Altschule, M.D.; Freedberg, A.S.; McMANUS, M.J. 1945: Circulation and respiration during an episode of chill and fever in man. Journal of Clinical Investigation 24: 878-889
Altschule, M.D.; Freedberg, A.S. 1945: Circulation and respiration in fever. Medicine 24: 403-440
Ouillon, S.; Douillet, P.; Lefebvre, J.P.; Le Gendre, R.; Jouon, A.; Bonneton, P.; Fernandez, J.M.; Chevillon, C.; Magand, O.; Lefèvre, J.; Le Hir, P.; Laganier, R.; Dumas, F.; Marchesiello, P.; Bel Madani, A.; Andréfouët, S.; Panché, J.Y.; Fichez, R. 2010: Circulation and suspended sediment transport in a coral reef lagoon: the south-west lagoon of new Caledonia. Marine Pollution Bulletin 61(7-12): 269-296
Stine, O.C.; Morris, J.G. 2014: Circulation and transmission of clones of Vibrio cholerae during cholera outbreaks. Current Topics in Microbiology and Immunology 379: 181-193
Pringle, J.M.; Byers, J.E.; Pappalardo, P.; Wares, J.P.; Marshall, D. 2014: Circulation constrains the evolution of larval development modes and life histories in the coastal ocean. Ecology 95(4): 1022-1032
Kuwasako, K.; Kitamura, K.; Nagata, S.; Kato, J. 2012: Circulation control by adrenomedullin 1 receptor complex. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 140(1): 8-13
Yang, J.; Zhang, P.; Wei, S.-H. 2018: Band Structure Engineering of Cs2AgBiBr6 Perovskite through Order-Disordered Transition: a First-Principle Study. Journal of Physical Chemistry Letters 9(1): 31-35
Hertz, B.Thomas. 2013: Circulation education. Medical Economics 90(8): 33-4 36
Lopes Cardozo, E.; Eggink, P. 1946: Circulation failure in hunger oedema. Canadian Medical Association Journal 54: 145-147
Mohiti, J.; Talebi, F.; Afkhami-Ardekani, M. 2009: Circulation free leptin in diabetic patients and its correlation to insulin level. Pakistan Journal of Biological Sciences: Pjbs 12(4): 397-400
Letellier, C.; Pardon, B.; Van der Heyden, S.; Deprez, P. 2010: Circulation in Belgium of a bovine viral diarrhoea virus type 2 closely related to North American hypervirulent viruses. Veterinary Record 166(20): 625-626
Wilson, W.C. 1947: Circulation in peritonitis. Lancet 2(6475): 518
Wells, W.F. 1945: Circulation in sanitary ventilation by bactericidal irradiation of air. Journal of the Franklin Institute 240: 379-395
Foxon, G.E.H. 1947: Circulation in the frog. Nature 159(4033): 236
Heggie, J.F. 1946: Circulation in the kidney. Lancet 2(6421): 436
Chi, F.; Wu, R.; Zeng, Y-can.; Xing, R.; Liu, Y. 2013: Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis. Molecular Biology Reports 40(5): 3583-3590
Shimokawa, H. 2010: Circulation journal: a cloud over the hill. Circulation Journal: Official Journal of the Japanese Circulation Society 74(1): 1-2
Ma, J.; Luo, X.; Wu, Q.; Chen, Z.; Kou, L.; Wang, H. 2010: Circulation levels of acute phase proteins in patients with Takayasu arteritis. Journal of Vascular Surgery 51(3): 700-706
Xu, J.; Wang, Y. 1997: Circulation method of ground-based atmospheric remote sensing inversion. Applied Optics 36(12): 2586-2593
Zywica, A.; Podbielski, J.ła.; Nowacki, P.ła.; Safranow, K. 2007: Circulation monitoring in anterior cerebral arteries in hypertensive patients with ischemic stroke, without hemodynamically significant stenosis in extracranial arteries. Annales Academiae Medicae Stetinensis 53(3): 34-38
Drexler, J.F.; Luna, L.K.d.S.; Stöcker, A.; Almeida, P.íc.S.; Ribeiro, T.C.M.; Petersen, N.; Herzog, P.; Pedroso, C.él.; Huppertz, H.I.; Ribeiro, H.d.C.; Baumgarte, S.; Drosten, C. 2008: Circulation of 3 lineages of a novel Saffold cardiovirus in humans. Emerging Infectious Diseases 14(9): 1398-1405
Verma, H.; Chitambar, S.D.; Gopalkrishna, V. 2011: Circulation of Aichi virus genotype B strains in children with acute gastroenteritis in India. Epidemiology and Infection 139(11): 1687-1691
Lu, Q-Bin.; Zhang, X-Ai.; Wo, Y.; Xu, H-Mei.; Li, X-Jun.; Wang, X-Jun.; Ding, S-Jun.; Chen, X-Dan.; He, C.; Liu, L-Juan.; Li, H.; Yang, H.; Li, T-Yu.; Liu, W.; Cao, W-Chun. 2012: Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011. PloS one 7(12): e52073
Di, B.; Zhang, Y.; Xie, H.; Li, X.; Chen, C.; Ding, P.; He, P.; Wang, D.; Geng, J.; Luo, L.; Bai, Z.; Yang, Z.; Wang, M. 2014: Circulation of Coxsackievirus A6 in hand-foot-mouth disease in Guangzhou, 2010-2012. Virology journal 11: 157
Gupta, E.; Mohan, S.; Bajpai, M.; Choudhary, A.; Singh, G. 2012: Circulation of Dengue virus-1 (DENV-1) serotype in Delhi, during 2010-11 after Dengue virus-3 (DENV-3) predominance: a single centre hospital-based study. Journal of Vector Borne Diseases 49(2): 82-85
Giuliani, M.; Santoro, M.M.; Lo Presti, A.; Cella, E.; Scognamiglio, P.; Lai, A.; Latini, A.; Fabeni, L.; Gori, C.; Pinnetti, C.; Girardi, E.; Perno, C.F.; Zehender, G.; Ciccozzi, M. 2013: Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study. Biomed Research International 2013: 810617
Houspie, L.; Lemey, P.; Keyaerts, E.; Reijmen, E.; Vergote, V.; Vankeerberghen, A.; Vaeyens, F.; De Beenhouwer, H.; Van Ranst, M. 2013: Circulation of HRSV in Belgium: from multiple genotype circulation to prolonged circulation of predominant genotypes. Plos one 8(4): E60416
Lindahl, J.F.; Ståhl, K.; Chirico, J.; Boqvist, S.; Thu, H.T.V.; Magnusson, U. 2013: Circulation of Japanese encephalitis virus in pigs and mosquito vectors within can Tho city, Vietnam. Plos Neglected Tropical Diseases 7(4): E2153
Fish, E.W. 1925: Circulation of Lymph in the Dentine. Proceedings of the Royal Society of Medicine 18(Odontol Sect): 35-37
Amin, O.G.M.; Valastro, V.; Salviato, A.; Drago, A.; Cattoli, G.; Monne, I. 2012: Circulation of QX-like infectious bronchitis virus in the Middle East. Veterinary Record 171(21): 530
Firacative, C.; Moreno, J.; Rosales, P.; Maldonado, A.; Sánchez, J.; Pesantes, C.; López, S.; de Quinzada, M.; Chamorro, G.; Morales, S.; Spadola, E.; Gabastou, J-Marc.; Castañeda, E. 2009: Circulation of Streptococcus pneumoniae clone Colombia 5 ST289 in nine Latin American countries. Revista Panamericana de Salud Publica 25(4): 337-343
Arnal, A.; Gómez-Díaz, E.; Cerdà-Cuéllar, M.; Lecollinet, S.; Pearce-Duvet, J.; Busquets, N.úr.; García-Bocanegra, I.; Pagès, N.; Vittecoq, M.; Hammouda, A.; Samraoui, B.ém.; Garnier, R.; Ramos, R.ül.; Selmi, S.; González-Solís, J.; Jourdain, E.; Boulinier, T. 2014: Circulation of a Meaban-like virus in yellow-legged gulls and seabird ticks in the western Mediterranean basin. Plos one 9(3): E89601
Mamani, E.; Alvarez, C.; García M, Mía.; Figueroa, D.; Gatti, M.; Guio, H.; Merino, S.; Valencia, P.; Calampa, C.; Franco, L.; Cabezas, César. 2011: Circulation of a different lineage of dengue virus serotype 2 American / Asian genotype in the Peruvian Amazon, 2010. Revista peruana de medicina experimental y salud publica 28(1): 72-77
Dey, R.Sharma.; Ghosh, S.; Chawla-Sarkar, M.; Panchalingam, S.; Nataro, J.P.; Sur, D.; Manna, B.; Ramamurthy, T. 2011: Circulation of a novel pattern of infections by enteric adenovirus serotype 41 among children below 5 years of age in Kolkata, India. Journal of clinical microbiology 49(2): 500-505
Colson, P.; Swiader, L.; Motte, A.; Ferretti, A.; Borentain, P.; Gerolami, R.é 2012: Circulation of almost genetically identical hepatitis e virus of genotype 4 in France. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 55(2): 181-183
Jesús Santesmases, M.; Gradmann, C. 2011: Circulation of antibiotics: an introduction. Dynamis 31(2): 293-303
Lima, M.A.; Romano-Lieber, N.S.; Duarte, A.M.R.d.C. 2010: Circulation of antibodies against yellow fever virus in a simian population in the area of Porto Primavera Hydroelectric Plant, São Paulo, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo 52(1): 11-16
Abdelwhab, E.M.; Selim, A.A.; Arafa, A.; Galal, S.; Kilany, W.H.; Hassan, M.K.; Aly, M.M.; Hafez, M.H. 2010: Circulation of avian influenza H5N1 in live bird markets in Egypt. Avian Diseases 54(2): 911-914
Cappelle, J.; Servan de Almeida, R.; Fofana, B.; Dakouo, M.; Balança, G.; Gil, P.; Albina, E.; Gaidet, N. 2012: Circulation of avian influenza viruses in wild birds in Inner Niger Delta, Mali. Influenza and other Respiratory Viruses 6(4): 240-244
Van Rijssel, R.G. 1946: Circulation of cerebrospinal fluid in Carassius gibelio. Archives of Neurology and Psychiatry 56(5): 522-543
Lange, J.; Groth, M.; Kanrai, P.; Pleschka, S.; Scholtissek, C.; Dürrwald, R.; Platzer, M.; Sauerbrei, A.; Zell, R. 2014: Circulation of classical swine influenza virus in Europe between the wars?. Archives of Virology 159(6): 1467-1473
Sojka, M.; Bopegamage, S.; Petrovicová, A. 2008: Circulation of coxsackieviruses in the Slovak population in 1985-2007. Epidemiologie Mikrobiologie Imunologie: Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti J.E. Purkyne 57(2): 57-60
Drumond, Bânia.Paiva.; Mondini, A.; Schmidt, D.J.; de Morais Bronzoni, R.Vieira.; Bosch, I.; Nogueira, Mício.Lacerda. 2013: Circulation of different lineages of Dengue virus 2, genotype American/Asian in Brazil: dynamics and molecular and phylogenetic characterization. Plos one 8(3): E59422
Añez, Gán.; Morales-Betoulle, M.E.; Rios, M. 2011: Circulation of different lineages of dengue virus type 2 in Central America, their evolutionary time-scale and selection pressure analysis. Plos one 6(11): E27459
Lu, Z.; Fu, S.-H.; Wang, F.-T.; Nasci, R.S.; Tang, Q.; Liang, G.-D. 2011: Circulation of diverse genotypes of Tahyna virus in Xinjiang, People's Republic of China. American Journal of Tropical Medicine and Hygiene 85(3): 442-445
Parrin, A.P.; Netherton, S.E.; Bross, L.S.; McFadden, C.S.; Blackstone, N.W. 2010: Circulation of fluids in the gastrovascular system of a stoloniferan octocoral. Biological Bulletin 219(2): 112-121
Jahfari, S.; Coipan, E.C.; Fonville, M.; van Leeuwen, A.D.; Hengeveld, P.; Heylen, D.; Heyman, P.; van Maanen, C.; Butler, C.M.; Földvári, G.áb.; Szekeres, S.án.; van Duijvendijk, G.; Tack, W.; Rijks, J.M.; van der Giessen, J.; Takken, W.; van Wieren, S.E.; Takumi, K.; Sprong, H. 2014: Circulation of four Anaplasma phagocytophilum ecotypes in Europe. Parasites and Vectors 7: 365
Haldipur, B.P.; Walimbe, A.M.; Arankalle, V.A. 2014: Circulation of genotype-i hepatitis B virus in the primitive tribes of Arunachal Pradesh in early sixties and molecular evolution of genotype-i. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 27: 366-374
Reusken, C.B.E.M.; Lina, P.H.C.; Pielaat, A.; de Vries, A.; Dam-Deisz, C.; Adema, J.; Drexler, J.F.; Drosten, C.; Kooi, E.A. 2010: Circulation of group 2 coronaviruses in a bat species common to urban areas in Western Europe. Vector Borne and Zoonotic Diseases 10(8): 785-791
Sharma, R.; Bora, D.P.; Chakraborty, P.; Das, S.; Barman, N.N. 2013: Circulation of group a rotaviruses among neonates of human, cow and pig: study from Assam, a north eastern state of India. Indian Journal of Virology: An Official Organ of Indian Virological Society 24(2): 250-255
Medeiros, D.B.A.; da Rosa, E.S.T.; Marques, A. A.R.; Simith, D.B.; Carneiro, A.R.; Chiang, J.O.; Prazeres, I.T.E.; Vasconcelos, P.F.C.; Nunes, M.ár.R.T. 2010: Circulation of hantaviruses in the influence area of the Cuiabá-Santarém Highway. Memorias do Instituto Oswaldo Cruz 105(5): 665-671
Barde, P.V.; Shukla, M.K.; Pathak, R.; Kori, B.K.; Bharti, P.K. 2014: Circulation of hepatitis a genotype IIIA virus in paediatric patients in central India. Indian Journal of Medical Research 139(6): 940-944
Njouom, R.; Mba, S.A.S.; Noah, D.N.; Gregory, V.; Collins, P.; Cappy, P.; Hay, A.; Rousset, D. 2010: Circulation of human influenza viruses and emergence of Oseltamivir-resistant A(H1N1) viruses in Cameroon, Central Africa. Bmc Infectious Diseases 10: 56
Venezuela, R.F.; Kiguen, A.X.; Frutos, M.C.; Cuffini, C.G. 2012: Circulation of human papillomavirus (HPV) genotypes in women from Córdoba, Argentina, with squamous intraepithelial lesions. Revista do Instituto de Medicina Tropical de Sao Paulo 54(1): 11-16
Etemadi, M.R.; Sekawi, Z.; Othman, N.; Lye, M.-S.; Moghaddam, F.Y. 2013: Circulation of human respiratory syncytial virus strains among hospitalized children with acute lower respiratory infection in malaysia. Evolutionary Bioinformatics Online 9: 151-161
Krapez, U.; Slavec, B.; Rojs, O.Z. 2011: Circulation of infectious bronchitis virus strains from Italy 02 and QX genotypes in Slovenia between 2007 and 2009. Avian Diseases 55(1): 155-161
Ruether, I.G.A.; Tsakogiannis, D.; Kyriakopoulou, Z.; Dimitriou, T.G.; Papamichail, C.; Gartzonika, C.; Leveidiotou-Stefanou, S.; Markoulatos, P. 2014: Circulation of intergenotype recombinant noroviruses GII.9/GII.6 from 2006 to 2011 in central Greece. Virus Genes 48(1): 23-31
Hsieh, Y-C.; Chang, L-Y.; Huang, Y-C.; Lin, H-C.; Huang, L-M.; Hsueh, P-R. 2010: Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 16(7): 973-978
Leoz, M.; Chaix, M-Laure.; Delaugerre, C.; Rivoisy, C.; Meyer, L.; Rouzioux, C.; Simon, Fçois.; Plantier, J-Christophe. 2011: Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02. Aids 25(11): 1371-1377
Echevarría, J.E.; Castellanos, A.; Sanz, J.C.; Pérez, C.; Palacios, G.; Martínez de Aragón, M.V.; Peña Rey, I.; Mosquera, M.; de Ory, F.; Royuela, E. 2010: Circulation of mumps virus genotypes in Spain from 1996 to 2007. Journal of Clinical Microbiology 48(4): 1245-1254
Ke, C.; Lu, J.; Wu, J.; Guan, D.; Zou, L.; Song, T.; Yi, L.; Zeng, X.; Liang, L.; Ni, H.; Kang, M.; Zhang, X.; Zhong, H.; He, J.; Lin, J.; Smith, D.; Burke, D.; Fouchier, R.A.M.; Koopmans, M.; Zhang, Y. 2014: Circulation of reassortant influenza A(H7N9) viruses in poultry and humans, Guangdong Province, China, 2013. Emerging Infectious Diseases 20(12): 2034-2040
Benkouiten, S.; Charrel, R.ém.; Belhouchat, K.; Drali, T.; Salez, N.; Nougairede, A.; Zandotti, C.; Memish, Z.A.; al Masri, M.; Gaillard, C.; Parola, P.; Brouqui, P.; Gautret, P. 2013: Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 57(7): 992-1000
Loman, J.; Myerson, A. 1947: Circulation of the brain and face; determinations of oxygen and sugar in arterial and in internal and external jugular venous blood. Archives of Neurology and Psychiatry 57(1): 94-97
Cabral, C.Couto.; Morais, A.Carolina.Nunes.de.; Dias, A.Valéria.de.Almeida.Barcelos.; Araújo, M.Garcia.; Moreira, W.Cal.; Mattos, Gáucio.Luis.Mata. 2012: Circulation of the rabies virus in non-hematophagous bats in the city of Rio de Janeiro, Brazil, during 2001-2010. Revista da Sociedade Brasileira de Medicina Tropical 45(2): 180-183
Pétillon, J.-M. 2013: Circulation of whale-bone artifacts in the northern Pyrenees during the late Upper Paleolithic. Journal of Human Evolution 65(5): 525-543
Zareba, K.M. 2007: Circulation over the centuries: William Harvey (1578-1657). Cardiology journal 14(2): 214-215
Odiete, O.; Hill, M.F.; Sawyer, D.B. 2012: Neuregulin in cardiovascular development and disease. Circulation Research 111(10): 1376-1385
Felicilda-Reynaldo, R.F. 2013: Circulation savers: thrombolytic therapy. Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 22(6): 393-397
Zheng, P.-P.; Severijnen, L.-A.; Willemsen, R.; Kros, J.M. 2009: Circulation status of subintestinal vessels is a sensitive parameter for monitoring suboptimal systemic circulation in experimental zebrafish embryos. Cell Cycle 8(22): 3782-3783
Adams, H.A.; Vogt, P.M. 2009: Circulation therapy for severe burn injuries. Der Unfallchirurg 112(5): 462-471
Hay, E.B. 1947: Circulation time in the diagnosis and differential diagnosis of thyroid disease. Western Journal of Surgery Obstetrics and Gynecology 55(6): 329-337
Kwon, Y.; Khan, T.; Pritzker, M.; Iber, C. 2014: Circulation time measurement from sleep studies in patients with obstructive sleep apnea. Journal of Clinical Sleep Medicine: Jcsm: Official Publication of the American Academy of Sleep Medicine 10(7): 759
Moller, T. 1949: Circulation time studies by the fluorescein method with particular reference to morbus caeruleus. Bibliotheca Cardiologica 1(4): 171-179
Bruner, H.D.; Clark, J.K.; Barker, H.G. 1947: Circulation time through the kidney. Federation Proceedings 6(1): 312
Miller, B.J. 1948: Circulation time; an accurate indicator for objective measurement. Journal of Laboratory and Clinical Medicine 33(7): 910-918
Tanaka, Y.; Sanchez, V.; Takata, N.; Yokomizo, T.; Yamanaka, Y.; Kataoka, H.; Hoppe, P.S.; Schroeder, T.; Nishikawa, S.-I. 2014: Circulation-independent differentiation pathway from extraembryonic mesoderm toward hematopoietic stem cells via hemogenic angioblasts. Cell Reports 8(1): 31-39
Pletikosić, I.; von Rohr, F.; Pervan, P.; Das, P.K.; Vobornik, I.; Cava, R.J.; Valla, T. 2018: Band Structure of the IV-Vi Black Phosphorus Analog and Thermoelectric SnSe. Physical Review Letters 120(15): 156403
Faxon, D.P. 2008: Circulation: cardiovascular interventions: keeping pace with progress. CIRCULATION. Cardiovascular Interventions 1(1): 1-2
Krumholz, H.M.; Spertus, J.A. 2012: Circulation: cardiovascular quality and outcomes annual report, 2012. Circulation. Cardiovascular quality and outcomes 5(4): e28-e32
Krumholz, H.M. 2008: Circulation: cardiovascular quality and outcomes: scholarship to improve health and health care for patients and populations. CIRCULATION. Cardiovascular Quality and Outcomes 1(1): 1-3
Gray, S.; Cilia, M.; Ghanim, M. 2014: Circulative, "nonpropagative" virus transmission: an orchestra of virus-, insect-, and plant-derived instruments. Advances in Virus Research 89: 141-199
Brooks, W.D. 1936: Circulatory Adjustments in Polycythaemia Rubra Vera: (Section of Medicine). Proceedings of the Royal Society of Medicine 29(11): 1379-1383
Collins, H.N. 1914: Circulatory and Trophic Disturbances of the Extremities: An Attempt at Classification. Annals of Surgery 60(6): 742-749
Seevers, M.H.; Waters, R.M. 1931: Circulatory Changes during Spinal Anesthesia. California and Western Medicine 35(3): 169-173
Fraser, J. 1935: Circulatory Diseases of the Extremities. British Medical Journal 1(3869): 401-406
Holder, H.G.; McDougall, M.W. 1931: Circulatory Diseases of the Lower Extremities: With Special References to Tests of Capillary Circulation. Annals of Surgery 93(3): 645-648
Gatch, W.D.; Culbertson, C.G. 1935: Circulatory Disturbances Caused by Intestinal Obstruction. Annals of Surgery 102(4): 619-635
Reichert, F.L. 1929: Circulatory Disturbances of the Extremities: with Special Reference to Thrombo-Angiitis Obliterans and Elephantoid Conditions. California and Western Medicine 31(4): 233-237
Lee, W.E.; Freeman, N.E. 1940: Circulatory Disturbances Produced by Extensive Angiomata of the Lower Extremities Associated with Varicose Veins. Annals of Surgery 112(5): 960-968
Moffatt, C.F. 1927: Circulatory Failure in Acute and Chronic Cardiac Diseases: Myocarditis, Valvular Disease, and Auricular Fibrillation. Canadian Medical Association Journal 17(6): 643-646
Campbell, D.G. 1927: Circulatory Failure in Acute Infectious Diseases: Typhoid, Diphtheria, Scarlet Fever, and Measles. Canadian Medical Association Journal 17(6): 639-642
Meakins, J.C. 1927: Circulatory Failure in Chronic Intoxications and Vascular Disturbances: Hyperthyroidism, Chronic Anaemia, Chronic Nephritis, Diabetes, Hypertension. Canadian Medical Association Journal 17(6): 647-651
Eberts, E.M. 1927: Circulatory Failure in Haemorrhage, and Shock. Canadian Medical Association Journal 17(6): 637-639
McIntosh, R. 1942: Circulatory Failure in Acute Glomerulonephritis. Canadian Medical Association Journal 46(5): 445-449
Richards, D.W.; Cournand, A. 1939: Circulatory Failure in Bilateral Pneumothorax with High Intrapleural Carbon Dioxide. Transactions of the American Clinical and Climatological Association 55: 51-64
Sharpey-Schafer, E.P.; Wallace, J.; Latham, A.; Pincock, A.C. 1942: Circulatory Overloading after Rapid Intravenous Injections. British Medical Journal 2(4262): 304-308
Rodman, J.S.; Leaman, W.G. 1939: Circulatory Problems of Surgical Importance in the Diagnosis of Abdominal Lesions. Annals of Surgery 110(4): 766-785
Frazee, E.N.; Lee, S.J.; Kalimullah, E.A.; Personett, H.A.; Nelson, D.R. 2014: Circulatory Support with Venoarterial ECMO Unsuccessful in Aiding Endogenous Diltiazem Clearance after Overdose. Case Reports in Critical Care 2014: 969578
Stuber, T.; Scherrer, U. 2010: Circulatory adaptation to long-term high altitude exposure in Aymaras and Caucasians. Progress in Cardiovascular Diseases 52(6): 534-539
Taquini, A.C.; Fasciolo, J.C. 1947: Circulatory adaptations in Ayerza's syndrome; black cardiacs. American Heart Journal 34(1): 50-64
Hecht, H.H.; Jager, B.V. 1947: Circulatory adjustments during treatment with large doses of sodium salicylate or acetylsalicylic acid. Proceedings. American Federation for Clinical Research 3: 94
Brúsik, M.; Ukropec, J.; Joppa, P.; Ukropcová, B.; Skyba, P.; Baláž, M.; Pobeha, P.; Kurdiová, T.; Klimeš, I.; Tkáč, I.; Gašperíková, D.; Tkáčová, R. 2012: Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease. Physiological Research 61(5): 469-480
Karr, N.W. 1948: Circulatory and adrenolytic actions of DHE and DHO. Federation Proceedings 7(1 Part 1): 232
Yamada, K.; Shingu, K.; Kimura, H.; Ikeda, S.; Tsushima, K.; Imanishi, T.; Murao, K. 1997: Circulatory and catecholamine responses to tracheal intubation and skin incision during sevoflurane, isoflurane, or halothane anesthesia. Journal of Anesthesia 11(2): 111-116
Liu, X.; Iwanaga, K.; Koda, S. 2011: Circulatory and central nervous system responses to different types of mental stress. Industrial Health 49(3): 265-273
Overman, R.R.; Feldman, H.A. 1947: Circulatory and fluid compartment physiology in the normal monkey with especial reference to seasonal variations. American Journal of Physiology 148(2): 455-459
Slocum, H.C.; Hoeflich, E.A.; Allen, C.R. 1947: Circulatory and respiratory distress from extreme positions on the operating table. Surgery Gynecology and Obstetrics 84(6): 1051-1058
Brichant, J.-F.; Brichant, G.; Dewandre, P.-Y.; Foidart, J.-M. 2010: Circulatory and respiratory problems in preeclampsia. Annales Francaises d'Anesthesie et de Reanimation 29(4): E91-E95
Wan, H.; Loch Macdonald, R. 2011: Circulatory and vascular changes after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgical Sciences 55(4): 329-341
Chang, S.-Y.; Song, J.-H.; Guleng, B.; Cotoner, C.A.; Arihiro, S.; Zhao, Y.; Chiang, H.-S.; O'Keeffe, M.; Liao, G.; Karp, C.L.; Kweon, M.-N.; Sharpe, A.H.; Bhan, A.; Terhorst, C.; Reinecker, H.-C. 2013: Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation. Immunity 38(1): 153-165
Schebesch, K.-M.; Proescholdt, M.; Ullrich, O.-W.; Camboni, D.; Moritz, S.; Wiesenack, C.; Brawanski, A. 2010: Circulatory arrest and deep hypothermia for the treatment of complex intracranial aneurysms--results from a single European center. Acta Neurochirurgica 152(5): 783-792
Cummings, B.; Noviski, N.; Moreland, M.P.; Paris, J.J. 2009: Circulatory arrest in a brain-dead organ donor: is the use of cardiac compression permissible?. Journal of Intensive Care Medicine 24(6): 389-392
Zdolsek, H.J.; Holmgren, S.; Wedenberg, K.; Lennmarken, C. 2009: Circulatory arrest in late pregnancy: caesarean section a vital decision for both mother and child. Acta Anaesthesiologica Scandinavica 53(6): 828-829
Hiestand, B.C. 2009: Circulatory assist devices in heart failure patients. Heart Failure Clinics 5(1): 55-62 Vi
Yamashita, M.; Ando, M.; Higuchi, Y.; Akita, K.; Tochii, M.; Ishida, M.; Kaneko, K.; Sato, M.; Takagi, Y. 2009: Circulatory assistance and surgery for residual pulmonary hypertension following thromboendarterectomy. Annals of Vascular Diseases 2(3): 144-147
Hermansen, S.E.; Naesheim, T.; How, O-Jakob.; Myrmel, T. 2009: Circulatory assistance in acute heart failure--where do we go from here?. Scandinavian Cardiovascular Journal: Scj 43(4): 211-216
Nau, J.-Y. 2009: Circulatory assistance in refractory heart arrest: for whom? (2). Revue Medicale Suisse 5(186): 153
Reiss, N.; Körfer, R. 2007: Circulatory assistance in small infants and neonates with a hydraulically driven system: a viable option?. Journal of Artificial Organs: the Official Journal of the Japanese Society for Artificial Organs 10(4): 195-200
Nylin, G. 1947: Circulatory blood volume of some organs. American Heart Journal 34(2): 174-179
Papadopoulou, V.; Tang, M.-X.; Balestra, C.; Eckersley, R.J.; Karapantsios, T.D. 2014: Circulatory bubble dynamics: from physical to biological aspects. Advances in Colloid and Interface Science 206: 239-249
Epple, A.; Hathaway, C.B.; Nibbio, B. 1989: Circulatory catecholamines in the eel: origins and functions. Fish Physiology and Biochemistry 7(1-6): 273-278
Dripps, R.D. 1946: Circulatory changes during spinal anesthesia: their physiological basis. Surgical Clinics of North America 26: 1377-1388
Ray, T.; Burch, G. 1947: Circulatory changes following ligation of the inferior vena cava. Proceedings. American Federation for Clinical Research 3: 41
Haynes, F.W.; Kinney, T.D. 1947: Circulatory changes in experimental pulmonary embolism. Federation Proceedings 6(1 Part 2): 125
Lyman, C.P.; O'brien, R.C. 1961: Circulatory changes in the 13-lined ground squirrel during the hibernating cycle. Technical Report.; Tr. Arctic Aeromedical Laboratory 60(24): 1-18
Tan, B.K.; Chen, J.; Hu, J.; Amar, O.; Mattu, H.S.; Ramanjaneya, M.; Patel, V.; Lehnert, H.; Randeva, H.S. 2014: Circulatory changes of the novel adipokine adipolin/CTRP12 in response to metformin treatment and an oral glucose challenge in humans. Clinical Endocrinology 81(6): 841-846
Watkins, E. 1947: Circulatory changes produced by clamping of the thoracic aorta. Surgery 22(3): 530-539
Mariappan, R.; Manninen, P.; Massicotte, E.M.; Bhatia, A. 2013: Circulatory collapse after topical application of vancomycin powder during spine surgery. Journal of Neurosurgery. Spine 19(3): 381-383
So, M.; Ito, H.; Sobue, K.; Tsuda, T.; Katsuya, H. 2007: Circulatory collapse caused by unnoticed hypermagnesemia in a hospitalized patient. Journal of Anesthesia 21(2): 273-276
Powers, B.R. 1948: Circulatory collapse following intravenous administration of nicotinic acid. Annals of Internal Medicine 29(3): 558-560
Lau, K.K.; Chan, K.W.; Lok, C.M.; Lam, A.W.S.; Lee, H.H.C.; Luk, W.F.; Mak, C.M.; Ching, C.K.; Lo, J.; Li, S.M.; Chan, A.Y.W. 2009: Circulatory collapse in a patient with gastrinoma after metoclopramide administration. Hong Kong Medical Journal 15(6): 478-481
Ravn, T.; Afshari, A.; Nielsen, J.S. 2010: Circulatory collapse in bodybuilder during anaesthesia. Ugeskrift for Laeger 172(29): 2094-2095
Juhl-Olsen, P.; Frederiksen, C.Alcaraz.; Jacobsen, C-Johan.; Sloth, E. 2010: Circulatory collapse in bodybuilder in connection with anesthesia. Ugeskrift for Laeger 172(35): 2403; Author Reply 2403
Franklin, K.J. 1948: Circulatory concepts. St. Bartholomew's Hospital Journal 52(1): 2; Passim
Molnár, G.; Csonka, E.; Vass, A.; Boros, Mály.; Kaszaki, J. 2011: Circulatory consequences of reduced endogenous nitric oxide production during small-volume resuscitation. Acta Physiologica Hungarica 98(4): 393-408
Nylin, G.; Biorck, G. 1947: Circulatory corpuscle and blood volume in a case of patent ductus arteriosus before and after ligation. Acta Medica Scandinavica 127(4): 434-438
Bernat, J.L.; Bleck, T.P.; Blosser, S.A.; Bratton, S.L.; Capron, A.M.; Cornell, D.; DeVita, M.A.; Fulda, G.J.; Glazier, A.K.; Gries, C.J.; Mathur, M.; Nakagawa, T.A.; Shemie, S.D. 2014: Circulatory death determination in uncontrolled organ donors: a panel viewpoint. Annals of Emergency Medicine 63(4): 384-390
Papper, E.M.; Reaves, D.P. 1947: Circulatory depression during controlled respiration; a case report. Anesthesiology 8(4): 407-409
Nunes, K.V.R.; Ignotti, E.; Hacon, S.d.S. 2013: Circulatory disease mortality rates in the elderly and exposure to PM(2.5) generated by biomass burning in the Brazilian Amazon in 2005. Cadernos de Saude Publica 29(3): 589-598
Chun, B.-Y. 2007: Circulatory disease surveillance system in Korea. Journal of Preventive Medicine and Public Health 40(4): 273-277
Guy, W. 1948: Circulatory diseases affecting the skin. Pennsylvania Medical Journal 51(10): 1098-1100
Schweisheimer, W. 1947: Circulatory diseases, 1947. Trained Nurse and Hospital Review 119(4): 277-280
Brunkhorst, R.; Lorenzen, H.P.; Zeller, T. 2009: Circulatory disorders of the renal and mesenteric arteries. Der Internist 50(8): 952-957
Yurugi, Y.; Maeta, H.; Ohno, T.; Hosoya, K.; Matsumura, A.; Nishimura, K.; Miyasaka, S.; Morimoto, K. 2013: Circulatory disturbance of middle lobe by bending of lobar pedicle after right upper lobectomy. Kyobu Geka. Japanese Journal of Thoracic Surgery 66(12): 1079-1082
Furukawa, S.; Sameshima, H.; Ikenoue, T. 2008: Circulatory disturbances during the first postnatal 24 hours in extremely premature infants 25 weeks or less of gestation with histological fetal inflammation. Journal of Obstetrics and Gynaecology Research 34(1): 27-33
Limarzi, L.R. 1948: Circulatory disturbances in hematologic disorders. Bulletin. Chicago Medical Society 51(3): 43-48
Baxter, J.H. 1948: Circulatory disturbances in hepatic and renal cortical necrosis. Federation Proceedings 7(1 Part 1): 145
Zaki, A.; Ragab, M.M. 1948: Circulatory dynamics in cholera; their mechanism and prognostic significance. Journal of the Egyptian Medical Association 31(10): 770-785
Gillanders, A.D. 1949: Circulatory dynamics in emphysema. Quarterly Journal of Medicine 18(71): 263-273
Joulia, F.; Lemaitre, F.; Fontanari, P.; Mille, M.L.; Barthelemy, P. 2009: Circulatory effects of apnoea in elite breath-hold divers. Acta Physiologica 197(1): 75-82
Noponen, T.; Nordh, A.; Berg, A.; Ley, D.; Hansson, S.R.; Pesonen, E.; Fellman, V. 2009: Circulatory effects of inhaled iloprost in the newborn preterm lamb. Pediatric Research 66(4): 416-422
Opdyke, D.F. 1946: Circulatory effects of partial cerebral ischemia. American Journal of Physiology 146: 467-477
Rushmer, R.F. 1947: Circulatory effects of three modifications of the Valsalva experiment: an experimental survey. American Heart Journal 34(3): 399-418
McMICHAEL, J. 1946: Circulatory failure. Schweizerische Medizinische Wochenschrift 76(37-38): 851-857
Vakil, R.J. 1946: Circulatory failure and its treatment. Indian Physician 5(9): 216; Passim
Opdyke, D.F. 1946: Circulatory failure induced by partial cerebral ischemia. Federation Proceedings 5(1 Part 2): 77
McMICHAEL, J. 1947: Circulatory failure studied by means of venous catheterization. Advances in Internal Medicine 2: 64-101
Webb, R.L.; Nicoll, P.A. 1947: Circulatory flow pattern in the bat's wing. Anatomical Record 97(3): 431
Li, W.-q.; Ni, H.-b.; Ke, L. 2012: Circulatory function supports for severe acute pancreatitis complicated with intra-abdominal hypertension. Zhonghua Yi Xue Za Zhi 92(45): 3189-3190
Miyajima, Y.; Tohyama, T.; Nanbu, Y.; Ohe, H.; Horita, H.; Sakai, Y.; Wada, T. 2011: Circulatory function test for the diagnosis of diabetic complications. Rinsho Byori. Japanese Journal of Clinical Pathology 59(11): 1043-1049
Burté, F.; Brown, B.J.; Orimadegun, A.E.; Ajetunmobi, W.A.; Afolabi, N.K.; Akinkunmi, F.; Kowobari, O.; Omokhodion, S.; Osinusi, K.; Akinbami, F.O.; Shokunbi, W.A.; Sodeinde, O.; Fernandez-Reyes, D. 2013: Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria. Blood 121(15): 3016-3022
Khan, R.; Gupta, S.; Sharma, A. 2012: Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-β) in patients with vitiligo. Journal of the American Academy of Dermatology 66(3): 510-511
Khan, R.; Satyam, A.; Gupta, S.; Sharma, V.K.; Sharma, A. 2009: Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo. Archives of Dermatological Research 301(10): 731-737
Clark, T.D.; Sandblom, E.; Cox, G.K.; Hinch, S.G.; Farrell, A.P. 2008: Circulatory limits to oxygen supply during an acute temperature increase in the Chinook salmon (Oncorhynchus tshawytscha). American Journal of Physiology. Regulatory Integrative and Comparative Physiology 295(5): R1631-R1639
Osaki, S.; Ishino, K.; Kotani, Y.; Honjo, O.; Suezawa, T.; Kohmoto, T.; Sano, S. 2009: Circulatory load during hypoxia impairs post-transplant myocardial functional recovery in donation after cardiac death. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 28(3): 266-272
Rodriguez Barrios, R. 1947: Circulatory mechanism of the iris. Archives of Ophthalmology 38(3): 406
Srivastava, A.; Goldberger, H.; Dimtchev, A.; Marian, C.; Soldin, O.; Li, X.; Collins, S.P.; Suy, S.; Kumar, D. 2014: Circulatory miR-628-5p is downregulated in prostate cancer patients. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(5): 4867-4873
Li, X.; Khanna, A.; Li, N.; Wang, E. 2011: Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging 3(10): 985-1002
Gan, C.S.; Wang, C.W.; Tan, K.S. 2012: Circulatory microRNA-145 expression is increased in cerebral ischemia. Genetics and Molecular Research: Gmr 11(1): 147-152
Weiss, M.; Reekers, M.; Vuyk, J.; Boer, F. 2011: Circulatory model of vascular and interstitial distribution kinetics of rocuronium: a population analysis in patients. Journal of Pharmacokinetics and Pharmacodynamics 38(2): 165-178
Mok, Y.; Nakayama, D.; Noh, M.; Jang, S.; Kim, T.; Lee, Y. 2013: Circulatory osmotic desalination driven by a mild temperature gradient based on lower critical solution temperature (LCST) phase transition materials. Physical Chemistry Chemical Physics: Pccp 15(44): 19510-19517
Pobeha, P.; Petrasova, D.; Tkacova, R.; Joppa, P. 2014: Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD. Respiratory Medicine 108(4): 621-627
Dimitrova, G.; Kato, S.; Fukushima, H.; Yamashita, H. 2009: Circulatory parameters in the retrobulbar central retinal artery and vein of patients with diabetes and medically treated systemic hypertension. Graefe's Archive for Clinical and Experimental Ophthalmology 247(1): 53-58
Dripps, R.D.; Comroe, J.H. 1946: Circulatory physiology; the adjustment to blood loss and postural changes. Surgical Clinics of North America 26: 1368-1376